
<html lang="en"     class="pb-page"  data-request-id="e89c0ce4-f904-4a38-8184-f987694609f5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm1003073;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-12"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity" /></meta><meta name="dc.Creator" content="Martina  Hieke" /></meta><meta name="dc.Creator" content="Julia  Ness" /></meta><meta name="dc.Creator" content="Ramona  Steri" /></meta><meta name="dc.Creator" content="Michaela  Dittrich" /></meta><meta name="dc.Creator" content="Christine  Greiner" /></meta><meta name="dc.Creator" content="Oliver  Werz" /></meta><meta name="dc.Creator" content="Karlheinz  Baumann" /></meta><meta name="dc.Creator" content="Manfred  Schubert-Zsilavecz" /></meta><meta name="dc.Creator" content="Sascha  Weggen" /></meta><meta name="dc.Creator" content="Heiko  Zettl" /></meta><meta name="dc.Description" content="We present a novel class of dual modulators of γ-secretase and peroxisome proliferator-activated receptor γ (PPARγ) based on the structure of 2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid 8 (..." /></meta><meta name="Description" content="We present a novel class of dual modulators of γ-secretase and peroxisome proliferator-activated receptor γ (PPARγ) based on the structure of 2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid 8 (..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 26, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1003073" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1003073" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1003073" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1003073" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1003073" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0006.jpeg" /></meta><meta property="og:description" content="We present a novel class of dual modulators of γ-secretase and peroxisome proliferator-activated receptor γ (PPARγ) based on the structure of 2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid 8 (IC50(Aβ42) = 22.8 μM, EC50(PPARγ) = 8.3 μM). The modulation of both targets with approved drugs (i.e., amyloid-β 42 (Aβ42)-lowering NSAIDs for γ-secretase and glitazones for PPARγ) has demonstrated beneficial effects in in vitro and in vivo models of Alzheimer’s disease (AD). However, although NSAIDs and PPARγ agonists share similar structural features, no druglike compounds with dual activities as γ-secretase modulators (GSMs) and PPARγ agonists have been designed so far. On the basis of our initial lead structure 8, we present the structure−activity relationships (SARs) of broad structural variations. A significant improvement was reached by the introduction of p-trifluoromethyl substituents at the phenyl residues yielding compound 16 (IC50(Aβ42) = 6.0 μM, EC50(PPARγ) = 11.0 μM) and the replacement of the two phenyl residues of 8 by cyclohexyl yielding compound 22 (IC50(Aβ42) = 5.1 μM, EC50(PPARγ) = 6.6 μM)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1003073"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1003073">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1003073&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1003073&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1003073&amp;href=/doi/10.1021/jm1003073" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4691-4700</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1002588" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100395q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Hieke">Martina Hieke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julia++Ness">Julia Ness</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramona++Steri">Ramona Steri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michaela++Dittrich">Michaela Dittrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Greiner">Christine Greiner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Werz">Oliver Werz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karlheinz++Baumann">Karlheinz Baumann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manfred++Schubert-Zsilavecz">Manfred Schubert-Zsilavecz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sascha++Weggen">Sascha Weggen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heiko++Zettl">Heiko Zettl</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institute of Pharmaceutical Chemistry, ZAFES/LiFF/Goethe University Frankfurt, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Molecular Neuropathology Group, Department of Neuropathology, Heinrich-Heine University Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmaceutical Analytics, Eberhard-Karls University Tuebingen, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Pharmaceuticals Division, Preclinical Research CNS, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For S.W.: phone, +49 (211) 8104506; fax, +49 (211) 8104577; e-mail, <a href="/cdn-cgi/l/email-protection#512226343636343f11243f387c3524342222343d353e23377f3534"><span class="__cf_email__" data-cfemail="215256444646444f61544f480c4554445252444d454e53470f4544">[email protected]</span></a>. For H.Z.: phone, +41 (44) 6339113; fax, +41 (44) 6331379; e-mail, <a href="/cdn-cgi/l/email-protection#29414c40424607534c5d5d45695941485b4448074c5d4153074a41"><span class="__cf_email__" data-cfemail="80e8e5e9ebefaefae5f4f4ecc0f0e8e1f2ede1aee5f4e8faaee3e8">[email protected]</span></a></div><div class="corresp-fn" id="fn1">⊥Present address: ETH Zurich, Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1003073&amp;href=/doi/10.1021%2Fjm1003073" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4691–4700</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 26, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 March 2010</li><li><span class="item_label"><b>Published</b> online</span>26 May 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 June 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1003073" title="DOI URL">https://doi.org/10.1021/jm1003073</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4691%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartina%2BHieke%252C%2BJulia%2BNess%252C%2BRamona%2BSteri%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D12%26contentID%3Djm1003073%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2Ba%2BNovel%2BClass%2Bof%2B%25CE%25B3-Secretase%2BModulators%2Bwith%2BPPAR%25CE%25B3%2BActivity%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4700%26publicationDate%3DJune%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1003073"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2088</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1003073" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Hieke&quot;},{&quot;first_name&quot;:&quot;Julia&quot;,&quot;last_name&quot;:&quot;Ness&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;Steri&quot;},{&quot;first_name&quot;:&quot;Michaela&quot;,&quot;last_name&quot;:&quot;Dittrich&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Greiner&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Werz&quot;},{&quot;first_name&quot;:&quot;Karlheinz&quot;,&quot;last_name&quot;:&quot;Baumann&quot;},{&quot;first_name&quot;:&quot;Manfred&quot;,&quot;last_name&quot;:&quot;Schubert-Zsilavecz&quot;},{&quot;first_name&quot;:&quot;Sascha&quot;,&quot;last_name&quot;:&quot;Weggen&quot;},{&quot;first_name&quot;:&quot;Heiko&quot;,&quot;last_name&quot;:&quot;Zettl&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;4691-4700&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1003073&quot;},&quot;abstract&quot;:&quot;We present a novel class of dual modulators of γ-secretase and peroxisome proliferator-activated receptor γ (PPARγ) based on the structure of 2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid 8 (IC50(Aβ42) = 22.8 μM, EC50(PPARγ) = 8.3 μM). The modulation of both targets with approved drugs (i.e., amyloid-β 42 (Aβ42)-lowering NSAIDs for γ-secretase and glitazones for PPARγ) has demonstrated beneficial effects in in vitro and in vivo models of Alzheimer’s disease (AD). However, although NSAIDs and PPARγ agonists share similar structural features, no druglike compounds with dual activities as γ-secretase modulators (GSMs) and PPARγ agonists have been designed so far. On the basis of our initial lead structure 8, we present the structure−activity relationships (SARs) of broad structural variations. A significant improvement was reached by the introduction of p-trifluoromethyl substituents at the phenyl residues yielding compound 16 (IC50(Aβ42) = 6.0 μM, EC50(PPARγ) = 11.0 μM) and the replacement of the two phen&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1003073&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003073" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1003073&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003073" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1003073&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003073" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1003073&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003073&amp;href=/doi/10.1021/jm1003073" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1003073" /></input><a href="/doi/pdf/10.1021/jm1003073" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1003073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1003073%26sid%3Dliteratum%253Aachs%26pmid%3D20503989%26genre%3Darticle%26aulast%3DHieke%26date%3D2010%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2Ba%2BNovel%2BClass%2Bof%2B%25CE%25B3-Secretase%2BModulators%2Bwith%2BPPAR%25CE%25B3%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D12%26spage%3D4691%26epage%3D4700%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We present a novel class of dual modulators of γ-secretase and peroxisome proliferator-activated receptor γ (PPARγ) based on the structure of 2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid <b>8</b> (IC<sub>50</sub>(Aβ42) = 22.8 μM, EC<sub>50</sub>(PPARγ) = 8.3 μM). The modulation of both targets with approved drugs (i.e., amyloid-β 42 (Aβ42)-lowering NSAIDs for γ-secretase and glitazones for PPARγ) has demonstrated beneficial effects in in vitro and in vivo models of Alzheimer’s disease (AD). However, although NSAIDs and PPARγ agonists share similar structural features, no druglike compounds with dual activities as γ-secretase modulators (GSMs) and PPARγ agonists have been designed so far. On the basis of our initial lead structure <b>8</b>, we present the structure−activity relationships (SARs) of broad structural variations. A significant improvement was reached by the introduction of <i>p</i>-trifluoromethyl substituents at the phenyl residues yielding compound <b>16</b> (IC<sub>50</sub>(Aβ42) = 6.0 μM, EC<sub>50</sub>(PPARγ) = 11.0 μM) and the replacement of the two phenyl residues of <b>8</b> by cyclohexyl yielding compound <b>22</b> (IC<sub>50</sub>(Aβ42) = 5.1 μM, EC<sub>50</sub>(PPARγ) = 6.6 μM).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: Aβ, amyloid β peptide; AD, Alzheimer’s disease; APP, amyloid precursor protein; COX, cyclooxygenase; GSM, γ-secretase modulator; NSAIDs, nonsteroidal anti-inflammatory drugs; PPAR, peroxisome proliferator-activated receptor; SAR structure−activity relationship.</p></div> is the most common age-related cause of dementia with 26.6 million patients worldwide in 2006 and over a 100 million predicted cases by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The cardinal symptom of the disease is progressive memory loss due to the degeneration of neurons and synapses in the cerebral cortex and subcortical regions of the brain. The neuropathology of AD is characterized by the extracellular deposition of amyloid-β (Aβ) plaques, the formation of intracellular neurofibrillary tangles, chronic brain inflammation, and oxidative damage.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> According to the modified amyloid hypothesis, small soluble oligomers of Aβ peptides, particularly those formed by the highly hydrophobic Aβ42 species, are the disease-initiating agents in AD.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Aβ42 is a proteolytic fragment resulting from sequential cleavage of the amyloid precursor protein (APP) by two aspartyl proteases, i.e., β-secretase and γ-secretase. Currently, a variety of potentially disease-modifying therapeutic approaches are under development that target the production, aggregation, or clearance of Aβ peptides in brain (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Substantial advances have been made with respect to inhibitors of the γ-secretase enzyme, a multiprotein complex that catalyzes the final step in the cellular generation of Aβ peptides. However, because of its essential role in the NOTCH signaling pathway, mechanism-based toxicity with severe phenotypes in the gastrointestinal and hematopoietic systems has been observed in preclinical studies of γ-secretase inhibitors<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> and might be a limiting factor in clinical efficacy. Intriguingly, a subset of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and indomethacin were found to modulate the γ-secretase activity in a way that allowed selective inhibition of Aβ42 production (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These compounds, termed γ-secretase-modulators (GSMs), shifted the proteolytic processing of APP toward higher production of shorter Aβ species such as Aβ38 at the expense of the highly toxic Aβ42. Importantly, impairment of NOTCH processing and signaling was not observed.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Unfortunately, these NSAID-type GSMs suffer from low potency against γ-secretase (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), poor brain permeability, and side effects related to inhibition of cyclooxygenases (COX) such as gastrointestinal toxicity and increased cardiovascular mortality.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Consequently, NSAID-type GSMs and derived analogues, whose consumption appeared to confer a reduced risk for AD in epidemiological studies, have produced negative or inconclusive clinical results in patients suffering from established AD<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> or showed unacceptable side effects for long-term treatment. Recently, potent GSMs with favorable pharmacological properties have emerged.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Amyloid Cascade</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. In vitro pharmacology of γ-secretase-modulating NSAIDs.<a onclick="showRef(event, 'ref15 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref15 ref47 ref48 ref49">(15, 47-49)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, some NSAIDs including the GSMs indomethacin and ibuprofen function as agonists of the peroxisome proliferator-activated receptor γ (PPARγ).<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> PPARγ belongs to a family of ligand-activated nuclear receptors that act as lipid sensors, and synthetic ligands for PPARγ include the widely prescribed antidiabetic drugs rosiglitazone and pioglitazone.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Evidence indicates that PPARγ agonists might have multiple beneficial effects in AD both on core pathological processes in brain and on peripheral factors such as serum glucose levels and insulin sensitivity that constitute potential risk factors for AD.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Several studies have demonstrated that AD is associated with perturbations in insulin metabolism, and diet-induced insulin resistance caused increased brain Aβ levels and plaque formation in a mouse model of AD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, a recent cross of an AD mouse model to leptin-deficient diabetic mice revealed accelerated learning deficits and severe cerebrovascular amyloid deposition.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Importantly, individuals with type 2 diabetes appear to have a 2-fold increased risk of developing AD.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Potential direct effects of PPARγ agonists on brain pathology in AD include lowering of Aβ levels, suppression of toxic proinflammatory mediators, and reduction of cerebrovascular impairment.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29 ref30">(25-30)</a> Recently, a phase III clinical study with the brain-impermeable PPARγ agonist rosiglitazone failed to demonstrate efficacy in patients with established AD.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, PPARγ agonists might be able to counteract the increased AD risk in patients with type 2 diabetes, and in fact, ongoing treatment and prevention trials for type 2 diabetes include cognition ancillary studies.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In this respect, a pilot study with the PPARγ agonist pioglitazone has provided evidence for cognitive stabilization in AD patients with concurrent type 2 diabetes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Notably, pioglitazone has been shown to have at least limited blood−brain barrier permeability.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">In summary, small molecules with dual GSM and PPARγ agonist activity could be a novel strategy for prevention of AD, particularly in patients with type 2 diabetes. In an initial screening of our in-house compound library, we have identified compound <b>8</b> (2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid) that displayed a typical GSM profile and concentration-dependently and selectively decreased Aβ42 levels with a concomitant increase in Aβ38 production (IC<sub>50</sub>(Aβ42) = 22.8 μM, EC<sub>50</sub>(Aβ38) = 11.3 μM, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Additionally, compound <b>8</b> is a subtype-selective PPARγ modulator (EC<sub>50</sub> = 8.3 μM, 60% max activation). Here, we describe the structure−activity relationships (SARs) of a novel class of dual γ-secretase/PPARγ modulators based on the scaffold of compound <b>8</b>. Our strategy aimed at improving the GSM activity while maintaining PPARγ agonism. Characteristic structural features of compound <b>8</b> are a carboxylic acid headgroup and two phenethyl residues forming a lipophilic backbone. As conventional NSAIDs have similar structural features, we further determined the inhibitory activity of all compounds for COX-1 and COX-2.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compound <b>8</b> and its impact on Aβ38, Aβ40, and Aβ42 formation. SARs based on <b>8</b> were obtained by structural modifications of the encircled residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthetic procedure of the compounds is illustrated in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Presented compounds were prepared in a three-step reaction, which has been described previously by Koeberle et al.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> First, a nucleophilic substitution between thiobarbituric acid and the respective α-bromoethyl ester using dimethylformamide (DMF) as solvent and triethylamine (TEA) as corresponding base was carried out. This step was followed by the etherification of the two hydroxyl groups, either by a Mitsunobu reaction or by a Williamson ether synthesis. In the case of the Mitsunobu reaction, we used the precursor, the respective alcohol, triphenylphosphine (TPP), and diethylazodicarboxylate (DEAD) and stirred the solution at room temperature under argon atmosphere.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The Williamson ether synthesis was carried out with the respective alkyl halogenide, K<sub>2</sub>CO<sub>3</sub>, and DMF at 80 °C. Finally, the ester group was hydrolyzed with LiOH in tetrahydrofuran (THF) and H<sub>2</sub>O to yield final compounds <b>6</b>−<b>25</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route of Compounds <b>6</b>−<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-bromo-<i>(R</i><sup>1</sup>)-ethyl acetate (1.5 equiv), thiobarbituric acid (1 equiv), TEA (1.5 equiv), DMF, 80 °C, 4 h; (iia) <b>6a</b>−<b>10a</b> (1 equiv), R<sup>2</sup>-Hal (2.1 equiv), K<sub>2</sub>CO<sub>3</sub> (2.3 equiv), DMF, 80 °C, 3−28 h or (iib) <b>6a</b>−<b>10a</b> (1 equiv), R<sup>2</sup>-OH (2 equiv), DEAD (2.5 equiv), TPP (2.5 equiv), THF, room temp, 1−3 h; (iii) LiOH (5 equiv), THF/MeOH, H<sub>2</sub>O, 25−50 °C, 2−24 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Biological Assays</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">PPAR activity of the final compounds was tested in a cellular luciferase-based PPAR transactivation assay, which has been described previously.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Final compounds <b>6</b>−<b>25</b> were fully characterized on all PPAR subtypes (α, γ, and δ). Since every derivative described in this paper was inactive on PPARα and PPARδ (tested concentration of 10 μM), the following discussion is only focused on PPARγ activity. For biological characterization of GSM activity, we measured the levels of Aβ38, Aβ40, and Aβ42 peptides in cell supernatants with an ELISA assay as described with some modifications.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Inhibition of COX was tested in a cell-free assay using isolated ovine COX-1 and human recombinant COX-2 enzymes.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Potential effects on proteolytic processing of NOTCH were investigated for the two compounds with the highest GSM activity using a previously described reporter assay.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Cytotoxicity of all compounds was determined using alamar blue reagent.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an initial screening of our in-house-library we have identified 2-(bis(phenethoxy)pyrimidine-2-ylthio)hexanoic acid <b>8</b>, a selective PPARγ modulator that displayed the characteristic GSM activity with IC<sub>50</sub>(Aβ42) = 22.8 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). As the first hit, compound <b>8</b> served as the structural template for all presented derivatives. Important structural features of <b>8</b> are two 2-phenethyl residues forming a lipophilic backbone and a carboxylic acid function as headgroup. This acidic headgroup is an essential structural element required for PPARγ activation<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and of NSAID-type GSMs.<a onclick="showRef(event, 'ref15 ref40'); return false;" href="javascript:void(0);" class="ref ref15 ref40">(15, 40)</a> Therefore, we have not modified the carboxylic acid group and focused our efforts on the remaining parts of lead structure <b>8</b>.</div><div class="NLM_p">In previous studies, we have observed that the length of the alkyl chain of α-substituted pirinixic acid derivatives has a high impact on PPAR activity.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Hence, we systematically varied this position by elongation and shortening of the α-<i>n</i>-butyl residue as well as by introduction of a α-phenyl residue (compounds <b>6</b>−<b>10</b>; see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The inhibitory activity on Aβ42 production showed clear SAR depending on the length of the α-alkyl chain. Removal of the α-chain (compound <b>6</b>, R<sup>1</sup> = H) caused a complete loss of GSM activity. In line with this observation, compound <b>7</b> with the shorter ethyl residue showed only weak GSM activity (IC<sub>50</sub>(Aβ42) = 41.6 μM). A slight decrease of GSM activity was also observed after elongation to <i>n</i>-hexyl (compound <b>9</b>). In regard to PPARγ activation, the length of the α-alkyl chain did not considerably influence the activity (EC<sub>50</sub> values of <b>6</b>−<b>9</b> between 3 and 9 μM, with a tendency for decreased activity with longer chains). Phenyl-substituted <b>10</b> showed no PPARγ activity and can thus be described as a conventional GSM. With an IC<sub>50</sub> of 29.3 μM for Aβ42 inhibition, compound <b>10</b> is somewhat less potent compared to the lead structure. Together, the initial <i>n</i>-butyl chain (<b>8</b>) turned out to have the optimal chain length in α-position for dual modulation of γ-secretase and PPARγ. Interestingly, it was possible to modify the activity profile toward a conventional GSM by the introduction of a bulky phenyl moiety in α-position to the carboxylic acid.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PPARγ Activation and γ-Secretase Modulation (Determined by Aβ42 Inhibition and Aβ38 Activation) of Compounds <b>6</b>−<b>25</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0005.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Inactive: tested concentration of 10 μM.</p></div></div></div><div class="NLM_p">On the basis of previous studies where we have assessed the influence of the stereochemical configuration of some α-alkyl substituted pirinixic acid derivatives on PPAR activity,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> we decided to investigate the stereochemical impact on the biological activity of <b>8</b>. We have separated <b>8</b> into its single enantiomers (<b>8c</b> and <b>8d</b>) using enantioselective preparative HPLC.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> While the (<i>R</i>)-enantiomer <b>8c</b> (IC<sub>50</sub>(Aβ42) = 21.5 μM) showed slightly superior activity compared to the (<i>S</i>)-enantiomer (<b>8d</b>) (IC<sub>50</sub>(Aβ42) = 32.6 μM) on γ-secretase, the results on PPARγ were vice versa (<b>8c</b>, 22% activation at 10 μM; <b>8d</b>, EC<sub>50</sub> = 10.4 μM). In summary, we were not able to identify any superior biological activity of one enantiomer. Thus, the stereocenter in the α-position of the carboxylic acid does not cause a significant impact on γ-secretase and PPARγ activity.</div><div class="NLM_p">Most space for structural modifications is provided by the two ether substituents of the central pyrimidine core of lead structure <b>8</b>. First, we elongated and shortened the aliphatic spacer between the two ether moieties and the phenyl residues (compounds <b>11</b>−<b>13</b>). Compound <b>11</b> (IC<sub>50</sub>(Aβ42) = 25.2 μM) with a shorter methylene and compound <b>13</b> with a longer butylene spacer were almost equipotent on γ-secretase compared to <b>8</b>, whereas the elongation to a propylene spacer (<b>12</b>) led to a decreased potency. In regard to PPARγ activation, the methylene analogue <b>11</b> showed a substantially decreased activity. The elongation to propylene and butylene spacers (<b>12</b> and <b>13</b>) did not cause considerable changes in PPARγ activity.</div><div class="NLM_p">Second, we introduced different substituents in para-position of both phenyl moieties based on lead structure <b>8</b>. Methyl (compound <b>14</b>) and methoxy (<b>15</b>) substituents increased GSM activity with methyl (IC<sub>50</sub>(Aβ42) = 13.0 μM) being slightly superior to methoxy (IC<sub>50</sub>(Aβ42) = 19.3 μM). Further improvement of Aβ42 inhibition was finally achieved by introduction of trifluoromethyl (<b>16</b>) (IC<sub>50</sub>(Aβ42) = 6.0 μM, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) and trifluoromethoxy moieties (<b>17</b>) (IC<sub>50</sub>(Aβ42) = 8.6 μM), which belong to the most potent GSMs from this series. Compounds <b>16</b> and <b>17</b> modulate PPARγ with an EC<sub>50</sub> of about 10 μM. In contrast to these four derivatives, introduction of nitro (<b>18</b>), cyano (<b>19</b>), and the bioisosteric replacement of both benzenes by thiophene (<b>20</b>) caused a clear decrease of GSM activity with IC<sub>50</sub> values above 30 μM.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GSM activity of compounds <b>16</b> and <b>22</b>: dose−response curves for Aβ40, Aβ42, and Aβ38 formation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, we replaced the phenyl moieties by aliphatic rings of various sizes. Substitution with cycloheptyl (<b>21</b>), cyclohexyl (<b>22</b>), and cyclopentyl (<b>23</b>) moieties improved the potency regarding inhibition of GSM activity with IC<sub>50</sub> values for Aβ42 in the low micromolar range. The cyclopentyl (IC<sub>50</sub>(Aβ42) = 17.2 μM) and cycloheptyl (IC<sub>50</sub>(Aβ42) = 11.3 μM) derivatives showed considerable activity. However, the most active compound is the cyclohexyl derivative <b>22</b> (IC<sub>50</sub>(Aβ42) = 5.1 μM), which represents the most potent GSM presented in this study (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Further size restriction to cyclopropyl (<b>24</b>) as well as ring-opening of the cyclopropyl (isopentyl-substituted <b>25</b>) was detrimental with IC<sub>50</sub> > 28 μM. Within this series, PPARγ activity remained in the range between 4 and 11 μM (<b>21</b>−<b>25</b>). The largest cycloheptyl substituent (<b>21</b>) caused a complete loss of PPARγ activity, thereby representing the second conventional GSM besides α-phenyl substituted <b>10</b>.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> NOTCH Processing</h3><div class="NLM_p">Potential effects on NOTCH processing were examined for compounds <b>16</b> and <b>22</b> that displayed the highest GSM activity with an established reporter assay.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Treatment of cells with the γ-secretase inhibitor L-685,458 or replacement of the plasmid encoding NOTCH with an empty vector caused a dramatic decrease in reporter activity as expected (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). However, treatment of cells with 5−40 μM compounds <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) and <b>22</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B) did not reduce reporter activity, indicating that these potent dual γ-secretase/PPARγ modulators did not affect NOTCH processing or signaling in this concentration range (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Lack of effect of compounds <b>16</b> and <b>22</b> in the NOTCH reporter gene assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cytotoxicity</h3><div class="NLM_p last">Cytotoxicity of all novel analogues was determined in the concentration range between 10 and 100 μM using Alamar blue reagent and is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. With one exception (i.e., compound <b>16</b>), none of the compounds displayed detectable cytotoxicity up to 60 μM. Compound <b>16</b> showed 25% cytotoxicity at 60 μM without significant effects at 40 μM, which is 6- to 7-fold above its IC<sub>50</sub> value for Aβ42 inhibition (6.0 μM).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> COX Inhibition</h3><div class="NLM_p">Most NSAIDs-type GSMs such as indomethacin inhibit COX-1 and COX-2 with IC<sub>50</sub> values in the nanomolar range (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Consequently, COX-related side effects are a major obstacle for their long-term clinical use. Thus, one of the main objectives of this study was to develop a potent dual γ-secretase/PPARγ modulator with substantially weaker COX inhibitory activity compared to NSAID-type GSMs. Inhibition of isolated ovine COX-1 and human recombinant COX-2 is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and presented as remaining activity at 10 μM. Importantly, all novel compounds synthesized within this study were weak COX-1 and COX-2 inhibitors with at least half-maximal remaining activities at 10 μM. Furthermore, we have determined IC<sub>50</sub> values for lead compound <b>8</b> as well as for the most active compounds <b>16</b> and <b>22</b>. Compound <b>8</b> displays moderate COX-1 inhibition with an IC<sub>50</sub> of 18.7 μM and very weak COX-2 inhibition (IC<sub>50</sub> > 40 μM). The introduction of cyclohexyl residues (compound <b>22</b>: IC<sub>50</sub>(Aβ42) = 5.1 μM, EC<sub>50</sub>(PPARγ) = 6.6 μM) improved dual γ-secretase/PPARγ activity but also caused slightly increased COX-1 inhibition and COX-2 inhibition (IC<sub>50</sub>(COX-1) = 13.4 μM, IC<sub>50</sub>(COX-2) = 10.9 μM). <i>p</i>-Trifluoromethylphenyl-substituted <b>16</b> (IC<sub>50</sub>(Aβ42) = 6.0 μM, EC<sub>50</sub>(PPARγ) = 11 μM) shows weaker COX-1 inhibitory activity (IC<sub>50</sub> = 16.9 μM) while sparing inhibition of COX-2. These results suggest an advantage of <i>p</i>-trifluorormethylphenyl over cyclohexyl substitution in regard to COX selectivity. In summary, the introduction of <i>p</i>-trifluoromethylphenyl residues (<b>16</b>) resulted in the most favorable pharmacological profile with superiority of GSM activity versus COX-inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. COX Inhibition of Compounds <b>6</b>−<b>25</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">remaining activity ± SD at 10 μM (%)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">remaining activity ± SD at 10 μM (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">COX-1</th><th class="colsep0 rowsep0" align="center">COX-2</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">COX-1</th><th class="colsep0 rowsep0" align="center">COX-2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">91.8 ± 5.5</td><td class="colsep0 rowsep0" align="left">91.7 ± 15.6</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">72.8 ± 29.1</td><td class="colsep0 rowsep0" align="left">94.6 ± 33.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">84.6 ± 5.5</td><td class="colsep0 rowsep0" align="left">56.9 ± 1.4</td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">54.4 ± 23.6<br /></br>IC<sub>50</sub> = 16.9 μM</td><td class="colsep0 rowsep0" align="left">69.0 ± 27.7<br /></br>IC<sub>50</sub> > 40 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">64.2 ± 24.8<br /></br>IC<sub>50</sub> = 18.7 μM</td><td class="colsep0 rowsep0" align="left">90.9 ± 28.8<br /></br>IC<sub>50</sub> > 40 μM</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">73.0 ± 11.5</td><td class="colsep0 rowsep0" align="left">75.8 ± 8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">73.9 ± 15.8</td><td class="colsep0 rowsep0" align="left">98.5 ± 11.1</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">82.1 ± 12.2</td><td class="colsep0 rowsep0" align="left">91.6 ± 14.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">83.5 ± 12.6</td><td class="colsep0 rowsep0" align="left">92.8 ± 2.1</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">88.8 ± 16.6</td><td class="colsep0 rowsep0" align="left">82.6 ± 24.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">61.8 ± 17.0</td><td class="colsep0 rowsep0" align="left">63.8 ± 16.8</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">76.6 ± 6.9</td><td class="colsep0 rowsep0" align="left">102.4 ± 16.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">72.2 ± 13.3</td><td class="colsep0 rowsep0" align="left">86.0 ± 21.8</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">56.1 ± 8.8</td><td class="colsep0 rowsep0" align="left">50.1 ± 9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">88.9 ± 21.3</td><td class="colsep0 rowsep0" align="left">61.6 ± 2.4</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">52.7 ± 11.1<br /></br>IC<sub>50</sub> = 13.4 μM</td><td class="colsep0 rowsep0" align="left">49.5 ± 18.5<br /></br>IC<sub>50</sub> = 10.9 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">78.8 ± 14.9</td><td class="colsep0 rowsep0" align="left">51.9 ± 11.3</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">68.2 ± 6.9</td><td class="colsep0 rowsep0" align="left">84.7 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">78.8 ± 14.0</td><td class="colsep0 rowsep0" align="left">53.9 ± 14.2</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">97.7 ± 17.4</td><td class="colsep0 rowsep0" align="left">87.9 ± 5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">57.2 ± 12.7</td><td class="colsep0 rowsep0" align="left">93.3 ± 20.0</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">72.4 ± 31.3</td><td class="colsep0 rowsep0" align="left">80.5 ± 25.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values were determined for compounds <b>8</b>, <b>16</b>, and <b>22</b>.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This study presents the successful establishment of a novel and robust scaffold for potent dual γ-secretase/PPARγ modulators. The structural starting point was our initial hit <b>8</b>, which was used as a template for structural variations with a special focus on the lipophilic parts of the molecule. Our SAR studies revealed clear SAR in α-position to the carboxylic acid, where the introduction of a <i>n</i>-butyl chain led to the highest GSM activity. In contrast, the lipophilic backbone of the molecule showed high tolerance toward structural modification. Introduction of different aromatic and aliphatic moieties linked by aliphatic spacers was well tolerated and showed activity on both γ-secretase and PPARγ. Substantial improvement was finally achieved by the replacement of the two phenyl residues with cyclohexyl (<b>22</b>) or by the attachment of <i>p</i>-trifluoromethyl substituents (<b>16</b>). Cyclohexyl-substituted <b>22</b> showed nearly equipotent activities in the low micromolar range with an Aβ42 IC<sub>50</sub> of 5.1 μM and a PPARγ EC<sub>50</sub> of 6.6 μM. The <i>p</i>-trifluoromethyl derivative had comparable GSM activity with an Aβ42 IC<sub>50</sub> of 6.0 μM, slightly weaker PPARγ activity with an EC<sub>50</sub> of 11 μM but the more promising selectivity profile (IC<sub>50</sub>(COX-1) =16.9 μM, IC<sub>50</sub>(COX-2) > 40 μM). Importantly, these compounds did not impair NOTCH processing in the noncytotoxic concentration range.</div><div class="NLM_p last">Taken together, this series represents the first class of compounds described as dual γ-secretase/PPARγ modulators. By structural modifications we were able to cover the whole range from selective GSMs to equipotent and low micromolar active dual γ-secretase/PPARγ modulators. A major liability of the initially discovered GSMs in the class of NSAIDs are COX-associated gastrointestinal and cardiovascular side effects. These side effects most likely preclude the long-term use of Aβ42-lowering NSAIDs to prevent AD.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, the here presented compounds show substantially lower COX inhibition compared to Aβ42-lowering NSAIDs such as ibuprofen (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). We propose that dual γ-secretase/PPARγ modulators could provide a promising strategy to address the increased dementia risk in patients with insulin resistance and type 2 diabetes. In these individuals, dual-active molecules might ameliorate the deleterious effects associated with insulin resistance by activation of PPARγ and further confront the elevated risk for AD by modulating γ-secretase activity and lowering Aβ42 levels in brain.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compounds and Chemistry</h3><div class="NLM_p">The structures of compounds <b>6</b>−<b>25</b> were confirmed by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass spectrometry (ESI). The purities of the final compounds described here were determined by combustion analysis and are 95% or higher. Commercial chemicals and solvents were reagent grade and used without further purification. <sup>1</sup>H and <sup>13</sup>C NMR spectra were measured in DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> on a Bruker ARX 300 (<sup>1</sup>H NMR) and AC 200 E (<sup>13</sup>C NMR) spectrometer. Chemical shifts are reported in parts per million (ppm) using tetramethylsilane (TMS) as internal standard. Mass spectra were obtained on a Fissous Instruments VG Platform 2 spectrometer measuring in the positive- or negative-ion mode (ESI-MS system). Combustion analysis was performed by the Microanalytical Laboratory of the Institute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt, on a Foss Heraeus CHNO rapid elemental analyzer (for details see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p last">The general synthesis of compounds (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) follows the routes described recently.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The synthetic procedure is described representatively for compounds <b>8</b> and <b>16</b>. Detailed synthesis and analytical data of all compounds are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Step i</h3><div class="NLM_p last">2-Thiobarbituric acid (4.33 g/30 mmol, 1 equiv) was suspended in anhydrous DMF (∼30 mL, quantum satis), and triethylamine (4.56 g/45 mmol, 1.5 equiv) was added. Heating to 80−90 °C yielded a clear solution, to which ethyl 2-bromohexanoate (10.05 g/45 mmol, 1.5 equiv) was added dropwise. After being stirred for 4 h at 80 °C (TLC control), the reaction mixture was quenched with at least four parts of water and extracted three times with ethyl acetate. Solvent evaporation of the organic phase yielded the crude product, which was purified by column chromatography using hexane/ethyl acetate to obtain <b>8a</b> as a white solid. Yield: 55.9% (4.8 g).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Step iia</h3><div class="NLM_p last">Compound <b>8b</b> was prepared under Williamson conditions. The precursor from step i (1.2 g/4.19 mmol, 1 equiv) and (2-bromoethyl)benzene (1.63 g/8.8 mmol, 2.1 equiv) were suspended in anhydrous DMF (quantum satis) and heated to 80−90 °C. K<sub>2</sub>CO<sub>3</sub> (1.34 g/9.72 mmol, 2.32 equiv) was added, and the resulting suspension was stirred for 9 h. After completion of the reaction (TLC control), DMF was evaporated in vacuo at 60 °C and the remaining solid was diluted with water. After neutralization to pH 7, the aqueous phase was extracted two times with ethyl acetate. The combined organic fractions were washed with brine and dried over MgSO<sub>4</sub>. Solvent evaporation gave the crude product, which was purified by column chromatography using hexane/ethyl acetate to yield <b>8b</b> as clear oil. Yield: 63.7% (1.32 g).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Step iib</h3><div class="NLM_p last">Compound <b>16b</b> was synthesized under Mitsunobu conditions. Thereby, <b>8a</b> (0.45 g/1.6 mmol, 1 equiv), 4-trifluormethylphenylethanol (0.6 g/3.2 mmol, 2.1 equiv), and triphenylphosphine (1.2 g/4.57 mmol, 2.5 equiv) were dissolved in anhydrous THF and stirred under argon atmosphere with ice bath cooling. Diethylazodicarboxylate (DEAD, 0.78 g/4.57 mmol, 2.5 equiv) diluted in 5 mL of THF was added dropwise via a syringe, and the solution was stirred for 1 h until the reaction was completed (TLC control). Subsequently, THF was evaporated and the remaining residue was purified by column chromatography using hexane/ethyl acetate to yield <b>16b</b> as clear oil in 64.3% (0.64 g) yield.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Step iii</h3><div class="NLM_p">The corresponding ester (<b>8b</b> (0.84 g/1.7 mmol, 1 equiv) or <b>16b</b> (0.4 g/0.6 mmol, 0.6 equiv)) was dissolved in a mixture of 5 mL of THF/10 mL of MeOH, and a solution of LiOH·H<sub>2</sub>O (3 equiv) in 3 mL of H<sub>2</sub>O was added. After the mixture was stirred at 50 °C until saponification was completed, the solvent was removed and the residue was dissolved in water (under heating; if necessary, low amounts of MeOH were added). The solution was acidified with diluted hydrochloric acid. The formed precipitate (<b>8</b>) was filtered, washed to neutrality with water, and then washed with <i>n</i>-hexane. Recrystallization from <i>n</i>-hexane/ethyl acetate yielded compound <b>8</b> as a white solid. Yield: 78.4% (0.62 g).</div><div class="NLM_p last">In the case of compound <b>16</b>, the precipitate formed after addition of diluted hydrochloric acid was oily. To purify the crude product, the residue was extracted with ethyl acetate and separated by column chromatography using <i>n</i>-hexane/ethyl acetate. Yield: 92.2% (0.35 g).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Ethyl 2-(4,6-Dihydroxypyrimidin-2-ylthio)hexanoate (<b>8a</b>)</h3><div class="NLM_p last">White solid, mp 173 °C. <sup>1</sup>H NMR (300.13 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 0.82−0.87 (t, 3H, <i>J</i> = 6.9 Hz, C<i>H</i><sub>3</sub>-Bu), 1.14−1.19 (t, 3H, <i>J</i> = 7.1 Hz, -C<i>H</i><sub>3</sub>), 1.28−1.31 (m, 4H, C<i>H</i><sub>2</sub>-Bu), 1.72−1.92 (m, 2H, C<i>H</i><sub>2</sub>-Bu), 4.08−4.15 (q, 2H, <i>J</i> = 7.1 Hz, OC<i>H</i><sub>2</sub>), 4.47−4.52 (t, 1H, <i>J</i> = 7.1 Hz, S-C<i>H</i>), 5.22 (s, 1H, Pyr-5<i>H</i>), 11.75 (s, br, 2H, Pyr-O<i>H</i>). <sup>13</sup>C NMR (75.44 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 13.63 (-<i>C</i>H<sub>3</sub>), 13.89 (<i>C</i>H<sub>3</sub>-Bu), 21.59 (<i>C</i>H<sub>2</sub>-Bu), 28.49 (<i>C</i>H<sub>2</sub>-Bu), 31.27 (<i>C</i>H<sub>2</sub>-Bu), 46.39 (S-<i>C</i>H), 61.06 (O<i>C</i>H<sub>2</sub>), 85.62 (Pyr-<i>C</i><sub>5</sub>), 167.79 (Pyr-<i>C</i><sub>2</sub>), 170.86 (<i>C</i>OO). MS (ESI−): <i>m</i>/<i>e</i> = 284.9 [M − 1]<sup>−</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Ethyl 2-(4,6-Diphenethoxypyrimidin-2-ylthio)hexanoate (<b>8b</b>)</h3><div class="NLM_p last">Clear oil. <sup>1</sup>H NMR (250.13 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 0.82 (t, 3H, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>-Bu), 1.05 (t, 3H, <i>J</i> = 7.1 Hz, -C<i>H</i><sub>3</sub>), 1.26−1.34 (m, 4H, C<i>H</i><sub>2</sub>-Bu), 1.74−1.91 (m, 2H, C<i>H</i><sub>2</sub>-Bu), 2.98 (t, 4H, <i>J</i> = 7.1 Hz, Ph-C<i>H</i><sub>2</sub>), 4.11 (q, 2H, <i>J</i> = 7.1 Hz, OC<i>H</i><sub>2</sub>), 4.32−4.48 (m, 5H, S-C<i>H</i><sub>2</sub> + Pyr-O-C<i>H</i><sub>2</sub>), 5.89 (s, 1H, Pyr-5<i>H</i>), 7.19−7.32 (m, 10H, Ph-<i>H)</i>. <sup>13</sup>C NMR (75.44 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 13.63 (<i>C</i>H<sub>3</sub>-Bu), 13.83 (−<i>C</i>H<sub>3</sub>), 21.60 (<i>C</i>H<sub>2</sub>-Bu), 28.79 (<i>C</i>H<sub>2</sub>-Bu), 30.72 (<i>C</i>H<sub>2</sub>-Bu), 34.43 (2C, Ph-<i>C</i>H<sub>2</sub>), 47.13 (S-<i>C</i>H<sub>2</sub>), 60.90 (O<i>C</i>H<sub>2</sub>), 67.12 (2C, Pyr-O-<i>C</i>H<sub>2</sub>), 86.01 (Pyr-<i>C</i>5), 126.34 (2C, Ph-<i>C</i>4), 128,12 (4C, Ph-<i>C</i><sub>2</sub> + -<i>C</i><sub>6</sub>), 128.61 (4C, Ph-<i>C</i><sub>3</sub> + -<i>C</i><sub>5</sub>), 137.80 (2C, Ph-<i>C</i>1), 168.54 (Pyr-<i>C</i><sub>2</sub>), 170.07 (2C, Pyr-<i>C</i><sub>4</sub> + -<i>C</i><sub>6</sub>), 171.35 (<i>C</i>OO). MS (ESI+): <i>m</i>/<i>e</i> = 495.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Ethyl 2-(4,6-Bis(4-(trifluoromethyl)phenethoxy)pyrimidin-2-ylthio)hexanoate (<b>16b</b>)</h3><div class="NLM_p last">Clear oil. <sup>1</sup>H NMR (300.13 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 0.79−0.83 (t, 3H, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>-Bu), 1.02−1.06 (t, 3H, <i>J</i> = 7.0 Hz, -C<i>H</i><sub>3</sub>), 1.29−1.40 (m, 4H, C<i>H</i><sub>2</sub>-Bu), 1.84−1.92 (m, 2H, C<i>H</i><sub>2</sub>-Bu), 3.07−3.11 (t, 4H, <i>J</i> = 6.6 Hz, Ph-C<i>H</i><sub>2</sub>), 3.97−4.08 (m, 2H, OC<i>H</i><sub>2</sub>), 4.29−4.35 (t, 1H, <i>J</i> = 7.2 Hz, S-C<i>H</i>), 4.47−4.53 (m, 4H, Pyr-O-C<i>H</i><sub>2</sub>), 5.89 (s, 1H, Pyr-5<i>H</i>), 7.49−7.52 (d, 4H, <i>J</i> = 8.0 Hz, Ph-C<sub>2</sub> + -C<sub>6</sub><i>H</i>), 7.63−7.66 (d, 4H, <i>J</i> = 8.1 Hz, Ph-C<sub>3</sub> + -C<sub>5</sub><i>H</i>). <sup>13</sup>C NMR (75.44 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 13.60 (<i>C</i>H<sub>3</sub>-Bu), 14.07 (-<i>C</i>H<sub>3</sub>), 21.60 (<i>C</i>H<sub>2</sub>-Bu), 28.79 (<i>C</i>H<sub>2</sub>-Bu), 30.64 (<i>C</i>H<sub>2</sub>-Bu), 34.15 (2C, Ph-<i>C</i>H<sub>2</sub>), 47.16 (S-<i>C</i>H), 60.88 (OC<i>H</i><sub>2</sub>), 66.59 (2C, Pyr-O-<i>C</i>H<sub>2</sub>), 86.06 (Pyr-<i>C</i><sub>5</sub>), 125.11 (4C, Ph-<i>C</i><sub>3</sub> + -<i>C</i><sub>5</sub>), 126.13−127.35 (2C, Ph-<i>C</i>F<sub>3</sub>), 129.71 (4C, Ph-<i>C</i><sub>2</sub> + -<i>C</i><sub>6</sub>), 143.01 (2C, Ph-<i>C</i><sub>1</sub>), 168.59 (Pyr-<i>C</i><sub>2</sub>), 169.99 (2C, Pyr-<i>C</i><sub>4</sub> + -<i>C</i><sub>6</sub>), 171.31 (<i>C</i>OO). MS (ESI+): <i>m</i>/<i>e</i> = 631.6 [M + 1]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(4,6-Diphenethoxypyrimidin-2-ylthio)hexanoic Acid (<b>8</b>)</h3><div class="NLM_p last">White solid, mp 99 °C. <sup>1</sup>H NMR (300.13 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 0.81 (t, 3H, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>-Bu), 1.23−1.38 (m, 4H, C<i>H</i><sub>2</sub>-Bu), 1.78−1.90 (m, 2H, C<i>H</i><sub>2</sub>-Bu), 2.98 (t, 4H, <i>J</i> = 6.9 Hz, Ph-C<i>H</i><sub>2</sub>), 4.29 (t, 1H, <i>J</i> = 7.2 Hz, S-C<i>H</i>), 4.46 (t, 4H, <i>J</i> = 6.9 Hz, Pyr−O-C<i>H</i><sub>2</sub>), 5.87 (s, 1H, Pyr-5<i>H</i>), 7.18−7.32 (m, 10H, Ph-<i>H)</i>. <sup>13</sup>C NMR (75.44 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 13.70 (<i>C</i>H<sub>3</sub>-Bu), 21.71 (<i>C</i>H<sub>2</sub>-Bu), 28.92 (<i>C</i>H<sub>2</sub>-Bu), 31.09 (<i>C</i>H<sub>2</sub>-Bu), 34.44 (2C, Ph-<i>C</i>H<sub>2</sub>), 47.61 (S-<i>C</i>H<sub>2</sub>), 67.08 (2C, Pyr-O-<i>C</i>H<sub>2</sub>), 85.87 (Pyr-<i>C</i>5), 126.31 (2C, Ph-<i>C</i>4), 128.30 (4C, Ph-<i>C</i>2 + -<i>C</i>6), 128.84 (4C, Ph-<i>C</i>3 + -<i>C</i>5), 137.88 (2C, Ph-<i>C</i>1), 169.01 (Pyr-<i>C</i>2), 170.03 (2C, Pyr-<i>C</i>4 + -<i>C</i>6), 172.70 (<i>C</i>OOH). MS (ESI+): <i>m</i>/<i>e</i> = 467.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(4,6-Bis(4-(trifluoromethyl)phenethoxy)pyrimidin-2-ylthio)hexanoic Acid (<b>16</b>)</h3><div class="NLM_p last">Yellow oil. <sup>1</sup>H NMR (300.13 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 0.78−0.83 (t, 3H, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>-Bu), 1.22−1.37 (m, 4H, C<i>H</i><sub>2</sub>-Bu), 1.74−1.92 (m, 2H, C<i>H</i><sub>2</sub>-Bu), 3.06−3.11 (t, 4H, <i>J</i> = 6.6 Hz, Ph-C<i>H</i><sub>2</sub>), 4.27−4.30 (t, 1H, <i>J</i> = 7.1 Hz, S-C<i>H</i>), 4.48−4.53 (t, 4H, <i>J</i> = 6.6 Hz, Pyr-O-C<i>H</i><sub>2</sub>), 5.87 (s, 1H, Pyr-5<i>H</i>), 7.49−7.52 (d, 4H, <i>J</i> = 8.0 Hz, Ph-C<sub>2</sub> + -C<sub>6</sub><i>H</i>), 7.63−7.66 (d, 4H, <i>J</i> = 8.0 Hz, Ph-C<sub>3</sub> + -C<sub>5</sub><i>H</i>), 12.82 (s, br, 1H, COO<i>H</i>). <sup>13</sup>C NMR (75.44 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ = 13.64 (<i>C</i>H<sub>3</sub>-Bu), 21.67 (<i>C</i>H<sub>2</sub>-Bu), 28.92 (<i>C</i>H<sub>2</sub>-Bu), 30.91 (<i>C</i>H<sub>2</sub>-Bu), 34.16 (2C, Ph-<i>C</i>H<sub>2</sub>), 47.46 (S-<i>C</i>H), 66.54 (2C, Pyr-O-<i>C</i>H<sub>2</sub>), 85.97 (Pyr-<i>C</i><sub>5</sub>), 124.99 (4C, Ph-<i>C</i><sub>3</sub> + -<i>C</i><sub>5</sub>), 125.14−127.74 (2C, Ph-<i>C</i>F<sub>3</sub>), 129.69 (4C, Ph-<i>C</i><sub>2</sub> + -<i>C</i><sub>6</sub>), 143.06 (2C, Ph-<i>C</i><sub>1</sub>), 168.95 (Pyr-<i>C</i><sub>2</sub>), 169.97 (2C, Pyr-<i>C</i><sub>4</sub> + -<i>C</i><sub>6</sub>), 172.23 (<i>C</i>OOH). MS (ESI-): <i>m</i>/<i>e</i> = 601.4 [M − 1]<sup>−</sup>.</div></div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> PPAR Transactivation Assay</h3><div class="NLM_p">COS7 cells were grown in DMEM supplemented with FCS, sodium pyruvate, and penicillin/streptomycine at 37 °C and 5% CO<sub>2</sub>. The day before transfection, cells were seeded in 96-well plates at a density of 30 000 cells per well. Transient transfection was carried out by Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s protocol with pFR-Luc (Stratagene), pRL-SV40 (Promega), and the Gal4-fusion receptor plasmids (pFA-CMV-hPPAR-LBD) of the respective subtype. At 5 h after transfection, the medium was changed to DMEM without phenol red and FCS, containing 0.1% DMSO and the respective concentrations of the test compounds.</div><div class="NLM_p last">Following overnight incubation with the test compounds, cells were assayed for reporter gene activity using Dual-Glo luciferase assay system (Promega) according to the manufacturer’s protocol. Luminescence was measured with a GENios Pro luminometer (Tecan Deutschland GmbH, Crailsheim, Germany). Each concentration of the compounds was tested in triplicate wells, and each experiment was repeated independently at least three times. Normalization for transfection efficacy and cell growth was done by division of the firefly luciferase data by renilla luciferase data resulting in relative light units. Activation factors were obtained by dividing by DMSO control. EC<sub>50</sub> and standard deviation values were calculated by mean values of at least three determinations by SigmaPlot 2001 (Systat Software GmbH, Erkrath, Germany) using a four-parameter logistic regression. All compounds were evaluated by comparison of the achieved maximum effect to that of the reference compound (pioglitazone for PPARγ, GW 7647 for PPARα, and L165,041 for PPARδ each with 1 μM).</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Determination of γ-Secretase Modulator Activity</h3><div class="NLM_p last">To characterize the GSM activity of novel analogues, their effects on the generation of Aβ40, Aβ42, and Aβ38 peptides were determined in a previously described cell-based ELISA assay with modifications.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> CHO cells with stable overexpression of wild type human amyloid precursor protein and wild type human presenilin-1<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> were maintained in DMEM supplemented with 10% FBS and treated in 96-well plates for 24 h with increasing concentrations of the respective compounds or DMSO vehicle. Culture media were collected and analyzed by ELISA as follows: monoclonal antibody IC16 raised against amino acids 1−15 of the Aβ sequence was used as a capture antibody.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> To distinguish different Aβ species, C-terminal antibodies specific for Aβ40, Aβ42, and Aβ38 labeled with horseradish peroxidase (HRP) using the Pierce EZ-Link Plus activated peroxidase kit (Thermo Fisher Scientific) were used for detection. The 96-well high-binding microtiter plates were coated overnight at 4 °C with capture antibody IC16 diluted 1:250 in PBS, pH 7.2. Capture antibody was removed, and conditioned media samples (10 μL for detection of Aβ40, 100 μL for Aβ42, 50 μL for Aβ38) or standard peptides were loaded. HRP-coupled detection antibodies diluted in assay buffer (PBS containing 0.05% Tween-20, 1% BSA) were added to each well and incubated overnight at 4 °C. Plates were washed 3 times with PBS containing 0.05% Tween-20 and once with PBS. Then 50 μL of TMB ultrasubstrate (Thermo Fisher Scientific) was added and incubated for 1−10 min at room temperature in the dark, and the reaction was stopped by adding 50 μL of 2 M H<sub>2</sub>SO<sub>4</sub>. Absorbance at 450 nm was recorded with a Paradigm microplate reader (Beckman-Coulter). Synthetic Aβ40, Aβ42, and Aβ38 peptides (Bachem AG) were used to generate standard curves. These Aβ peptides were solubilized in DMSO at 1 mg/mL, aliquoted, and stored frozen at −80 °C. Immediately before use, peptides were diluted in assay buffer to 250−3000 pg/mL. Triplicate measurements from each drug concentration were averaged and normalized to DMSO control condition. For calculation of IC<sub>50</sub> values, cells were treated with eight increasing concentrations of each compound, and a nonlinear curve fit with variable slope model was applied to the results from two to four independent experiments. Statistics were performed using GraphPad Prism (GraphPad Software).</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> NOTCH Reporter Assay</h3><div class="NLM_p last">The NOTCH reporter assay was performed as described.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In brief, subconfluent CHO cells were transiently transfected in 96-well plates with plasmid pCDNA3-Notch-ΔE-GVP encoding truncated NOTCH fused to a Gal4 DNA-binding/VP16 transactivation domain and the MH100 reporter plasmid encoding firefly luciferase under the UAS promotor (50 ng each) using GeneJuice transfection reagent (Merck Chemicals Ltd.). Co-transfection of the MH100 reporter with empty pcDNA3 plasmid served as a negative control. Then 5 ng of plasmid pRL-TK encoding renilla luciferase was added to the plasmid mix to control for transfection efficiency. At 24 h after the transfection, cells were treated for an additional 24 h with increasing concentrations of the compounds <b>16</b> and <b>22</b>, 0.5 μM γ-secretase inhibitor LY-411575, or DMSO vehicle. The cells were then lysed, and firefly and renilla luciferase activities were quantified using the Dual Glo luciferase assay system (Promega) and a PARADIGM microplate reader (Beckman-Coulter). Normalization for transfection efficacy and cell growth was achieved by dividing the firefly luciferase values by the renilla luciferase values. Percent activation of the reporter was then calculated by normalization of triplicate measurements from each condition to the DMSO control values. Unpaired <i>t</i> test analysis was performed from two independent experiments using GraphPad Prism: ∗∗∗, <i>p</i> < 0.001.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cytotoxicity Assay</h3><div class="NLM_p last">CHO cells with stable overexpression of wild type human amyloid precursor protein and wild type human presenilin-1 were seeded at low density in 96-well plates (4000 cells/well) and cultured for 24 h. The cells were then treated in duplicate with increasing concentrations (0−100 μM) of the respective compounds or DMSO vehicle for an additional 24 h. Cell viability was assessed using the Alamar blue reagent (Invitrogen). Then 20 μL of Alamar blue was added to cells cultured in 200 μL of medium and incubated overnight. Absorbance was measured with a Paradigm microplate reader (Beckman-Coulter) at 570 nm, using 600 nm as the reference wavelength. The values expressed as percent viability of vehicle control represent averages of two independent experiments.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Determination of COX Inhibition</h3><div class="NLM_p last">Inhibition of the activities of isolated ovine COX-1 and human recombinant COX-2 was performed as described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Briefly, purified COX-1 (ovine, 50 units) or COX-2 (human recombinant, 20 units) were diluted in 1 mL of reaction mixture containing 100 mM Tris buffer, pH 8, 5 mM glutathione, 5 μM hemoglobin, and 100 μM EDTA at 4 °C and preincubated with the test compounds for 5 min. Samples were prewarmed for 60 s at 37 °C, and arachidonic acid (5 μM for COX-1, 2 μM for COX-2) was added to start the reaction. After 5 min at 37 °C, the COX product 12-HHT was extracted and then analyzed by HPLC as described.<a onclick="showRef(event, 'ref41 ref47'); return false;" href="javascript:void(0);" class="ref ref41 ref47">(41, 47)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/jm1003073">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Chemical synthesis, <sup>1</sup>H and <sup>13</sup>C NMR data of intermediates and final compounds, mass spectrometry, combustion analysis, and cytotoxicity data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1003073/suppl_file/jm1003073_si_001.pdf">jm1003073_si_001.pdf (399.28 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1003073" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sascha Weggen</span> - <span class="hlFld-Affiliation affiliation">Molecular Neuropathology Group, Department of Neuropathology, Heinrich-Heine University Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d6a5a1b3b1b1b3b896a3b8bffbb2a3b3a5a5b3bab2b9a4b0f8b2b3f6beb3bfbdb9f8acb3a2a2ba96a6beb7a4bbb7f8b3a2beacf8b5be"><span class="__cf_email__" data-cfemail="96e5e1f3f1f1f3f8d6e3f8ffbbf2e3f3e5e5f3faf2f9e4f0b8f2f3">[email protected]</span> <span class="__cf_email__" data-cfemail="a6cec3cfcdc988dcc3d2d2cae6d6cec7d4cbc788c3d2cedc88c5ce">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heiko Zettl</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical Chemistry, ZAFES/LiFF/Goethe University Frankfurt, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a696d7f7d7d7f745a6f7473377e6f7f69697f767e75687c347e7f3a727f73717534607f6e6e765a6a727b68777b347f6e7260347972"><span class="__cf_email__" data-cfemail="245753414343414a64514a4d0940514157574148404b56420a4041">[email protected]</span> <span class="__cf_email__" data-cfemail="462e232f2d29683c2332322a06362e27342b276823322e3c68252e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Hieke</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical Chemistry, ZAFES/LiFF/Goethe University Frankfurt, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julia Ness</span> - <span class="hlFld-Affiliation affiliation">Molecular Neuropathology Group, Department of Neuropathology, Heinrich-Heine University Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona Steri</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical Chemistry, ZAFES/LiFF/Goethe University Frankfurt, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michaela Dittrich</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical Chemistry, ZAFES/LiFF/Goethe University Frankfurt, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Greiner</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Analytics, Eberhard-Karls University Tuebingen, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Werz</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Analytics, Eberhard-Karls University Tuebingen, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karlheinz Baumann</span> - <span class="hlFld-Affiliation affiliation">Pharmaceuticals Division, Preclinical Research CNS, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manfred Schubert-Zsilavecz</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmaceutical Chemistry, ZAFES/LiFF/Goethe University Frankfurt, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Jan Näslund (Karolinska Institute, Sweden) for the NOTCH reporter plasmids, Dr. Manfred Brockhaus (F. Hoffmann-La Roche Ltd., Switzerland) for carboxyl-terminus-specific Aβ antibodies, Dr. Michael Lämmerhofer (Universität Wien, Austria) for enantioselective separation of compound <b>8</b>, and Dr. Boris Schmidt (TU Darmstadt, Germany) for scientific advice. This study was supported by the Competence Network Degenerative Dementias of the Federal Ministry of Education (Grant 01 GI 0718 to S.W.).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler-Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrighi, H. M.</span><span> </span><span class="NLM_article-title">Forecasting the global burden of Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.jalz.2007.04.381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19595937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=186-191&author=R.+Brookmeyerauthor=E.+Johnsonauthor=K.+Ziegler-Grahamauthor=H.+M.+Arrighi&title=Forecasting+the+global+burden+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Forecasting the global burden of Alzheimer's disease</span></div><div class="casAuthors">Brookmeyer Ron; Johnson Elizabeth; Ziegler-Graham Kathryn; Arrighi H Michael</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Our goal was to forecast the global burden of Alzheimer's disease and evaluate the potential impact of interventions that delay disease onset or progression.  METHODS:  A stochastic, multistate model was used in conjunction with United Nations worldwide population forecasts and data from epidemiological studies of the risks of Alzheimer's disease.  RESULTS:  In 2006, the worldwide prevalence of Alzheimer's disease was 26.6 million.  By 2050, the prevalence will quadruple, by which time 1 in 85 persons worldwide will be living with the disease.  We estimate about 43% of prevalent cases need a high level of care, equivalent to that of a nursing home.  If interventions could delay both disease onset and progression by a modest 1 year, there would be nearly 9.2 million fewer cases of the disease in 2050, with nearly the entire decline attributable to decreases in persons needing a high level of care.  CONCLUSIONS:  We face a looming global epidemic of Alzheimer's disease as the world's population ages.  Modest advances in therapeutic and preventive strategies that lead to even small delays in the onset and progression of Alzheimer's disease can significantly reduce the global burden of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScBQJ_4Qj7YMSzjBFCN0BJfW6udTcc2eYsM_QasphiLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D&md5=f89fab48e87760875e35c68876a42664</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.04.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.04.381%26sid%3Dliteratum%253Aachs%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DZiegler-Graham%26aufirst%3DK.%26aulast%3DArrighi%26aufirst%3DH.%2BM.%26atitle%3DForecasting%2520the%2520global%2520burden%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2007%26volume%3D3%26spage%3D186%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: genes, proteins, and therapy</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=741-766&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease%3A+genes%2C+proteins%2C+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520genes%252C%2520proteins%252C%2520and%2520therapy%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D741%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aβ oligomers—a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers%E2%80%94a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lgx4YrVLTGUxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%25E2%2580%2594a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Strategies for disease modification in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1038%2Fnrn1495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=15322526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVaqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=677-685&author=M.+Citron&title=Strategies+for+disease+modification+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for disease modification in Alzheimer's disease</span></div><div class="casAuthors">Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">677-685</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Treating Alzheimer's disease (AD) is the biggest unmet medical need in neurol.  Current drugs improve symptoms, but do not have profound disease-modifying effects.  Three main classes of disease-modification approaches can be defined: one that is broadly neurotrophic or neuroprotective, one that targets specific aspects of AD pathol., and one that is based on epidemiol. observation.  This review discusses all three approaches, with particular emphasis on anti-amyloid strategies - currently the most active area of investigation.  The approaches that are reviewed include secretase inhibition, amyloid-β aggregation inhibition, immunotherapy and strategies that might indirectly affect the amyloid pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDLZiWsusmqLVg90H21EOLACvtfcHk0likV5IxRtJPMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVaqsr8%253D&md5=83246f7a6ac826196f4d962077487d03</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrn1495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1495%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DStrategies%2520for%2520disease%2520modification%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2004%26volume%3D5%26spage%3D677%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Disease modifying therapy for AD?</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1111%2Fj.1471-4159.2006.04211.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17076654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=689-707&author=T.+E.+Golde&title=Disease+modifying+therapy+for+AD%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Disease modifying therapy for AD?</span></div><div class="casAuthors">Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">689-707</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia in industrialized nations.  If more effective therapies are not developed that either prevent AD or block progression of the disease in its very early stages, the economic and societal cost of caring for AD patients will be devastating.  Only two types of drugs are currently approved for the treatment of AD: inhibitors of acetyl cholinesterase, which symptomatically enhance cognitive state to some degree but are not disease modifying; and the adamantane deriv., memantine.  Memantine preferentially blocks excessive NMDA receptor activity without disrupting normal receptor activity and is thought to be a neuroprotective agent that blocks excitotoxicty.  Memantine therefore may have a potentially disease modifying effect in multiple neurodegenerative conditions.  An improved understanding of the pathogeneses of AD has now led to the identification of numerous therapeutic targets designed to alter amyloid β protein (Aβ) or tau accumulation.  Therapies that alter Aβ and tau through these various targets are likely to have significant disease modifying effects.  Many of these targets have been validated in proof of concept studies in preclin. animal models, and some potentially disease modifying therapies targeting Aβ or tau are being tested in the clinic.  This review will highlight both the promise of and the obstacles to developing such disease modifying AD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-BcH4FI9sOrVg90H21EOLACvtfcHk0likV5IxRtJPMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FL&md5=cd7a9f8222d36922503600f8f25f0600</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04211.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04211.x%26sid%3Dliteratum%253Aachs%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDisease%2520modifying%2520therapy%2520for%2520AD%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D689%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span> </span><span class="NLM_article-title">Gamma-secretase inhibitors for Alzheimer’s disease: balancing efficacy and toxicity</span> <span class="citation_source-journal">Drugs R&D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2165%2F00126839-200607020-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16542055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVWksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=87-97&author=D.+M.+Bartenauthor=J.+E.+Meredithauthor=R.+Zaczekauthor=J.+G.+Houstonauthor=C.+F.+Albright&title=Gamma-secretase+inhibitors+for+Alzheimer%E2%80%99s+disease%3A+balancing+efficacy+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity</span></div><div class="casAuthors">Barten, Donna M.; Meredith, Jere E., Jr.; Zaczek, Robert; Houston, John G.; Albright, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs in R&D</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">DRDDFD</span>;
        ISSN:<span class="NLM_cas:issn">1174-5886</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis, which states that β-amyloid (Aβ) aggregates cause the onset and progression of Alzheimer's disease (AD), is a leading proposal to explain AD etiol.  Based on this hypothesis, compds. that inhibit γ-secretase, one of the enzymes responsible for forming Aβ, are potential therapeutics for AD.  Preclin. studies clearly establish that γ-secretase inhibitors can reduce brain Aβ in rodent models.  The initial investigation of the effects of a γ-secretase inhibitor on Aβ-induced cognitive deficits in transgenic mice showed that modest Aβ redns. (15-30%) are sufficient to reverse Aβ-induced cognitive deficits in Tg2576 mice.  Extending these studies to other γ-secretase inhibitors and other models with Aβ-induced cognitive deficits will be important.  Unfortunately, γ-secretase inhibitors also cause abnormalities in the gastrointestinal tract, thymus and spleen in rodents.  These changes likely result from inhibition of Notch cleavage, a transmembrane receptor involved in regulating cell-fate decisions.  Two recent studies in rodents suggest that Aβ redn. using γ-secretase inhibitors can be partially sepd. from Notch inhibition.  Given the uncertain Aβ redn. target and the potential for mechanism-based toxicity, biomarkers for efficacy and toxicity would be helpful in clin. trials.  The first report of γ-secretase inhibitors in clin. trials was recently published.  In this study, LY-450139 reduced plasma Aβ, but not cerebrospinal fluid Aβ.  Taken together, the results of studies to date suggest that γ-secretase inhibitors have the potential to address a large unmet medical need if the tech. challenges can be overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM-QRR65BRqLVg90H21EOLACvtfcHk0likV5IxRtJPMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVWksrg%253D&md5=6bff8dba9196e7eebbe741f50e6e88c3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2165%2F00126839-200607020-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00126839-200607020-00003%26sid%3Dliteratum%253Aachs%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26atitle%3DGamma-secretase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520balancing%2520efficacy%2520and%2520toxicity%26jtitle%3DDrugs%2520R%2526D%26date%3D2006%26volume%3D7%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrijvers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=518-522&author=B.+De+Strooperauthor=W.+Annaertauthor=P.+Cupersauthor=P.+Saftigauthor=K.+Craessaertsauthor=J.+S.+Mummauthor=E.+H.+Schroeterauthor=V.+Schrijversauthor=M.+S.+Wolfeauthor=W.+J.+Rayauthor=A.+Goateauthor=R.+Kopan&title=A+presenilin-1-dependent+gamma-secretase-like+protease+mediates+release+of+Notch+intracellular+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DCupers%26aufirst%3DP.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DMumm%26aufirst%3DJ.%2BS.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DSchrijvers%26aufirst%3DV.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DA%2520presenilin-1-dependent%2520gamma-secretase-like%2520protease%2520mediates%2520release%2520of%2520Notch%2520intracellular%2520domain%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D518%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon-Ortiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12876</span><span class="NLM_x">–</span> <span class="NLM_lpage">12882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12876-12882&author=G.+T.+Wongauthor=D.+Manfraauthor=F.+M.+Pouletauthor=Q.+Zhangauthor=H.+Josienauthor=T.+Baraauthor=L.+Engstromauthor=M.+Pinzon-Ortizauthor=J.+S.+Fineauthor=H.+J.+Leeauthor=L.+Zhangauthor=G.+A.+Higginsauthor=E.+M.+Parker&title=Chronic+treatment+with+the+gamma-secretase+inhibitor+LY-411%2C575+inhibits+beta-amyloid+peptide+production+and+alters+lymphopoiesis+and+intestinal+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BT.%26aulast%3DManfra%26aufirst%3DD.%26aulast%3DPoulet%26aufirst%3DF.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPinzon-Ortiz%26aufirst%3DM.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520gamma-secretase%2520inhibitor%2520LY-411%252C575%2520inhibits%2520beta-amyloid%2520peptide%2520production%2520and%2520alters%2520lymphopoiesis%2520and%2520intestinal%2520cell%2520differentiation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12876%26epage%3D12882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+Abeta42+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520Abeta42%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Leuchtenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Selective modulation of Abeta42 production in Alzheimer’s disease: non-steroidal anti-inflammatory drugs (NSAIDs) and beyond</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4337</span><span class="NLM_x">–</span> <span class="NLM_lpage">4355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F138161206778793029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17105431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4337-4355&author=S.+Leuchtenbergerauthor=D.+Beherauthor=S.+Weggen&title=Selective+modulation+of+Abeta42+production+in+Alzheimer%E2%80%99s+disease%3A+non-steroidal+anti-inflammatory+drugs+%28NSAIDs%29+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Selective modulation of Aβ42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond</span></div><div class="casAuthors">Leuchtenberger, Stefanie; Beher, Dirk; Weggen, Sascha</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4337-4355</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) peptides and in particular the longer, highly amyloidogenic isoform Aβ42 are believed by many to be the central disease-causing agents in Alzheimer's disease (AD).  Consequently, academic and pharmaceutical labs. have focused on elucidating the mechanisms of Aβ prodn. and developing strategies to diminish Aβ formation for treatment or prevention of AD.  The most substantial advances have been made with respect to inhibitors of the γ-secretase enzyme, which catalyzes the final step in the generation of Aβ from the amyloid precursor protein (APP).  Highly potent γ-secretase inhibitors which suppress prodn. of all Aβ peptides are available today.  However, due to the promiscuous substrate specificity of γ-secretase and its essential role in the NOTCH signaling pathway overt mechanism-based toxicity has been obsd. in preclin. studies of γ-secretase inhibitors.  For that reason, specific blockage of Aβ42 prodn. might be preferable over non-discriminatory γ-secretase inhibition but small mol. inhibitors of Aβ42 prodn. have remained elusive until recently.  This has changed with the discovery that certain non-steroidal anti-inflammatory drugs (NSAIDs) including ibuprofen possess preferential Aβ42-lowering activity.  These compds. seem to offer a window of modulation where Aβ42 prodn. is potently inhibited whereas processing of the NOTCH receptor and other γ-secretase substrates remains unaffected.  The Aβ42-lowering activity of NSAIDs is not related to inhibition of cyclooxygenases and can be dissocd. from the anti-inflammatory properties of this class of drugs.  Ongoing efforts conc. on uncovering the mechanism of action and improving potency and brain permeability of Aβ42-lowering compds.  Hopes are high that in the near future this will lead to the development of clin. viable compds. which selectively target Aβ42 as a key mol. in the pathogenesis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh7VQGQCnNUrVg90H21EOLACvtfcHk0lgAJiFH7rV3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbO&md5=30dd82a2b1ed0f1062ab908cc2e7f048</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161206778793029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778793029%26sid%3Dliteratum%253Aachs%26aulast%3DLeuchtenberger%26aufirst%3DS.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DSelective%2520modulation%2520of%2520Abeta42%2520production%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520non-steroidal%2520anti-inflammatory%2520drugs%2520%2528NSAIDs%2529%2520and%2520beyond%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4337%26epage%3D4355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J.</span><span> </span><span class="NLM_article-title">NSAIDs: small molecules for prevention of Alzheimer’s disease or precursors for future drug development?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=536-543&author=S.+Weggenauthor=M.+Rogersauthor=J.+Eriksen&title=NSAIDs%3A+small+molecules+for+prevention+of+Alzheimer%E2%80%99s+disease+or+precursors+for+future+drug+development%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DM.%26aulast%3DEriksen%26aufirst%3DJ.%26atitle%3DNSAIDs%253A%2520small%2520molecules%2520for%2520prevention%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520or%2520precursors%2520for%2520future%2520drug%2520development%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D536%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Green, R. C.; Schneider, L. S.; Hendrix, S. B.; Zavitz, K. H.; Swabb, E.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of Tarenflurbil in Subjects with Mild Alzheimer’s Disease: Results from an 18-Month Multi-Center Phase 3 Trial</span>. Presented at the International Conference on Alzheimer’s Disease, Chicago, IL, July 2008; Alzheimer’s and Dementia; No. O3-04-01, T165.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Green%2C+R.+C.%3B+Schneider%2C+L.+S.%3B+Hendrix%2C+S.+B.%3B+Zavitz%2C+K.+H.%3B+Swabb%2C+E.+Safety+and+Efficacy+of+Tarenflurbil+in+Subjects+with+Mild+Alzheimer%E2%80%99s+Disease%3A+Results+from+an+18-Month+Multi-Center+Phase+3+Trial.+Presented+at+the+International+Conference+on+Alzheimer%E2%80%99s+Disease%2C+Chicago%2C+IL%2C+July+2008%3B+Alzheimer%E2%80%99s+and+Dementia%3B+No.+O3-04-01%2C+T165."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BC.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520Tarenflurbil%2520in%2520Subjects%2520with%2520Mild%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Results%2520from%2520an%252018-Month%2520Multi-Center%2520Phase%25203%2520Trial" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">in 't Veld, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stijnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breteler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, B. H.</span><span> </span><span class="NLM_article-title">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1056%2FNEJMoa010178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=11794217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2001&pages=1515-1521&author=B.+A.+in+%27t+Veldauthor=A.+Ruitenbergauthor=A.+Hofmanauthor=L.+J.+Launerauthor=C.+M.+van+Duijnauthor=T.+Stijnenauthor=M.+M.+Bretelerauthor=B.+H.+Stricker&title=Nonsteroidal+antiinflammatory+drugs+and+the+risk+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease</span></div><div class="casAuthors">In't Veld, Bas A.; Ruitenberg, Annemieke; Hofman, Albert; Launer, Lenore J.; van Duijn, Cornelia M.; Stijnen, Theo; Bretteler, Monique M. B.; Stricker, Bruno H. C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1515-1521</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease.  The results, however, have been inconsistent.  Methods: We studied the assocn. between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 yr of age or older who were free of dementia at base line.  The risk of Alzheimer's disease was estd. in relation to the use of NSAIDs as documented in pharmacy records.  We defined four mutually exclusive categories of use: non-use, short-term use (1 mo or less of cumulative use), intermediate-term use (more than 1 but less than 24 mo of cumulative use), and long-term use (24 mo or more of cumulative use).  Adjustments were made by Cox regression anal. for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H2-receptor antagonists, antihypertensive agents, and hypoglycemic agents.  Results: During an av. follow-up period of 6.8 yr, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia.  The relative risk of Alzheimer's disease was 0.95 (95% confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95% confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95% confidence interval, 0.05 to 0.83) in those with long-term use.  The risk did not vary according to age.  The use of NSAIDs was not assocd. with a redn. in the risk of vascular dementia.  Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Ao_Olp-rxrVg90H21EOLACvtfcHk0lgPykiquct6qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D&md5=d9c721051ba69eb547622be825531202</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa010178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa010178%26sid%3Dliteratum%253Aachs%26aulast%3Din%2B%2527t%2BVeld%26aufirst%3DB.%2BA.%26aulast%3DRuitenberg%26aufirst%3DA.%26aulast%3DHofman%26aufirst%3DA.%26aulast%3DLauner%26aufirst%3DL.%2BJ.%26aulast%3Dvan%2BDuijn%26aufirst%3DC.%2BM.%26aulast%3DStijnen%26aufirst%3DT.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%26aulast%3DStricker%26aufirst%3DB.%2BH.%26atitle%3DNonsteroidal%2520antiinflammatory%2520drugs%2520and%2520the%2520risk%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D345%26spage%3D1515%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Vlad, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D. T.</span><span> </span><span class="NLM_article-title">Protective effects of NSAIDs on the development of Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1672</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=1672-1677&author=S.+C.+Vladauthor=D.+R.+Millerauthor=N.+W.+Kowallauthor=D.+T.+Felson&title=Protective+effects+of+NSAIDs+on+the+development+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlad%26aufirst%3DS.%2BC.%26aulast%3DMiller%26aufirst%3DD.%2BR.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26atitle%3DProtective%2520effects%2520of%2520NSAIDs%2520on%2520the%2520development%2520of%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2008%26volume%3D70%26spage%3D1672%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Porta, E.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulation and its promise for Alzheimer’s disease: a medicinal chemistry perspective</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F156802608783334097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18220931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=38-46&author=I.+Perettoauthor=E.+La+Porta&title=Gamma-secretase+modulation+and+its+promise+for+Alzheimer%E2%80%99s+disease%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective</span></div><div class="casAuthors">Peretto, Ilaria; La Porta, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase modulation holds the promise for the development of a disease-modifying therapy for Alzheimer's disease (AD).  This novel concept of manipulating the cleavage specificity of the γ-secretase enzyme by pharmacol. means implies that steady state levels of the potentially disease-causing amyloid-β(1-42) peptide can be lowered without the undesired side effects assocd. with full inhibition of this aspartyl-type protease.  Following on from the initial discovery that certain non-steroidal anti-inflammatory drugs (NSAIDs) exhibit properties characteristic of γ-secretase modulators, this class of compds. has been extensively studied and exploited, leading to the discovery of NSAIDs derivs. endowed with improved potency for the redn. of amyloid-β(1-42) peptide prodn.  In addn., a very limited no. of non-NSAID derived γ-secretase modulators has also been recently claimed in the patent literature, suggesting that only a restricted no. of pharmacophores might be involved in the modulation of γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYysZpzm8stLVg90H21EOLACvtfcHk0lgPykiquct6qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D&md5=0771c6dc024355e125e2554c446d2423</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F156802608783334097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334097%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DLa%2BPorta%26aufirst%3DE.%26atitle%3DGamma-secretase%2520modulation%2520and%2520its%2520promise%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D38%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Generation of Abeta 38 and Abeta 42 is independently and differentially affected by FAD-associated presenilin 1 mutations and gamma-secretase modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=677-683&author=R.+M.+Pageauthor=K.+Baumannauthor=M.+Tomiokaauthor=B.+I.+Perez-Revueltaauthor=A.+Fukumoriauthor=H.+Jacobsenauthor=A.+Flohrauthor=T.+Luebbersauthor=L.+Ozmenauthor=H.+Steinerauthor=C.+Haass&title=Generation+of+Abeta+38+and+Abeta+42+is+independently+and+differentially+affected+by+FAD-associated+presenilin+1+mutations+and+gamma-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DPerez-Revuelta%26aufirst%3DB.%2BI.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520Abeta%252038%2520and%2520Abeta%252042%2520is%2520independently%2520and%2520differentially%2520affected%2520by%2520FAD-associated%2520presenilin%25201%2520mutations%2520and%2520gamma-secretase%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D677%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jaradat, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wongsud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phornchirasilp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangwala, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romstedt, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noonan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feller, D. R.</span><span> </span><span class="NLM_article-title">Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1587-1595&author=M.+S.+Jaradatauthor=B.+Wongsudauthor=S.+Phornchirasilpauthor=S.+M.+Rangwalaauthor=G.+Shamsauthor=M.+Suttonauthor=K.+J.+Romstedtauthor=D.+J.+Noonanauthor=D.+R.+Feller&title=Activation+of+peroxisome+proliferator-activated+receptor+isoforms+and+inhibition+of+prostaglandin+H%282%29+synthases+by+ibuprofen%2C+naproxen%2C+and+indomethacin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaradat%26aufirst%3DM.%2BS.%26aulast%3DWongsud%26aufirst%3DB.%26aulast%3DPhornchirasilp%26aufirst%3DS.%26aulast%3DRangwala%26aufirst%3DS.%2BM.%26aulast%3DShams%26aufirst%3DG.%26aulast%3DSutton%26aufirst%3DM.%26aulast%3DRomstedt%26aufirst%3DK.%2BJ.%26aulast%3DNoonan%26aufirst%3DD.%2BJ.%26aulast%3DFeller%26aufirst%3DD.%2BR.%26atitle%3DActivation%2520of%2520peroxisome%2520proliferator-activated%2520receptor%2520isoforms%2520and%2520inhibition%2520of%2520prostaglandin%2520H%25282%2529%2520synthases%2520by%2520ibuprofen%252C%2520naproxen%252C%2520and%2520indomethacin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D62%26spage%3D1587%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lehmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenhard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringold, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">3406</span><span class="NLM_x">–</span> <span class="NLM_lpage">3410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=3406-3410&author=J.+M.+Lehmannauthor=J.+M.+Lenhardauthor=B.+B.+Oliverauthor=G.+M.+Ringoldauthor=S.+A.+Kliewer&title=Peroxisome+proliferator-activated+receptors+alpha+and+gamma+are+activated+by+indomethacin+and+other+non-steroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DLenhard%26aufirst%3DJ.%2BM.%26aulast%3DOliver%26aufirst%3DB.%2BB.%26aulast%3DRingold%26aufirst%3DG.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptors%2520alpha%2520and%2520gamma%2520are%2520activated%2520by%2520indomethacin%2520and%2520other%2520non-steroidal%2520anti-inflammatory%2520drugs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D3406%26epage%3D3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lehrke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span> </span><span class="NLM_article-title">The many faces of PPARgamma</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.cell.2005.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16360030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVOj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2005&pages=993-999&author=M.+Lehrkeauthor=M.+A.+Lazar&title=The+many+faces+of+PPARgamma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of PPARγ</span></div><div class="casAuthors">Lehrke, Michael; Lazar, Mitchell A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  In an era marked by the increasing prevalence of obesity, diabetes, and cardiovascular disease, the nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) has emerged as a transcriptional regulator of metab. whose activity can be modulated by direct binding of small mols.  As the master regulator of fat-cell formation, PPARγ is required for the accumulation of adipose tissue and hence contributes to obesity.  Yet PPARγ ligands are clin. effective antidiabetic drugs, although side effects limit their utility.  Can PPARγ be targeted with greater benefit and with less risk to patients.  The answer depends upon the basic biol. of PPARγ, and the possibility of selectively modulating the activity of this nuclear receptor in a tissue- and target-gene-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ7RQYS8G8SbVg90H21EOLACvtfcHk0liZstFPgi0R_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVOj&md5=ef6bf675ef97d097e6518d5e5c5241ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DLehrke%26aufirst%3DM.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26atitle%3DThe%2520many%2520faces%2520of%2520PPARgamma%26jtitle%3DCell%26date%3D2005%26volume%3D123%26spage%3D993%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Landreth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandrekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M.</span><span> </span><span class="NLM_article-title">PPARgamma agonists as therapeutics for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=481-489&author=G.+Landrethauthor=Q.+Jiangauthor=S.+Mandrekarauthor=M.+Heneka&title=PPARgamma+agonists+as+therapeutics+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DMandrekar%26aufirst%3DS.%26aulast%3DHeneka%26aufirst%3DM.%26atitle%3DPPARgamma%2520agonists%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2008%26volume%3D5%26spage%3D481%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompl, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambareri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobbs, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=902-904&author=L.+Hoauthor=W.+Qinauthor=P.+N.+Pomplauthor=Z.+Xiangauthor=J.+Wangauthor=Z.+Zhaoauthor=Y.+Pengauthor=G.+Cambareriauthor=A.+Rocherauthor=C.+V.+Mobbsauthor=P.+R.+Hofauthor=G.+M.+Pasinetti&title=Diet-induced+insulin+resistance+promotes+amyloidosis+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DPompl%26aufirst%3DP.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCambareri%26aufirst%3DG.%26aulast%3DRocher%26aufirst%3DA.%26aulast%3DMobbs%26aufirst%3DC.%2BV.%26aulast%3DHof%26aufirst%3DP.%2BR.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DDiet-induced%2520insulin%2520resistance%2520promotes%2520amyloidosis%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D902%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchio-Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunieda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurinami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, R.</span><span> </span><span class="NLM_article-title">Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7036</span><span class="NLM_x">–</span> <span class="NLM_lpage">7041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7036-7041&author=S.+Takedaauthor=N.+Satoauthor=K.+Uchio-Yamadaauthor=K.+Sawadaauthor=T.+Kuniedaauthor=D.+Takeuchiauthor=H.+Kurinamiauthor=M.+Shinoharaauthor=H.+Rakugiauthor=R.+Morishita&title=Diabetes-accelerated+memory+dysfunction+via+cerebrovascular+inflammation+and+Abeta+deposition+in+an+Alzheimer+mouse+model+with+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DUchio-Yamada%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DK.%26aulast%3DKunieda%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DD.%26aulast%3DKurinami%26aufirst%3DH.%26aulast%3DShinohara%26aufirst%3DM.%26aulast%3DRakugi%26aufirst%3DH.%26aulast%3DMorishita%26aufirst%3DR.%26atitle%3DDiabetes-accelerated%2520memory%2520dysfunction%2520via%2520cerebrovascular%2520inflammation%2520and%2520Abeta%2520deposition%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520with%2520diabetes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D7036%26epage%3D7041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Biessels, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staekenborg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span> </span><span class="NLM_article-title">Risk of dementia in diabetes mellitus: a systematic review</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2FS1474-4422%2805%2970284-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16361024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD2MnnsVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=64-74&author=G.+J.+Biesselsauthor=S.+Staekenborgauthor=E.+Brunnerauthor=C.+Brayneauthor=P.+Scheltens&title=Risk+of+dementia+in+diabetes+mellitus%3A+a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of dementia in diabetes mellitus: a systematic review</span></div><div class="casAuthors">Biessels Geert Jan; Staekenborg Salka; Brunner Eric; Brayne Carol; Scheltens Philip</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-74</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">The relation between diabetes and major types of dementia is controversial.  This systematic review examines the incidence of dementia in people with diabetes mellitus.  We identified 14 eligible longitudinal population-based studies of variable methodological quality.  The incidence of "any dementia" was higher in individuals with diabetes than in those without diabetes in seven of ten studies reporting this aggregate outcome.  This high risk included both Alzheimer's disease and vascular dementia (eight of 13 studies and six of nine studies respectively).  Detailed data on modulating and mediating effects of glycaemic control, microvascular complications, and comorbidity (eg, hypertension and stroke) were generally absent.  The findings of mechanistic studies suggest that vascular disease and alterations in glucose, insulin, and amyloid metabolism underlie the pathophysiology, but which of these mechanisms are clinically relevant is unclear.  Further high quality studies need to be initiated, with objective diabetes assessment, together with reliable methods to establish the contribution of vascular disease and other comorbidity to dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRw6_2C-aXsbTslzEEsg76ufW6udTcc2eaLqwbyQxz5PLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnnsVSrtg%253D%253D&md5=c528e0dfbfc47f7b6138090a53b9e5db</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2805%2970284-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252805%252970284-2%26sid%3Dliteratum%253Aachs%26aulast%3DBiessels%26aufirst%3DG.%2BJ.%26aulast%3DStaekenborg%26aufirst%3DS.%26aulast%3DBrunner%26aufirst%3DE.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DScheltens%26aufirst%3DP.%26atitle%3DRisk%2520of%2520dementia%2520in%2520diabetes%2520mellitus%253A%2520a%2520systematic%2520review%26jtitle%3DLancet%2520Neurol.%26date%3D2006%26volume%3D5%26spage%3D64%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Luchsinger, J. A.</span><span> </span><span class="NLM_article-title">Adiposity, hyperinsulinemia, diabetes and Alzheimer’s disease: an epidemiological perspective</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.ejphar.2008.02.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18384771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2qu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2008&pages=119-129&author=J.+A.+Luchsinger&title=Adiposity%2C+hyperinsulinemia%2C+diabetes+and+Alzheimer%E2%80%99s+disease%3A+an+epidemiological+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease</span></div><div class="casAuthors">Luchsinger, Jose Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-129</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The objective of this manuscript is to provide a comprehensive review of the epidemiol. evidence linking the continuum of adiposity, hyperinsulinemia, and diabetes with Alzheimer's disease.  The mechanisms for these assocns. remain to be elucidated, but may include direct actions from insulin, advanced products of glycosilation, cerebrovascular disease, and products of adipose tissue metab.  Elevated adiposity in middle age is related to a higher risk of Alzheimer's disease.  The evidence relating adiposity in old age to Alzheimer's disease is conflicting.  Several studies have shown that hyperinsulinemia, a consequence of higher adiposity and insulin resistance, is also related to a higher risk of Alzheimer's disease.  Hyperinsulinemia is a risk factor for diabetes, and numerous studies have shown a relation of diabetes with higher Alzheimer's disease risk.  Most studies fail the take into account the continuum linking these risk factors which may result in underestimation of their importance in Alzheimer's disease.  The implication of these assocns. is that a large proportion of the world population may be at increased risk of Alzheimer's disease given the trends for increasing prevalence of overweight, obesity, hyperinsulinemia, and diabetes.  However, if proven causal, these assocns. also present a unique opportunity for prevention and treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoovYRswr76fbVg90H21EOLACvtfcHk0liZstFPgi0R_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2qu7Y%253D&md5=0d0edcada5526f76f3c96eb5beb77ba5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.02.048%26sid%3Dliteratum%253Aachs%26aulast%3DLuchsinger%26aufirst%3DJ.%2BA.%26atitle%3DAdiposity%252C%2520hyperinsulinemia%252C%2520diabetes%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520epidemiological%2520perspective%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D585%26spage%3D119%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bernardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minghetti, L.</span><span> </span><span class="NLM_article-title">PPAR-gamma agonists as regulators of microglial activation and brain inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F138161206780574579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16454728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=93-109&author=A.+Bernardoauthor=L.+Minghetti&title=PPAR-gamma+agonists+as+regulators+of+microglial+activation+and+brain+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-γ agonists as regulators of microglial activation and brain inflammation</span></div><div class="casAuthors">Bernardo, Antonietta; Minghetti, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-109</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The peroxisome proliferator-activated receptor-γ (PPAR-γ) belongs to a large group of nuclear receptors controlling reprodn., metab., development and immune response.  Upon activation by specific agonists, these receptors form dimers and translocate to the nucleus, where they act as agonist-dependent transcription factors and regulate gene expression by binding to specific promoter regions of target genes.  The observation that PPAR-γ is involved in the regulation of macrophage differentiation and activation in the peripheral organs has prompted the investigation of the functional role of PPAR-γ in microglial cells, the main macrophage population of the CNS.  The present review summarizes the several lines of evidence supporting that PPAR-γ natural and synthetic agonists may control brain inflammation by inhibiting several functions assocd. to microglial activation, such as the expression of surface antigens and the synthesis of nitric oxide, prostaglandins, inflammatory cytokines and chemokines.  Moreover, one of the major natural PPAR-γ agonist, 15d-prostaglandin J2 may contribute to the safe elimination of activated microglia by inducing apoptosis.  Synthetic PPAR-γ agonists do not entirely reproduce the range of 15d-prostaglandin J2 effects, suggesting that PPAR-γ independent mechanisms are also involved in the action of this prostaglandin.  In addn. to microglia, PPAR-γ agonists affect functions and survival of other neural cells, including astrocytes, oligodendrocytes and neurons.  Although most of the evidence comes from in vitro observations, an increasing no. of studies in animal models further supports the potential therapeutic use of PPAR-γ agonists in human brain diseases including multiple sclerosis, Parkinson's disease and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNX9pN2If_nrVg90H21EOLACvtfcHk0liuGdVUwWbl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGhsg%253D%253D&md5=cc4a06dcf6cde721af01217c7e151a64</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F138161206780574579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206780574579%26sid%3Dliteratum%253Aachs%26aulast%3DBernardo%26aufirst%3DA.%26aulast%3DMinghetti%26aufirst%3DL.%26atitle%3DPPAR-gamma%2520agonists%2520as%2520regulators%2520of%2520microglial%2520activation%2520and%2520brain%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D93%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Combs, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannady, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Inflammatory mechanisms in Alzheimer’s disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=10632585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtF2hsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=558-567&author=C.+K.+Combsauthor=D.+E.+Johnsonauthor=J.+C.+Karloauthor=S.+B.+Cannadyauthor=G.+E.+Landreth&title=Inflammatory+mechanisms+in+Alzheimer%E2%80%99s+disease%3A+inhibition+of+beta-amyloid-stimulated+proinflammatory+responses+and+neurotoxicity+by+PPARgamma+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists</span></div><div class="casAuthors">Combs, Colin K.; Johnson, Derrick E.; Karlo, J. Colleen; Cannady, Steven B.; Landreth, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">558-567</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by the extracellular deposition of β-amyloid fibrils within the brain and the subsequent assocn. and phenotypic activation of microglial cells assocd. with the amyloid plaque.  The activated microglia mount a complex local proinflammatory response with the secretion of a diverse range of inflammatory products.  Nonsteroidal anti-inflammatory drugs (NSAIDs) are efficacious in reducing the incidence and risk of AD and significantly delaying disease progression.  A recently appreciated target of NSAIDs is the ligand-activated nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ).  PPARγ is a DNA-binding transcription factor whose transcriptional regulatory actions are activated after agonist binding.  We report that NSAIDs, drugs of the thiazolidinedione class, and the natural ligand prostaglandin J2 act as agonists for PPARγ and inhibit the β-amyloid-stimulated secretion of proinflammatory products by microglia and monocytes responsible for neurotoxicity and astrocyte activation.  The activation of PPARγ also arrested the differentiation of monocytes into activated macrophages.  PPARγ agonists were shown to inhibit the β-amyloid-stimulated expression of the cytokine genes interleukin-6 and tumor necrosis factor α.  Furthermore, PPARγ agonists inhibited the expression of cyclooxygenase-2.  These data provide direct evidence that PPARγ plays a crit. role in regulating the inflammatory responses of microglia and monocytes to β-amyloid.  We argue that the efficacy of NSAIDs in the treatment of AD may be a consequence of their actions on PPARγ rather than on their canonical targets the cyclooxygenases.  Importantly, the efficacy of these agents in inhibiting a broad range of inflammatory responses suggests PPARγ agonists may provide a novel therapeutic approach to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOOr_ebQNjI7Vg90H21EOLACvtfcHk0liuGdVUwWbl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtF2hsLk%253D&md5=29681e57cbb5fa43d62a6ed9526663c4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DC.%2BK.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DKarlo%26aufirst%3DJ.%2BC.%26aulast%3DCannady%26aufirst%3DS.%2BB.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DInflammatory%2520mechanisms%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520inhibition%2520of%2520beta-amyloid-stimulated%2520proinflammatory%2520responses%2520and%2520neurotoxicity%2520by%2520PPARgamma%2520agonists%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D20%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumitrescu-Ozimek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiperi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Banion, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1−42 levels in APPV717I transgenic mice</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1442</span><span class="NLM_x">–</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1442-1453&author=M.+T.+Henekaauthor=M.+Sastreauthor=L.+Dumitrescu-Ozimekauthor=A.+Hankeauthor=I.+Dewachterauthor=C.+Kuiperiauthor=K.+O%E2%80%99Banionauthor=T.+Klockgetherauthor=F.+Van+Leuvenauthor=G.+E.+Landreth&title=Acute+treatment+with+the+PPARgamma+agonist+pioglitazone+and+ibuprofen+reduces+glial+inflammation+and+Abeta1%E2%88%9242+levels+in+APPV717I+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDumitrescu-Ozimek%26aufirst%3DL.%26aulast%3DHanke%26aufirst%3DA.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DKuiperi%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Banion%26aufirst%3DK.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DAcute%2520treatment%2520with%2520the%2520PPARgamma%2520agonist%2520pioglitazone%2520and%2520ibuprofen%2520reduces%2520glial%2520inflammation%2520and%2520Abeta1%25E2%2588%259242%2520levels%2520in%2520APPV717I%2520transgenic%2520mice%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1442%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Camacho, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spittaels, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchiers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">10908</span><span class="NLM_x">–</span> <span class="NLM_lpage">10917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1523%2FJNEUROSCI.3987-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=15574741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFShu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10908-10917&author=I.+E.+Camachoauthor=L.+Serneelsauthor=K.+Spittaelsauthor=P.+Merchiersauthor=D.+Dominguezauthor=B.+De+Strooper&title=Peroxisome+proliferator-activated+receptor+gamma+induces+a+clearance+mechanism+for+the+amyloid-beta+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide</span></div><div class="casAuthors">Camacho, Ira Espuny; Serneels, Lutgarde; Spittaels, Kurt; Merchiers, Pascal; Dominguez, Diana; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">10908-10917</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We investigated whether peroxisome proliferator-activated receptor γ (PPARγ) could be involved in the modulation of the amyloid cascade causing Alzheimer's disease.  Inducing expression or activating PPARγ using synthetic agonists of the thiazolinedione family results in a dramatic decrease in the levels of the amyloid-β (Aβ) peptide in the conditioned medium of neuronal and non-neuronal cells.  PPARγ does not affect expression or activity of any of the secretases involved in the generation of the Aβ peptide but induces a fast, cell-bound clearing mechanism responsible for the removal of the Aβ peptide from the medium.  Although PPARγ expression is generally low in the CNS, induction of PPARγ expression during inflammation could be beneficial for inducing Aβ clearance.  We confirm that the Aβ clearance mechanism can indeed be induced by PPARγ activation in primary murine-mixed glia and cortical neuronal cultures.  Our results suggest that PPARγ-controlled mechanisms should be explored further as potential drug targets for Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsr8SzaoJWLrVg90H21EOLACvtfcHk0liuGdVUwWbl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFShu77N&md5=17620a15996c1cd88506c509c5c787cc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3987-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3987-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DCamacho%26aufirst%3DI.%2BE.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DSpittaels%26aufirst%3DK.%26aulast%3DMerchiers%26aufirst%3DP.%26aulast%3DDominguez%26aufirst%3DD.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma%2520induces%2520a%2520clearance%2520mechanism%2520for%2520the%2520amyloid-beta%2520peptide%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D10908%26epage%3D10917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghgraef, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evert, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumitrescu-Ozimek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs repress {beta}-secretase gene promoter activity by the activation of PPAR{gamma}</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=443-448&author=M.+Sastreauthor=I.+Dewachterauthor=S.+Rossnerauthor=N.+Bogdanovicauthor=E.+Rosenauthor=P.+Borghgraefauthor=B.+O.+Evertauthor=L.+Dumitrescu-Ozimekauthor=D.+R.+Thalauthor=G.+Landrethauthor=J.+Walterauthor=T.+Klockgetherauthor=F.+van+Leuvenauthor=M.+T.+Heneka&title=Nonsteroidal+anti-inflammatory+drugs+repress+%7Bbeta%7D-secretase+gene+promoter+activity+by+the+activation+of+PPAR%7Bgamma%7D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DE.%26aulast%3DBorghgraef%26aufirst%3DP.%26aulast%3DEvert%26aufirst%3DB.%2BO.%26aulast%3DDumitrescu-Ozimek%26aufirst%3DL.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3Dvan%2BLeuven%26aufirst%3DF.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520repress%2520%257Bbeta%257D-secretase%2520gene%2520promoter%2520activity%2520by%2520the%2520activation%2520of%2520PPAR%257Bgamma%257D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D443%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Nicolakakis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboulkassim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongali, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecrux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa-Neto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Complete rescue of cerebrovascular function in aged Alzheimer’s disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">9287</span><span class="NLM_x">–</span> <span class="NLM_lpage">9296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1523%2FJNEUROSCI.3348-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18784309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sns7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=9287-9296&author=N.+Nicolakakisauthor=T.+Aboulkassimauthor=B.+Ongaliauthor=C.+Lecruxauthor=P.+Fernandesauthor=P.+Rosa-Netoauthor=X.+K.+Tongauthor=E.+Hamel&title=Complete+rescue+of+cerebrovascular+function+in+aged+Alzheimer%E2%80%99s+disease+transgenic+mice+by+antioxidants+and+pioglitazone%2C+a+peroxisome+proliferator-activated+receptor+gamma+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist</span></div><div class="casAuthors">Nicolakakis, Nektaria; Aboulkassim, Tahar; Ongali, Brice; Lecrux, Clotilde; Fernandes, Priscilla; Rosa-Neto, Pedro; Tong, Xin-Kang; Hamel, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9287-9296</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that cerebrovascular dysfunction is an important factor in the pathogenesis of Alzheimer's disease (AD).  Using aged (∼16 mo) amyloid precursor protein (APP) transgenic mice that exhibit increased prodn. of the amyloid-β (Aβ) peptide and severe cerebrovascular and memory deficits, we examd. the capacity in vivo treatments with the antioxidants N-acetyl-L-cysteine (NAC) and tempol, or the peroxisome proliferator-activated receptor γ agonist pioglitazone to rescue cerebrovascular function and selected markers of AD neuropathol.  Addnl., we tested the ability of pioglitazone to normalize the impaired increases in cerebral blood flow (CBF) and glucose uptake (CGU) induced by whisker stimulation, and to reverse spatial memory deficits in the Morris water maze.  All compds. fully restored cerebrovascular reactivity of isolated cerebral arteries concomitantly with changes in proteins regulating oxidative stress, without reducing brain Aβ levels or Aβ plaque load.  Pioglitazone, but not NAC, significantly attenuated astroglial activation and improved, albeit nonsignificantly, the reduced cortical cholinergic innervation.  Furthermore, pioglitazone completely normalized the CBF and CGU responses to increased neuronal activity, but it failed to improve spatial memory.  Our results are the first to demonstrate that late pharmacol. intervention with pioglitazone not only overcomes cerebrovascular dysfunction and altered neurometabolic coupling in aged APP mice, but also counteracts cerebral oxidative stress, glial activation, and, partly, cholinergic denervation.  Although early or combined therapy may be warranted to improve cognition, these findings unequivocally point to pioglitazone as a most promising strategy for restoring cerebrovascular function and counteracting several AD markers detrimental to neuronal function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojir8viGYQ0LVg90H21EOLACvtfcHk0lhGoWdICHrv7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sns7nP&md5=7af2862379b34ecc2e92d4ee59b94e16</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3348-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3348-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DNicolakakis%26aufirst%3DN.%26aulast%3DAboulkassim%26aufirst%3DT.%26aulast%3DOngali%26aufirst%3DB.%26aulast%3DLecrux%26aufirst%3DC.%26aulast%3DFernandes%26aufirst%3DP.%26aulast%3DRosa-Neto%26aufirst%3DP.%26aulast%3DTong%26aufirst%3DX.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DComplete%2520rescue%2520of%2520cerebrovascular%2520function%2520in%2520aged%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520mice%2520by%2520antioxidants%2520and%2520pioglitazone%252C%2520a%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520agonist%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D9287%26epage%3D9296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzimopoulou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvartau-Hind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthewsw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, P. M.</span><span> </span><span class="NLM_article-title">Effects of 12 months of treatment with the PPARgamma agonist rosiglitazone on brain glucose metabolism in Alzheimer’s disease: a 18F-FDG PET study</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.jalz.2009.04.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19362884" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=207&author=E.+A.+Rabinerauthor=S.+Tzimopoulouauthor=V.+J.+Cunninghamauthor=B.+Jeterauthor=M.+Zvartau-Hindauthor=M.+Castigliaauthor=P.+Mistryauthor=N.+P.+Birdauthor=J.+Matthewswauthor=B.+Whitcherauthor=T.+E.+Nicholsauthor=R.+Laiauthor=N.+Lotayauthor=A.+Saundersauthor=E.+Reimanauthor=K.+Chenauthor=M.+Goldauthor=P.+M.+Matthews&title=Effects+of+12+months+of+treatment+with+the+PPARgamma+agonist+rosiglitazone+on+brain+glucose+metabolism+in+Alzheimer%E2%80%99s+disease%3A+a+18F-FDG+PET+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2009.04.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2009.04.117%26sid%3Dliteratum%253Aachs%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DTzimopoulou%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DV.%2BJ.%26aulast%3DJeter%26aufirst%3DB.%26aulast%3DZvartau-Hind%26aufirst%3DM.%26aulast%3DCastiglia%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DP.%26aulast%3DBird%26aufirst%3DN.%2BP.%26aulast%3DMatthewsw%26aufirst%3DJ.%26aulast%3DWhitcher%26aufirst%3DB.%26aulast%3DNichols%26aufirst%3DT.%2BE.%26aulast%3DLai%26aufirst%3DR.%26aulast%3DLotay%26aufirst%3DN.%26aulast%3DSaunders%26aufirst%3DA.%26aulast%3DReiman%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DMatthews%26aufirst%3DP.%2BM.%26atitle%3DEffects%2520of%252012%2520months%2520of%2520treatment%2520with%2520the%2520PPARgamma%2520agonist%2520rosiglitazone%2520on%2520brain%2520glucose%2520metabolism%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%252018F-FDG%2520PET%2520study%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sato, T.; Hanyu, H.; Hirao, K.; Kanetaka, H.; Sakurai, H.; Iwamoto, T.</span><span> </span><span class="NLM_article-title">Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease</span>.  <span class="citation_source-journal">Neurobiol. Aging</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2009.10.009</span> . Published Online: Nov 17, 2009.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.neurobiolaging.2009.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sato%2C+T.%3B+Hanyu%2C+H.%3B+Hirao%2C+K.%3B+Kanetaka%2C+H.%3B+Sakurai%2C+H.%3B+Iwamoto%2C+T.+Efficacy+of+PPAR-gamma+agonist+pioglitazone+in+mild+Alzheimer+disease.+Neurobiol.+Aging+%5BOnline+early+access%5D.+DOI%3A+10.1016%2Fj.neurobiolaging.2009.10.009.+Published+Online%3A+Nov+17%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26atitle%3DEfficacy%2520of%2520PPAR-gamma%2520agonist%2520pioglitazone%2520in%2520mild%2520Alzheimer%2520disease%26jtitle%3DNeurobiol.%2520Aging%26doi%3D10.1016%2Fj.neurobiolaging.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Maeshiba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motohashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanayama, S.</span><span> </span><span class="NLM_article-title">Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=9037440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADyaK2sXptlCmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1997&pages=29-35&author=Y.+Maeshibaauthor=Y.+Kiyotaauthor=K.+Yamashitaauthor=Y.+Yoshimuraauthor=M.+Motohashiauthor=S.+Tanayama&title=Disposition+of+the+new+antidiabetic+agent+pioglitazone+in+rats%2C+dogs%2C+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys</span></div><div class="casAuthors">Maeshiba, Yoshihiro; Kiyota, Yutaka; Yamashita, Kenji; Yoshimura, Yoshinobu; Motohashi, Michio; Tanayama, Shigeharu</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Cantor</span>)
        </div><div class="casAbstract">The disposition of pioglitazone was studied after oral administration to rats, dogs, and monkeys using 14C-labeled drug.  After oral dosing, pioglitazone was well absorbed from the gastrointestinal tract at an extent of 96, 95, and 90% in rats, dogs, and monkeys, resp.  In rats, the concn. of pioglitazone in plasma reached a peak (Cmax 0.71 μg/mL) at 4 h (tmax) after dosing and declined with a half-life (t1/2) of 2.6 h.  In dogs, tmax, Cmax and t1/2 were 0.5 h, 0.32 μg/mL and 2.1 h, and those for monkeys were 4.3 h, 0.48 μg/mL and 5.3 h, resp.  The drug was metabolized mainly to M-I to M-VI including the pharmacol. active metabolites (M-II, III, and IV).  The pharmacol. active compds. (total of the unchanged compd. and the above three active metabolites) accounted for 87, 71 and 73% of the radioactivity in plasma of rats, dogs, and monkeys, resp.  The radioactivity was widely distributed in tissues after oral administration to rats, and decreased to the very low concn. within 24 to 72 h after dosing.  Radioactivity dose was almost completely excreted in urine and feces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOCPe49ZgLkLVg90H21EOLACvtfcHk0lgKCjYjGAj8zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXptlCmtA%253D%253D&md5=7f144eaf15e2bb1e2507316fb2f3df52</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaeshiba%26aufirst%3DY.%26aulast%3DKiyota%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DY.%26aulast%3DMotohashi%26aufirst%3DM.%26aulast%3DTanayama%26aufirst%3DS.%26atitle%3DDisposition%2520of%2520the%2520new%2520antidiabetic%2520agent%2520pioglitazone%2520in%2520rats%252C%2520dogs%252C%2520and%2520monkeys%26jtitle%3DArzneim.%2520Forsch.%26date%3D1997%26volume%3D47%26spage%3D29%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Koeberle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurglics, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werz, O.</span><span> </span><span class="NLM_article-title">Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8068</span><span class="NLM_x">–</span> <span class="NLM_lpage">8076</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801085s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8068-8076&author=A.+Koeberleauthor=H.+Zettlauthor=C.+Greinerauthor=M.+Wurglicsauthor=M.+Schubert-Zsilaveczauthor=O.+Werz&title=Pirinixic+acid+derivatives+as+novel+dual+inhibitors+of+microsomal+prostaglandin+E2+synthase-1+and+5-lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm801085s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801085s%26sid%3Dliteratum%253Aachs%26aulast%3DKoeberle%26aufirst%3DA.%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DGreiner%26aufirst%3DC.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DWerz%26aufirst%3DO.%26atitle%3DPirinixic%2520acid%2520derivatives%2520as%2520novel%2520dual%2520inhibitors%2520of%2520microsomal%2520prostaglandin%2520E2%2520synthase-1%2520and%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8068%26epage%3D8076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Mitsunobu, O.</span><span> </span><span class="NLM_article-title">The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1055%2Fs-1981-29317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1981&pages=1-28&author=O.+Mitsunobu&title=The+use+of+diethyl+azodicarboxylate+and+triphenylphosphine+in+synthesis+and+transformation+of+natural+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29317%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26atitle%3DThe%2520use%2520of%2520diethyl%2520azodicarboxylate%2520and%2520triphenylphosphine%2520in%2520synthesis%2520and%2520transformation%2520of%2520natural%2520products%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4421</span><span class="NLM_x">–</span> <span class="NLM_lpage">4426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4421-4426&author=H.+Zettlauthor=R.+Steriauthor=M.+Lammerhoferauthor=M.+Schubert-Zsilavecz&title=Discovery+of+a+novel+class+of+2-mercaptohexanoic+acid+derivatives+as+highly+active+PPARalpha+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DSteri%26aufirst%3DR.%26aulast%3DLammerhofer%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%25202-mercaptohexanoic%2520acid%2520derivatives%2520as%2520highly%2520active%2520PPARalpha%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4421%26epage%3D4426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuchtenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorner-Ciossek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Insensitivity to Abeta 42-lowering non-steroidal anti-inflammatory drugs (NSAIDs) and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">24504</span><span class="NLM_x">–</span> <span class="NLM_lpage">24513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=24504-24513&author=E.+Czirrauthor=S.+Leuchtenbergerauthor=C.+Dorner-Ciossekauthor=A.+Schneiderauthor=M.+Juckerauthor=E.+H.+Kooauthor=C.+U.+Pietrzikauthor=K.+Baumannauthor=S.+Weggen&title=Insensitivity+to+Abeta+42-lowering+non-steroidal+anti-inflammatory+drugs+%28NSAIDs%29+and+gamma-secretase+inhibitors+is+common+among+aggressive+presenilin-1+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DLeuchtenberger%26aufirst%3DS.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DInsensitivity%2520to%2520Abeta%252042-lowering%2520non-steroidal%2520anti-inflammatory%2520drugs%2520%2528NSAIDs%2529%2520and%2520gamma-secretase%2520inhibitors%2520is%2520common%2520among%2520aggressive%2520presenilin-1%2520mutations%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D24504%26epage%3D24513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Karlstrom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lendahl, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naslund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">A sensitive and quantitative assay for measuring cleavage of presenilin substrates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">6763</span><span class="NLM_x">–</span> <span class="NLM_lpage">6766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=6763-6766&author=H.+Karlstromauthor=A.+Bergmanauthor=U.+Lendahlauthor=J.+Naslundauthor=J.+Lundkvist&title=A+sensitive+and+quantitative+assay+for+measuring+cleavage+of+presenilin+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlstrom%26aufirst%3DH.%26aulast%3DBergman%26aufirst%3DA.%26aulast%3DLendahl%26aufirst%3DU.%26aulast%3DNaslund%26aufirst%3DJ.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DA%2520sensitive%2520and%2520quantitative%2520assay%2520for%2520measuring%2520cleavage%2520of%2520presenilin%2520substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D6763%26epage%3D6766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavatte, P.</span><span> </span><span class="NLM_article-title">Structural insight into PPARgamma ligands binding</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F092986709788186165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19442144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslagtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=1768-1789&author=A.+Farceauthor=N.+Renaultauthor=P.+Chavatte&title=Structural+insight+into+PPARgamma+ligands+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into PPARγ ligands binding</span></div><div class="casAuthors">Farce, A.; Renault, N.; Chavatte, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1768-1789</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxisome Proliferator Activated Receptors (PPARs) are a family of three related nuclear receptors first cloned in 1990.  Their involvement in glucidic and lipidic homeostasis quickly made them an attractive target for the treatment of metabolic syndrome, the most prevalent mortality factor in developed countries.  They therefore attracted much synthetical efforts, more particularly PPARγ.  Supported by a large no. of crystallog. studies, data derived from these compds. lead to a fairly clear view of the agonist binding mode into the Ligand Binding Domain (LBD).  Nearly all the compds. conform to a three-module structure, with a binder group involved in a series of hydrogen bonds in front of the ligand-dependent Activation Function (AF2), a linker mostly arranged around a phenoxyethyl and an effector end occupying the large cavity of the binding site.  Following the marketing of the glitazones and the observation of the hepatotoxicity of troglitazone, variations in the binder led to the glitazars, and then pharmacomodulations have been undertaken on the two other modules, leading to a large family of highly related chem. structures.  Some compds., while still adhering to the three-module structure, diverge from the mainstream, such as the phthalates.  Curiously, these plasticizers were known to elicit biol. effects that led to the discovery of PPARs but were not actively studied as PPARs agonists.  As the biol. effects of PPARs became clearer, new compds. were also found to exert at least a part of their actions by the activation of PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXIzPjMWM9rrVg90H21EOLACvtfcHk0lic08nh4cfI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslagtbY%253D&md5=4a5217779abc9d8d640bf8b9f2600599</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F092986709788186165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788186165%26sid%3Dliteratum%253Aachs%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DRenault%26aufirst%3DN.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DStructural%2520insight%2520into%2520PPARgamma%2520ligands%2520binding%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D1768%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kache, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasiadis, P. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1038%2Fnm1235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=15834426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=545-550&author=T.+Kukarauthor=M.+P.+Murphyauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=S.+Weggenauthor=T.+E.+Smithauthor=T.+Laddauthor=M.+A.+Khanauthor=R.+Kacheauthor=J.+Beardauthor=M.+Dodsonauthor=S.+Meritauthor=V.+V.+Ozolsauthor=P.+Z.+Anastasiadisauthor=P.+Dasauthor=A.+Fauqauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Diverse+compounds+mimic+Alzheimer+disease-causing+mutations+by+augmenting+Abeta42+production"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production</span></div><div class="casAuthors">Kukar, Thomas; Murphy, Michael Paul; Eriksen, Jason L.; Sagi, Sarah A.; Weggen, Sascha; Smith, Tawnya E.; Ladd, Thomas; Khan, Murad A.; Kache, Rajashaker; Beard, Jenny; Dodson, Mark; Merit, Sami; Ozols, Victor V.; Anastasiadis, Panos Z.; Das, Pritam; Fauq, Abdul; Koo, Edward H.; Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-550</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increased Aβ42 prodn. has been linked to the development of Alzheimer disease.  We now identify a no. of compds. that raise Aβ42.  Among the more potent Aβ42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID.  Many COX-2-selective NSAIDs tested raised Aβ42, including multiple COX-2-selective derivs. of two Aβ42-lowering NSAIDs.  Compds. devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Aβ42.  These compds. seem to target the γ-secretase complex, increasing γ-secretase-catalyzed prodn. of Aβ42 in vitro.  Short-term in vivo studies show that two Aβ42-raising compds. increase Aβ42 levels in the brains of mice.  The elevations in Aβ42 by these compds. are comparable to the increases in Aβ42 induced by Alzheimer disease-causing mutations in the genes encoding amyloid β protein precursor and presenilins, raising the possibility that exogenous compds. or naturally occurring isoprenoids might increase Aβ42 prodn. in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtRxKDIW3Gh7Vg90H21EOLACvtfcHk0lic08nh4cfI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D&md5=78e435c12ca6f7c6af227cd38bffe131</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnm1235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1235%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DLadd%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DKache%26aufirst%3DR.%26aulast%3DBeard%26aufirst%3DJ.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DMerit%26aufirst%3DS.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DAnastasiadis%26aufirst%3DP.%2BZ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDiverse%2520compounds%2520mimic%2520Alzheimer%2520disease-causing%2520mutations%2520by%2520augmenting%2520Abeta42%2520production%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Popescu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syha, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1002%2Fardp.200700042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17610302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosV2gsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2007&pages=367-371&author=L.+Popescuauthor=O.+Rauauthor=J.+Bottcherauthor=Y.+Syhaauthor=M.+Schubert-Zsilavecz&title=Quinoline-based+derivatives+of+pirinixic+acid+as+dual+PPAR+alpha%2Fgamma+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline-based derivatives of pirinixic acid as dual PPAR α/γ agonists</span></div><div class="casAuthors">Popescu, Laura; Rau, Oliver; Boettcher, Jark; Syha, Yvonne; Schubert-Zsilavecz, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">367-371</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Pirinixic acid is known for its peroxisome proliferator-activated receptor (PPAR) agonistic action.  In a recent publication, we have shown that aliph. α-substitution of pirinixic acid enhances both PPARα and PPARγ agonism.  The goal of this study was to evaluate, whether the PPAR agonism of pirinixic acid may be also maintained in quinoline-based derivs.  The present study revealed that the mere substitution of the di-Me aniline moiety of pirinixic acid by quinoline leads to a total loss of PPARα/γ agonism, whereas concomitant α-substitution with Bu or n-hexyl groups restores and even enforces PPAR activation, leading to potent dual PPARα/γ agonists.  In the following we report the synthesis of quinoline-based derivs. of pirinixic acid, which in a Gal4-based luciferase-reporter gene assay proved to be potent dual PPARα/γ agonists.  Mol. docking of compd. 4 (I) with FlexX suggests a binding mode resembling to that of tesaglitazar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreXsClnUkbcLVg90H21EOLACvtfcHk0lic08nh4cfI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosV2gsbw%253D&md5=113559980eb2dca3ba5d15030d00fc2e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700042%26sid%3Dliteratum%253Aachs%26aulast%3DPopescu%26aufirst%3DL.%26aulast%3DRau%26aufirst%3DO.%26aulast%3DBottcher%26aufirst%3DJ.%26aulast%3DSyha%26aufirst%3DY.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DQuinoline-based%2520derivatives%2520of%2520pirinixic%2520acid%2520as%2520dual%2520PPAR%2520alpha%252Fgamma%2520agonists%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2007%26volume%3D340%26spage%3D367%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Rau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syha, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1002%2Fardp.200700209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18275039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVersL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=191-195&author=O.+Rauauthor=Y.+Syhaauthor=H.+Zettlauthor=M.+Kockauthor=A.+Bockauthor=M.+Schubert-Zsilavecz&title=Alpha-alkyl+substituted+pirinixic+acid+derivatives+as+potent+dual+agonists+of+the+peroxisome+proliferator+activated+receptor+alpha+and+gamma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">α-Alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma</span></div><div class="casAuthors">Rau, Oliver; Syha, Yvonne; Zettl, Heiko; Kock, Michael; Bock, Andreas; Schubert-Zsilavecz, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-195</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors, playing a pivotal role in energy homeostasis.  Activators of the PPARα subtype are in widespread use for the treatment of hyperlipidemia, while activators of the PPARγ subtype are in clin. use for the treatment of type-2 diabetes.  Since both of these diseases are frequently assocd., the combined treatment with one drug simultaneously activating PPARα and PPARγ seems worthwhile.  Starting with pirinixic acid, which is a moderately active dual PPARα/γ agonist, we improved potency at the human PPARα and PPARγ by substituting the α-position with an aliph. chain.  The maximal effect was achieved at a chain length of four and six carbons, resp., leading to an activity induction by a factor of 36 for PPARα and 18 for PPARγ, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquwvfYMh_G_7Vg90H21EOLACvtfcHk0lgknlKB4iCobw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVersL4%253D&md5=5e8202ec55cf61294272c0a73728a29c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700209%26sid%3Dliteratum%253Aachs%26aulast%3DRau%26aufirst%3DO.%26aulast%3DSyha%26aufirst%3DY.%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DKock%26aufirst%3DM.%26aulast%3DBock%26aufirst%3DA.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DAlpha-alkyl%2520substituted%2520pirinixic%2520acid%2520derivatives%2520as%2520potent%2520dual%2520agonists%2520of%2520the%2520peroxisome%2520proliferator%2520activated%2520receptor%2520alpha%2520and%2520gamma%26jtitle%3DArch.%2520Pharm.%26date%3D2008%26volume%3D341%26spage%3D191%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proschak, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Novel pirinixic acids as PPARalpha preferential dual PPARalpha/gamma agonists</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=576-586&author=H.+Zettlauthor=M.+Dittrichauthor=R.+Steriauthor=O.+Proschakauthor=O.+Rauauthor=D.+Steinhilberauthor=G.+Schneiderauthor=M.+Lammerhoferauthor=M.+Schubert-Zsilavecz&title=Novel+pirinixic+acids+as+PPARalpha+preferential+dual+PPARalpha%2Fgamma+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DDittrich%26aufirst%3DM.%26aulast%3DSteri%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DO.%26aulast%3DRau%26aufirst%3DO.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DLammerhofer%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DNovel%2520pirinixic%2520acids%2520as%2520PPARalpha%2520preferential%2520dual%2520PPARalpha%252Fgamma%2520agonists%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2009%26volume%3D28%26spage%3D576%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lammerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiesel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, W.</span><span> </span><span class="NLM_article-title">Enantiomer separation and indirect chromatographic absolute configuration prediction of chiral pirinixic acid derivatives: limitations of polysaccharide-type chiral stationary phases in comparison to chiral anion-exchangers</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1217</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1217&publication_year=2010&pages=1033-1040&author=M.+Lammerhoferauthor=R.+Pellauthor=M.+Mahutauthor=M.+Richterauthor=S.+Schieselauthor=H.+Zettlauthor=M.+Dittrichauthor=M.+Schubert-Zsilaveczauthor=W.+Lindner&title=Enantiomer+separation+and+indirect+chromatographic+absolute+configuration+prediction+of+chiral+pirinixic+acid+derivatives%3A+limitations+of+polysaccharide-type+chiral+stationary+phases+in+comparison+to+chiral+anion-exchangers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLammerhofer%26aufirst%3DM.%26aulast%3DPell%26aufirst%3DR.%26aulast%3DMahut%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DSchiesel%26aufirst%3DS.%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DDittrich%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DLindner%26aufirst%3DW.%26atitle%3DEnantiomer%2520separation%2520and%2520indirect%2520chromatographic%2520absolute%2520configuration%2520prediction%2520of%2520chiral%2520pirinixic%2520acid%2520derivatives%253A%2520limitations%2520of%2520polysaccharide-type%2520chiral%2520stationary%2520phases%2520in%2520comparison%2520to%2520chiral%2520anion-exchangers%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2010%26volume%3D1217%26spage%3D1033%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Meinert, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, J. C.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease anti-inflammatory prevention trial: design, methods, and baseline results</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.jalz.2008.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19328435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ktFGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=93-104&author=C.+L.+Meinertauthor=L.+D.+McCaffreyauthor=J.+C.+Breitner&title=Alzheimer%E2%80%99s+disease+anti-inflammatory+prevention+trial%3A+design%2C+methods%2C+and+baseline+results"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results</span></div><div class="casAuthors">Meinert Curtis L; McCaffrey Lee D; Breitner John C S</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-104</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) was designed to address whether non-steroidal anti-inflammatory drugs (NSAIDs) can prevent or delay the onset of Alzheimer's disease (AD).  METHODS:  ADAPT was a randomized, double-placebo-controlled, multicenter chemoprevention trial conducted at six U.S. dementia research clinics.  At entry, participants were required to test "normal" on a battery of cognitive tests and to be age 70+ with a family history of Alzheimer-like dementia.  Persons were randomly assigned to 200 mg b.i.d. celecoxib (Celebrex, Pfizer), 220 mg b.i.d. naproxen sodium (Aleve, Bayer), or placebo.  The primary outcome measure was AD.  Secondary outcome measures were cognitive decline and measures related to safety of the treatments when used long term.  ADAPT was designed to detect a 30% reduction in AD incidence with 80% power.  The estimated sample size requirement was 2,625.  RESULTS:  Enrollment began in March 2001 and ended in December 2004 when treatments were suspended because of concerns regarding cardiovascular safety of the treatments.  Followup ranged from 1 to 46 months.  The achieved enrollment was 2,528.  Recruitment was achieved primarily via mailings to people aged 70+ living in the catchment areas of the six field sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-IJDr0TD4ycjl5L8hwNX0fW6udTcc2eZ2oKn3j7bWF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ktFGnug%253D%253D&md5=d4f8ff962d90a2e440a49857378ede46</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2008.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2008.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DMeinert%26aufirst%3DC.%2BL.%26aulast%3DMcCaffrey%26aufirst%3DL.%2BD.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520anti-inflammatory%2520prevention%2520trial%253A%2520design%252C%2520methods%252C%2520and%2520baseline%2520results%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3D93%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Jager, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuchtenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesselowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldron, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span> </span><span class="NLM_article-title">Alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1111%2Fj.1471-4159.2009.06420.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19804379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD1MfjtlWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=1369-1382&author=S.+Jagerauthor=S.+Leuchtenbergerauthor=A.+Martinauthor=E.+Czirrauthor=J.+Wesselowskiauthor=M.+Dieckmannauthor=E.+Waldronauthor=C.+Korthauthor=E.+H.+Kooauthor=M.+Henekaauthor=S.+Weggenauthor=C.+U.+Pietrzik&title=Alpha-secretase+mediated+conversion+of+the+amyloid+precursor+protein+derived+membrane+stub+C99+to+C83+limits+Abeta+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation</span></div><div class="casAuthors">Jager Sebastian; Leuchtenberger Stefanie; Martin Anne; Czirr Eva; Wesselowski Johanna; Dieckmann Marco; Waldron Elaine; Korth Carsten; Koo Edward H; Heneka Michael; Weggen Sascha; Pietrzik Claus U</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1369-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Swedish mutation within the amyloid precursor protein (APP) causes early-onset Alzheimer's disease due to increased cleavage of APP by BACE1.  While beta-secretase shedding of Swedish APP (APPswe) largely results from an activity localized in the late secretory pathway, cleavage of wild-type APP occurs mainly in endocytic compartments.  However, we show that liberation of Abeta from APPswe is still dependent on functional internalization from the cell surface.  Inspite the unchanged overall beta-secretase cleaved soluble APP released from APP(swe) secretion, mutations of the APPswe internalization motif strongly reduced C99 levels and substantially decreased Abeta secretion.  We point out that alpha-secretase activity-mediated conversion of C99 to C83 is the main cause of this Abeta reduction.  Furthermore, we demonstrate that alpha-secretase cleavage of C99 even contributes to the reduction of Abeta secretion of internalization deficient wild-type APP.  Therefore, inhibition of alpha-secretase cleavage increased Abeta secretion through diminished conversion of C99 to C83 in APP695, APP695swe or C99 expressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfAmsBbKr5SHRxY89Cm6SyfW6udTcc2eZ2oKn3j7bWF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MfjtlWkug%253D%253D&md5=ee577954f25c0f714cfeb2ccefe9f605</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06420.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06420.x%26sid%3Dliteratum%253Aachs%26aulast%3DJager%26aufirst%3DS.%26aulast%3DLeuchtenberger%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DWesselowski%26aufirst%3DJ.%26aulast%3DDieckmann%26aufirst%3DM.%26aulast%3DWaldron%26aufirst%3DE.%26aulast%3DKorth%26aufirst%3DC.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DHeneka%26aufirst%3DM.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26atitle%3DAlpha-secretase%2520mediated%2520conversion%2520of%2520the%2520amyloid%2520precursor%2520protein%2520derived%2520membrane%2520stub%2520C99%2520to%2520C83%2520limits%2520Abeta%2520generation%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D1369%26epage%3D1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitasato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1211%2F0022357011778070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=11804398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1alsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=1679-1685&author=M.+Katoauthor=S.+Nishidaauthor=H.+Kitasatoauthor=N.+Sakataauthor=S.+Kawai&title=Cyclooxygenase-1+and+cyclooxygenase-2+selectivity+of+non-steroidal+anti-inflammatory+drugs%3A+investigation+using+human+peripheral+monocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes</span></div><div class="casAuthors">Kato, Miyako; Nishida, Shinichi; Kitasato, Hidero; Sakata, Natsue; Kawai, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1679-1685</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Since the pharmacol. profiles of various non-steroidal anti-inflammatory drugs (NSAIDs) might depend on their differing selectivity for cyclooxygenase 1 (COX-1) and 2 (COX-2), we developed a new screening method using human peripheral monocytes.  Monocytes from healthy volunteers were sepd., and the cells were incubated with or without lipopolysaccharide (LPS).  Monocytes without LPS stimulation exclusively expressed COX-1 on Western blotting anal., whereas LPS stimulation induced COX-2 expression.  Unstimulated monocytes (COX-1) and LPS-stimulated monocytes (COX-2) were then used to det. the COX selectivity of various NSAIDs.  The resp. mean IC50 values for COX-1 and COX-2 IC50 (μM), and the COX-1/COX-2 ratio of each NSAID were as follows: celecoxib, 82, 6.8, 12; diclofenac, 0.076, 0.026, 2.9; etodolac, > 100, 53, > 1.9; ibuprofen, 12, 80, 0.15; indometacin, 0.0090, 0.31, 0.029; meloxicam, 37, 6.1, 6.1; 6-MNA (the active metabolite of nabumetone), 149, 230, 0.65; NS-398, 125, 5.6, 22; piroxicam, 47, 25, 1.9; rofecoxib, > 100, 25, > 4.0; S-2474, > 100, 8.9, > 11; SC-560, 0.0048, 1.4, 0.0034.  The percentage inhibition of COX-1 activity at the IC50 of COX-2 also showed a wide variation among these NSAIDs.  The bioassay system using human monocytes to assess the inhibitory effects of various NSAIDs on COX-1 and COX-2 may become a clin. useful screening method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRB4Yns9-eB7Vg90H21EOLACvtfcHk0lgJ7b57nXXQaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1alsA%253D%253D&md5=e129115e26cfcea58c3468b8ed5537a4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1211%2F0022357011778070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011778070%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DNishida%26aufirst%3DS.%26aulast%3DKitasato%26aufirst%3DH.%26aulast%3DSakata%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%26atitle%3DCyclooxygenase-1%2520and%2520cyclooxygenase-2%2520selectivity%2520of%2520non-steroidal%2520anti-inflammatory%2520drugs%253A%2520investigation%2520using%2520human%2520peripheral%2520monocytes%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2001%26volume%3D53%26spage%3D1679%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Demello, K. L.; Ricketts, A. P.</span><span> </span><span class="NLM_article-title">Cox-2 Selective Carprofen for Treating Pain and Inflammation in Dogs</span>. US2003212123 (A1),<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=K.+L.+Demello&author=A.+P.+Ricketts&title=Cox-2+Selective+Carprofen+for+Treating+Pain+and+Inflammation+in+Dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDemello%26aufirst%3DK.%2BL.%26atitle%3DCox-2%2520Selective%2520Carprofen%2520for%2520Treating%2520Pain%2520and%2520Inflammation%2520in%2520Dogs%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Pairet, M.; van Ryn, J.</span>, Eds.  <span class="citation_source-book">COX-2 Inhibitors</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Birkhäuser</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1007%2F978-3-0348-7879-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Pairet&author=J.+van+Ryn&title=COX-2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2F978-3-0348-7879-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-0348-7879-1%26sid%3Dliteratum%253Aachs%26aulast%3DPairet%26aufirst%3DM.%26btitle%3DCOX-2%2520Inhibitors%26pub%3DBirkh%25C3%25A4user%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ning Tang, Arun K. Somavarapu, <span class="NLM_string-name hlFld-ContribAuthor">Kasper P. Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Recipe for γ-Secretase Modulation from Computational Analysis of 60 Active Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 18078-18088. <a href="https://doi.org/10.1021/acsomega.8b02196" title="DOI URL">https://doi.org/10.1021/acsomega.8b02196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02196%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DMolecular%252BRecipe%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%252Bfrom%252BComputational%252BAnalysis%252Bof%252B60%252BActive%252BCompounds%26aulast%3DTang%26aufirst%3DNing%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28082018%26date%3D10122018%26volume%3D3%26issue%3D12%26spage%3D18078%26epage%3D18088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heiko  Zettl</span>, <span class="hlFld-ContribAuthor ">Julia  Ness</span>, <span class="hlFld-ContribAuthor ">Volker  Hähnke</span>, <span class="hlFld-ContribAuthor ">Dirk  Beher</span>, <span class="hlFld-ContribAuthor ">Thorsten  Jumpertz</span>, <span class="hlFld-ContribAuthor ">Arman  Saric</span>, <span class="hlFld-ContribAuthor ">Karlheinz  Baumann</span>, <span class="hlFld-ContribAuthor ">Claus U.  Pietrzik</span>, <span class="hlFld-ContribAuthor ">Bruno  Bulic</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>, and <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of γ-Secretase Modulators with a Novel Activity Profile by Text-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (9)
                                     , 1488-1495. <a href="https://doi.org/10.1021/cb3001952" title="DOI URL">https://doi.org/10.1021/cb3001952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb3001952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb3001952%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%252Bwith%252Ba%252BNovel%252BActivity%252BProfile%252Bby%252BText-Based%252BVirtual%252BScreening%26aulast%3DZettl%26aufirst%3DHeiko%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25042012%26date%3D22062012%26date%3D02072012%26date%3D21092012%26date%3D22062012%26volume%3D7%26issue%3D9%26spage%3D1488%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martina  Hieke</span>, <span class="hlFld-ContribAuthor ">Christine  Greiner</span>, <span class="hlFld-ContribAuthor ">Michaela  Dittrich</span>, <span class="hlFld-ContribAuthor ">Felix  Reisen</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>, and <span class="hlFld-ContribAuthor ">Oliver  Werz</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Biological Evaluation of a Novel Class of Dual Microsomal Prostaglandin E2 Synthase-1/5-lipoxygenase Inhibitors Based on 2-[(4,6-Diphenethoxypyrimidin-2-yl)thio]hexanoic Acid. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (13)
                                     , 4490-4507. <a href="https://doi.org/10.1021/jm200092b" title="DOI URL">https://doi.org/10.1021/jm200092b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200092b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200092b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BNovel%252BClass%252Bof%252BDual%252BMicrosomal%252BProstaglandin%252BE2%252BSynthase-1%25252F5-lipoxygenase%252BInhibitors%252BBased%252Bon%252B2-%25255B%2525284%25252C6-Diphenethoxypyrimidin-2-yl%252529thio%25255Dhexanoic%252BAcid%26aulast%3DHieke%26aufirst%3DMartina%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D27012011%26date%3D08062011%26date%3D14072011%26date%3D18052011%26volume%3D54%26issue%3D13%26spage%3D4490%26epage%3D4507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Didier J.-C.  Berthelot</span>, and <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>  . </span><span class="cited-content_cbyCitation_article-title">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (3)
                                     , 669-698. <a href="https://doi.org/10.1021/jm101168r" title="DOI URL">https://doi.org/10.1021/jm101168r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101168r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B3-Secretase%252BModulators%252Bas%252BPotential%252BDisease%252BModifying%252BAnti-Alzheimer%2525E2%252580%252599s%252BDrugs%26aulast%3DOehlrich%26aufirst%3DDaniel%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D08092010%26date%3D09122010%26date%3D10022011%26volume%3D54%26issue%3D3%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rukmankesh  Mehra</span>, <span class="hlFld-ContribAuthor ">Kasper Planeta  Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding familial Alzheimer's disease: The fit‐stay‐trim mechanism of γ‐secretase. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.1002/wcms.1556" title="DOI URL">https://doi.org/10.1002/wcms.1556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1556%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DUnderstanding%252Bfamilial%252BAlzheimer%252527s%252Bdisease%25253A%252BThe%252Bfit%2525E2%252580%252590stay%2525E2%252580%252590trim%252Bmechanism%252Bof%252B%2525CE%2525B3%2525E2%252580%252590secretase%26aulast%3DMehra%26aufirst%3DRukmankesh%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina  Chufarova</span>, <span class="hlFld-ContribAuthor ">Kamila  Czarnecka</span>, <span class="hlFld-ContribAuthor ">Robert  Skibiński</span>, <span class="hlFld-ContribAuthor ">Magda  Cuchra</span>, <span class="hlFld-ContribAuthor ">Ireneusz  Majsterek</span>, <span class="hlFld-ContribAuthor ">Paweł  Szymański</span>. </span><span class="cited-content_cbyCitation_article-title">New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (7)
                                     , 1800050. <a href="https://doi.org/10.1002/ardp.201800050" title="DOI URL">https://doi.org/10.1002/ardp.201800050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800050%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DNew%252Btacrine-acridine%252Bhybrids%252Bas%252Bpromising%252Bmultifunctional%252Bdrugs%252Bfor%252Bpotential%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DChufarova%26aufirst%3DNina%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D7%26spage%3D1800050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-Xin  Gong</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Khalid  Iqbal</span>, , , , , . </span><span class="cited-content_cbyCitation_article-title">Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2018,</strong> <em>64 </em>
                                    (s1)
                                     , S107-S117. <a href="https://doi.org/10.3233/JAD-179921" title="DOI URL">https://doi.org/10.3233/JAD-179921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-179921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-179921%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DMultifactorial%252BHypothesis%252Band%252BMulti-Targets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGong%26aufirst%3DCheng-Xin%26date%3D2018%26volume%3D64%26issue%3Ds1%26spage%3DS107%26epage%3DS117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Ligands in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 477-508. <a href="https://doi.org/10.1002/9783527674381.ch16" title="DOI URL">https://doi.org/10.1002/9783527674381.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DMultiple%252BLigands%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2017%26date%3D2017%26spage%3D477%26epage%3D508%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 87-118. <a href="https://doi.org/10.1007/7355_2016_19" title="DOI URL">https://doi.org/10.1007/7355_2016_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_19%26sid%3Dliteratum%253Aachs%26atitle%3D%2525CE%2525B3-Secretase%252BModulators%252Bas%252BA%2525CE%2525B242-Lowering%252BPharmacological%252BAgents%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26spage%3D87%26epage%3D118%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BII%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2017%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Luca  Piemontese</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2017,</strong> <em>12 </em>
                                    (8)
                                     , 1256. <a href="https://doi.org/10.4103/1673-5374.213541" title="DOI URL">https://doi.org/10.4103/1673-5374.213541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.213541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.213541%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DHeterocyclic%252Bcompounds%252Bas%252Bkey%252Bstructures%252Bfor%252Bthe%252Binteraction%252Bwith%252Bold%252Band%252Bnew%252Btargets%252Bin%252BAlzheimer%252527s%252Bdisease%252Btherapy%26aulast%3DHiremathad%26aufirst%3DAsha%26date%3D2017%26volume%3D12%26issue%3D8%26spage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Michaelis</span>, <span class="hlFld-ContribAuthor ">Florian  Rothweiler</span>, <span class="hlFld-ContribAuthor ">Mario  Wurglics</span>, <span class="hlFld-ContribAuthor ">Natália  Aniceto</span>, <span class="hlFld-ContribAuthor ">Michaela  Dittrich</span>, <span class="hlFld-ContribAuthor ">Heiko  Zettl</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>, <span class="hlFld-ContribAuthor ">Mark  Wass</span>, <span class="hlFld-ContribAuthor ">Taravat  Ghafourian</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>, <span class="hlFld-ContribAuthor ">Jindrich  Cinatl</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 11664-11676. <a href="https://doi.org/10.18632/oncotarget.7345" title="DOI URL">https://doi.org/10.18632/oncotarget.7345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.7345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.7345%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DSubstrate-specific%252Beffects%252Bof%252Bpirinixic%252Bacid%252Bderivatives%252Bon%252BABCB1-mediated%252Bdrug%252Btransport%26aulast%3DMichaelis%26aufirst%3DMartin%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D10%26spage%3D11664%26epage%3D11676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maximilian  Pohland</span>, <span class="hlFld-ContribAuthor ">Stephanie  Hagl</span>, <span class="hlFld-ContribAuthor ">Maren  Pellowska</span>, <span class="hlFld-ContribAuthor ">Mario  Wurglics</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>, <span class="hlFld-ContribAuthor ">Gunter P.  Eckert</span>. </span><span class="cited-content_cbyCitation_article-title">MH84: A Novel γ-Secretase Modulator/PPARγ Agonist—Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2016,</strong> <em>41 </em>
                                    (1-2)
                                     , 231-242. <a href="https://doi.org/10.1007/s11064-015-1765-0" title="DOI URL">https://doi.org/10.1007/s11064-015-1765-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-015-1765-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-015-1765-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3DMH84%25253A%252BA%252BNovel%252B%2525CE%2525B3-Secretase%252BModulator%25252FPPAR%2525CE%2525B3%252BAgonist%2525E2%252580%252594Improves%252BMitochondrial%252BDysfunction%252Bin%252Ba%252BCellular%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPohland%26aufirst%3DMaximilian%26date%3D2016%26date%3D2015%26volume%3D41%26issue%3D1-2%26spage%3D231%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Merk</span>, <span class="hlFld-ContribAuthor ">Martina  Zettl</span>, <span class="hlFld-ContribAuthor ">Dieter  Steinhilber</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>. </span><span class="cited-content_cbyCitation_article-title">Pirinixic acids: flexible fatty acid mimetics with various biological activities. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (12)
                                     , 1597-1616. <a href="https://doi.org/10.4155/fmc.15.87" title="DOI URL">https://doi.org/10.4155/fmc.15.87</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.87%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DPirinixic%252Bacids%25253A%252Bflexible%252Bfatty%252Bacid%252Bmimetics%252Bwith%252Bvarious%252Bbiological%252Bactivities%26aulast%3DMerk%26aufirst%3DDaniel%26date%3D2015%26volume%3D7%26issue%3D12%26spage%3D1597%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Flesch</span>, <span class="hlFld-ContribAuthor ">Julia  Ness</span>, <span class="hlFld-ContribAuthor ">Christina  Lamers</span>, <span class="hlFld-ContribAuthor ">Friederike  Dehm</span>, <span class="hlFld-ContribAuthor ">Sven  Popella</span>, <span class="hlFld-ContribAuthor ">Ramona  Steri</span>, <span class="hlFld-ContribAuthor ">Isabella  Ogorek</span>, <span class="hlFld-ContribAuthor ">Martina  Hieke</span>, <span class="hlFld-ContribAuthor ">Gerd  Dannhardt</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>. </span><span class="cited-content_cbyCitation_article-title">SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 841-846. <a href="https://doi.org/10.1016/j.bmcl.2014.12.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR-studies%252Bof%252B%2525CE%2525B3-secretase%252Bmodulators%252Bwith%252BPPAR%2525CE%2525B3-agonistic%252Band%252B5-lipoxygenase-inhibitory%252Bactivity%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DFlesch%26aufirst%3DDaniel%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D841%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Pellowska</span>, <span class="hlFld-ContribAuthor ">C.  Stein</span>, <span class="hlFld-ContribAuthor ">M.  Pohland</span>, <span class="hlFld-ContribAuthor ">D.  Merk</span>, <span class="hlFld-ContribAuthor ">J.  Klein</span>, <span class="hlFld-ContribAuthor ">G.P.  Eckert</span>, <span class="hlFld-ContribAuthor ">M.  Schubert-Zsilavecz</span>, <span class="hlFld-ContribAuthor ">M.  Wurglics</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic properties of MH84, a γ-secretase modulator with PPARγ agonistic activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2015,</strong> <em>102 </em>, 417-424. <a href="https://doi.org/10.1016/j.jpba.2014.10.001" title="DOI URL">https://doi.org/10.1016/j.jpba.2014.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2014.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2014.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DPharmacokinetic%252Bproperties%252Bof%252BMH84%25252C%252Ba%252B%2525CE%2525B3-secretase%252Bmodulator%252Bwith%252BPPAR%2525CE%2525B3%252Bagonistic%252Bactivity%26aulast%3DPellowska%26aufirst%3DM.%26date%3D2015%26volume%3D102%26spage%3D417%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina  Lamers</span>, <span class="hlFld-ContribAuthor ">Michaela  Dittrich</span>, <span class="hlFld-ContribAuthor ">Ramona  Steri</span>, <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants for improved activity at PPARα: Structure–activity relationship of pirinixic acid derivatives, docking study and site-directed mutagenesis of PPARα. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 4048-4052. <a href="https://doi.org/10.1016/j.bmcl.2014.05.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.05.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.05.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMolecular%252Bdeterminants%252Bfor%252Bimproved%252Bactivity%252Bat%252BPPAR%2525CE%2525B1%25253A%252BStructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bpirinixic%252Bacid%252Bderivatives%25252C%252Bdocking%252Bstudy%252Band%252Bsite-directed%252Bmutagenesis%252Bof%252BPPAR%2525CE%2525B1%26aulast%3DLamers%26aufirst%3DChristina%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D4048%26epage%3D4052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Hanke</span>, <span class="hlFld-ContribAuthor ">Christina  Lamers</span>, <span class="hlFld-ContribAuthor ">Roberto Carrasco  Gomez</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3757-3763. <a href="https://doi.org/10.1016/j.bmcl.2014.06.077" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.077%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpirinixic%252Bacid%252Bderivatives%252Bbearing%252Ba%252B2-aminothiazole%252Bmoiety%252Bcombines%252Bdual%252BPPAR%2525CE%2525B1%25252F%2525CE%2525B3%252Bactivation%252Band%252Bdual%252B5-LO%25252FmPGES-1%252Binhibition%26aulast%3DHanke%26aufirst%3DThomas%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3757%26epage%3D3763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  González-Naranjo</span>, <span class="hlFld-ContribAuthor ">Natalia  Pérez-Macias</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Vicente J.  Arán</span>, <span class="hlFld-ContribAuthor ">Rocio  Girón</span>, <span class="hlFld-ContribAuthor ">Eva  Sánchez-Robles</span>, <span class="hlFld-ContribAuthor ">María Isabel  Martín</span>, <span class="hlFld-ContribAuthor ">María  Gómez-Cañas</span>, <span class="hlFld-ContribAuthor ">Moisés  García-Arencibia</span>, <span class="hlFld-ContribAuthor ">Javier  Fernández-Ruiz</span>, <span class="hlFld-ContribAuthor ">Juan A.  Páez</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>73 </em>, 56-72. <a href="https://doi.org/10.1016/j.ejmech.2013.11.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.11.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.11.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCannabinoid%252Bagonists%252Bshowing%252BBuChE%252Binhibition%252Bas%252Bpotential%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DGonz%25C3%25A1lez-Naranjo%26aufirst%3DPedro%26date%3D2014%26volume%3D73%26spage%3D56%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Antonio G.  Garcia</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (1)
                                     , 139-189. <a href="https://doi.org/10.1002/med.20248" title="DOI URL">https://doi.org/10.1002/med.20248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20248%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bmultitarget-directed%252Bligands%252Bapproach%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLe%25C3%25B3n%26aufirst%3DRafael%26date%3D2013%26date%3D2011%26volume%3D33%26issue%3D1%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antje  Hillmann</span>, <span class="hlFld-ContribAuthor ">Stefanie  Hahn</span>, <span class="hlFld-ContribAuthor ">Stephan  Schilling</span>, <span class="hlFld-ContribAuthor ">Torsten  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Hans-Ulrich  Demuth</span>, <span class="hlFld-ContribAuthor ">Bruno  Bulic</span>, <span class="hlFld-ContribAuthor ">Thomas  Schneider-Axmann</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Bayer</span>, <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>, <span class="hlFld-ContribAuthor ">Oliver  Wirths</span>. </span><span class="cited-content_cbyCitation_article-title">No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Aging</span><span> <strong>2012,</strong> <em>33 </em>
                                    (4)
                                     , 833.e39-833.e50. <a href="https://doi.org/10.1016/j.neurobiolaging.2011.08.006" title="DOI URL">https://doi.org/10.1016/j.neurobiolaging.2011.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neurobiolaging.2011.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neurobiolaging.2011.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Aging%26atitle%3DNo%252Bimprovement%252Bafter%252Bchronic%252Bibuprofen%252Btreatment%252Bin%252Bthe%252B5XFAD%252Bmouse%252Bmodel%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DHillmann%26aufirst%3DAntje%26date%3D2012%26volume%3D33%26issue%3D4%26spage%3D833.e39%26epage%3D833.e50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus  Hartenfeller</span>, <span class="hlFld-ContribAuthor ">Heiko  Zettl</span>, <span class="hlFld-ContribAuthor ">Miriam  Walter</span>, <span class="hlFld-ContribAuthor ">Matthias  Rupp</span>, <span class="hlFld-ContribAuthor ">Felix  Reisen</span>, <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>, . </span><span class="cited-content_cbyCitation_article-title">DOGS: Reaction-Driven de novo Design of Bioactive Compounds. </span><span class="cited-content_cbyCitation_journal-name">PLoS Computational Biology</span><span> <strong>2012,</strong> <em>8 </em>
                                    (2)
                                     , e1002380. <a href="https://doi.org/10.1371/journal.pcbi.1002380" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1002380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1002380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1002380%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Computational%2520Biology%26atitle%3DDOGS%25253A%252BReaction-Driven%252Bde%252Bnovo%252BDesign%252Bof%252BBioactive%252BCompounds%26aulast%3DHartenfeller%26aufirst%3DMarkus%26date%3D2012%26date%3D2012%26volume%3D8%26issue%3D2%26spage%3De1002380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thorsten  Jumpertz</span>, <span class="hlFld-ContribAuthor ">Andreas  Rennhack</span>, <span class="hlFld-ContribAuthor ">Julia  Ness</span>, <span class="hlFld-ContribAuthor ">Sandra  Baches</span>, <span class="hlFld-ContribAuthor ">Claus U.  Pietrzik</span>, <span class="hlFld-ContribAuthor ">Bruno  Bulic</span>, <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>, . </span><span class="cited-content_cbyCitation_article-title">Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2012,</strong> <em>7 </em>
                                    (1)
                                     , e30484. <a href="https://doi.org/10.1371/journal.pone.0030484" title="DOI URL">https://doi.org/10.1371/journal.pone.0030484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0030484%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DPresenilin%252BIs%252Bthe%252BMolecular%252BTarget%252Bof%252BAcidic%252B%2525CE%2525B3-Secretase%252BModulators%252Bin%252BLiving%252BCells%26aulast%3DJumpertz%26aufirst%3DThorsten%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D1%26spage%3De30484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martina  Hieke</span>, <span class="hlFld-ContribAuthor ">Julia  Ness</span>, <span class="hlFld-ContribAuthor ">Ramona  Steri</span>, <span class="hlFld-ContribAuthor ">Christine  Greiner</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>, <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>, <span class="hlFld-ContribAuthor ">Heiko  Zettl</span>. </span><span class="cited-content_cbyCitation_article-title">SAR studies of acidic dual γ-secretase/PPARγ modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (18)
                                     , 5372-5382. <a href="https://doi.org/10.1016/j.bmc.2011.08.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSAR%252Bstudies%252Bof%252Bacidic%252Bdual%252B%2525CE%2525B3-secretase%25252FPPAR%2525CE%2525B3%252Bmodulators%26aulast%3DHieke%26aufirst%3DMartina%26date%3D2011%26volume%3D19%26issue%3D18%26spage%3D5372%26epage%3D5382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belal O.  Al-Najjar</span>, <span class="hlFld-ContribAuthor ">Habibah A.  Wahab</span>, <span class="hlFld-ContribAuthor ">Tengku Sifzizul  Tengku Muhammad</span>, <span class="hlFld-ContribAuthor ">Alexander Chong  Shu-Chien</span>, <span class="hlFld-ContribAuthor ">Nur Adelina  Ahmad Noruddin</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (6)
                                     , 2513-2529. <a href="https://doi.org/10.1016/j.ejmech.2011.03.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.03.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.03.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bnanomolar%252Bperoxisome%252Bproliferator-activated%252Breceptor%252B%2525CE%2525B3%252Bactivators%252Bvia%252Belaborate%252Bligand-based%252Bmodeling%26aulast%3DAl-Najjar%26aufirst%3DBelal%2BO.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2513%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Hahn</span>, <span class="hlFld-ContribAuthor ">Tanja  Brüning</span>, <span class="hlFld-ContribAuthor ">Julia  Ness</span>, <span class="hlFld-ContribAuthor ">Eva  Czirr</span>, <span class="hlFld-ContribAuthor ">Sandra  Baches</span>, <span class="hlFld-ContribAuthor ">Harrie  Gijsen</span>, <span class="hlFld-ContribAuthor ">Carsten  Korth</span>, <span class="hlFld-ContribAuthor ">Claus U.  Pietrzik</span>, <span class="hlFld-ContribAuthor ">Bruno  Bulic</span>, <span class="hlFld-ContribAuthor ">Sascha  Weggen</span>. </span><span class="cited-content_cbyCitation_article-title">Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer’s disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2011,</strong> <em>116 </em>
                                    (3)
                                     , 385-395. <a href="https://doi.org/10.1111/j.1471-4159.2010.07118.x" title="DOI URL">https://doi.org/10.1111/j.1471-4159.2010.07118.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1471-4159.2010.07118.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1471-4159.2010.07118.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DPresenilin-1%252Bbut%252Bnot%252Bamyloid%252Bprecursor%252Bprotein%252Bmutations%252Bpresent%252Bin%252Bmouse%252Bmodels%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Battenuate%252Bthe%252Bresponse%252Bof%252Bcultured%252Bcells%252Bto%252B%2525CE%2525B3-secretase%252Bmodulators%252Bregardless%252Bof%252Btheir%252Bpotency%252Band%252Bstructure%26aulast%3DHahn%26aufirst%3DStefanie%26date%3D2011%26date%3D2010%26volume%3D116%26issue%3D3%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Amyloid Cascade</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. In vitro pharmacology of γ-secretase-modulating NSAIDs.<a onclick="showRef(event, 'ref15 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref15 ref47 ref48 ref49">(15, 47-49)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compound <b>8</b> and its impact on Aβ38, Aβ40, and Aβ42 formation. SARs based on <b>8</b> were obtained by structural modifications of the encircled residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route of Compounds <b>6</b>−<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-bromo-<i>(R</i><sup>1</sup>)-ethyl acetate (1.5 equiv), thiobarbituric acid (1 equiv), TEA (1.5 equiv), DMF, 80 °C, 4 h; (iia) <b>6a</b>−<b>10a</b> (1 equiv), R<sup>2</sup>-Hal (2.1 equiv), K<sub>2</sub>CO<sub>3</sub> (2.3 equiv), DMF, 80 °C, 3−28 h or (iib) <b>6a</b>−<b>10a</b> (1 equiv), R<sup>2</sup>-OH (2 equiv), DEAD (2.5 equiv), TPP (2.5 equiv), THF, room temp, 1−3 h; (iii) LiOH (5 equiv), THF/MeOH, H<sub>2</sub>O, 25−50 °C, 2−24 h.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GSM activity of compounds <b>16</b> and <b>22</b>: dose−response curves for Aβ40, Aβ42, and Aβ38 formation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/medium/jm-2010-003073_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Lack of effect of compounds <b>16</b> and <b>22</b> in the NOTCH reporter gene assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003073/production/images/large/jm-2010-003073_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003073&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler-Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrighi, H. M.</span><span> </span><span class="NLM_article-title">Forecasting the global burden of Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.jalz.2007.04.381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19595937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=186-191&author=R.+Brookmeyerauthor=E.+Johnsonauthor=K.+Ziegler-Grahamauthor=H.+M.+Arrighi&title=Forecasting+the+global+burden+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Forecasting the global burden of Alzheimer's disease</span></div><div class="casAuthors">Brookmeyer Ron; Johnson Elizabeth; Ziegler-Graham Kathryn; Arrighi H Michael</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Our goal was to forecast the global burden of Alzheimer's disease and evaluate the potential impact of interventions that delay disease onset or progression.  METHODS:  A stochastic, multistate model was used in conjunction with United Nations worldwide population forecasts and data from epidemiological studies of the risks of Alzheimer's disease.  RESULTS:  In 2006, the worldwide prevalence of Alzheimer's disease was 26.6 million.  By 2050, the prevalence will quadruple, by which time 1 in 85 persons worldwide will be living with the disease.  We estimate about 43% of prevalent cases need a high level of care, equivalent to that of a nursing home.  If interventions could delay both disease onset and progression by a modest 1 year, there would be nearly 9.2 million fewer cases of the disease in 2050, with nearly the entire decline attributable to decreases in persons needing a high level of care.  CONCLUSIONS:  We face a looming global epidemic of Alzheimer's disease as the world's population ages.  Modest advances in therapeutic and preventive strategies that lead to even small delays in the onset and progression of Alzheimer's disease can significantly reduce the global burden of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScBQJ_4Qj7YMSzjBFCN0BJfW6udTcc2eY7KLGR55Hn2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D&md5=f89fab48e87760875e35c68876a42664</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.04.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.04.381%26sid%3Dliteratum%253Aachs%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DZiegler-Graham%26aufirst%3DK.%26aulast%3DArrighi%26aufirst%3DH.%2BM.%26atitle%3DForecasting%2520the%2520global%2520burden%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2007%26volume%3D3%26spage%3D186%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: genes, proteins, and therapy</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=741-766&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease%3A+genes%2C+proteins%2C+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520genes%252C%2520proteins%252C%2520and%2520therapy%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D741%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aβ oligomers—a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers%E2%80%94a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lhM6Y7rJNDEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%25E2%2580%2594a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Strategies for disease modification in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1038%2Fnrn1495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=15322526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVaqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=677-685&author=M.+Citron&title=Strategies+for+disease+modification+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for disease modification in Alzheimer's disease</span></div><div class="casAuthors">Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">677-685</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Treating Alzheimer's disease (AD) is the biggest unmet medical need in neurol.  Current drugs improve symptoms, but do not have profound disease-modifying effects.  Three main classes of disease-modification approaches can be defined: one that is broadly neurotrophic or neuroprotective, one that targets specific aspects of AD pathol., and one that is based on epidemiol. observation.  This review discusses all three approaches, with particular emphasis on anti-amyloid strategies - currently the most active area of investigation.  The approaches that are reviewed include secretase inhibition, amyloid-β aggregation inhibition, immunotherapy and strategies that might indirectly affect the amyloid pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDLZiWsusmqLVg90H21EOLACvtfcHk0lhM6Y7rJNDEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVaqsr8%253D&md5=83246f7a6ac826196f4d962077487d03</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrn1495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1495%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DStrategies%2520for%2520disease%2520modification%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2004%26volume%3D5%26spage%3D677%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Disease modifying therapy for AD?</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1111%2Fj.1471-4159.2006.04211.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17076654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=689-707&author=T.+E.+Golde&title=Disease+modifying+therapy+for+AD%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Disease modifying therapy for AD?</span></div><div class="casAuthors">Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">689-707</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia in industrialized nations.  If more effective therapies are not developed that either prevent AD or block progression of the disease in its very early stages, the economic and societal cost of caring for AD patients will be devastating.  Only two types of drugs are currently approved for the treatment of AD: inhibitors of acetyl cholinesterase, which symptomatically enhance cognitive state to some degree but are not disease modifying; and the adamantane deriv., memantine.  Memantine preferentially blocks excessive NMDA receptor activity without disrupting normal receptor activity and is thought to be a neuroprotective agent that blocks excitotoxicty.  Memantine therefore may have a potentially disease modifying effect in multiple neurodegenerative conditions.  An improved understanding of the pathogeneses of AD has now led to the identification of numerous therapeutic targets designed to alter amyloid β protein (Aβ) or tau accumulation.  Therapies that alter Aβ and tau through these various targets are likely to have significant disease modifying effects.  Many of these targets have been validated in proof of concept studies in preclin. animal models, and some potentially disease modifying therapies targeting Aβ or tau are being tested in the clinic.  This review will highlight both the promise of and the obstacles to developing such disease modifying AD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-BcH4FI9sOrVg90H21EOLACvtfcHk0lhM6Y7rJNDEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FL&md5=cd7a9f8222d36922503600f8f25f0600</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04211.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04211.x%26sid%3Dliteratum%253Aachs%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDisease%2520modifying%2520therapy%2520for%2520AD%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D689%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span> </span><span class="NLM_article-title">Gamma-secretase inhibitors for Alzheimer’s disease: balancing efficacy and toxicity</span> <span class="citation_source-journal">Drugs R&D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2165%2F00126839-200607020-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16542055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVWksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=87-97&author=D.+M.+Bartenauthor=J.+E.+Meredithauthor=R.+Zaczekauthor=J.+G.+Houstonauthor=C.+F.+Albright&title=Gamma-secretase+inhibitors+for+Alzheimer%E2%80%99s+disease%3A+balancing+efficacy+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity</span></div><div class="casAuthors">Barten, Donna M.; Meredith, Jere E., Jr.; Zaczek, Robert; Houston, John G.; Albright, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs in R&D</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">DRDDFD</span>;
        ISSN:<span class="NLM_cas:issn">1174-5886</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis, which states that β-amyloid (Aβ) aggregates cause the onset and progression of Alzheimer's disease (AD), is a leading proposal to explain AD etiol.  Based on this hypothesis, compds. that inhibit γ-secretase, one of the enzymes responsible for forming Aβ, are potential therapeutics for AD.  Preclin. studies clearly establish that γ-secretase inhibitors can reduce brain Aβ in rodent models.  The initial investigation of the effects of a γ-secretase inhibitor on Aβ-induced cognitive deficits in transgenic mice showed that modest Aβ redns. (15-30%) are sufficient to reverse Aβ-induced cognitive deficits in Tg2576 mice.  Extending these studies to other γ-secretase inhibitors and other models with Aβ-induced cognitive deficits will be important.  Unfortunately, γ-secretase inhibitors also cause abnormalities in the gastrointestinal tract, thymus and spleen in rodents.  These changes likely result from inhibition of Notch cleavage, a transmembrane receptor involved in regulating cell-fate decisions.  Two recent studies in rodents suggest that Aβ redn. using γ-secretase inhibitors can be partially sepd. from Notch inhibition.  Given the uncertain Aβ redn. target and the potential for mechanism-based toxicity, biomarkers for efficacy and toxicity would be helpful in clin. trials.  The first report of γ-secretase inhibitors in clin. trials was recently published.  In this study, LY-450139 reduced plasma Aβ, but not cerebrospinal fluid Aβ.  Taken together, the results of studies to date suggest that γ-secretase inhibitors have the potential to address a large unmet medical need if the tech. challenges can be overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM-QRR65BRqLVg90H21EOLACvtfcHk0lhQgsI1uTCLWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVWksrg%253D&md5=6bff8dba9196e7eebbe741f50e6e88c3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2165%2F00126839-200607020-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00126839-200607020-00003%26sid%3Dliteratum%253Aachs%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26atitle%3DGamma-secretase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520balancing%2520efficacy%2520and%2520toxicity%26jtitle%3DDrugs%2520R%2526D%26date%3D2006%26volume%3D7%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrijvers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=518-522&author=B.+De+Strooperauthor=W.+Annaertauthor=P.+Cupersauthor=P.+Saftigauthor=K.+Craessaertsauthor=J.+S.+Mummauthor=E.+H.+Schroeterauthor=V.+Schrijversauthor=M.+S.+Wolfeauthor=W.+J.+Rayauthor=A.+Goateauthor=R.+Kopan&title=A+presenilin-1-dependent+gamma-secretase-like+protease+mediates+release+of+Notch+intracellular+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DCupers%26aufirst%3DP.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DMumm%26aufirst%3DJ.%2BS.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DSchrijvers%26aufirst%3DV.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DA%2520presenilin-1-dependent%2520gamma-secretase-like%2520protease%2520mediates%2520release%2520of%2520Notch%2520intracellular%2520domain%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D518%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon-Ortiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12876</span><span class="NLM_x">–</span> <span class="NLM_lpage">12882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12876-12882&author=G.+T.+Wongauthor=D.+Manfraauthor=F.+M.+Pouletauthor=Q.+Zhangauthor=H.+Josienauthor=T.+Baraauthor=L.+Engstromauthor=M.+Pinzon-Ortizauthor=J.+S.+Fineauthor=H.+J.+Leeauthor=L.+Zhangauthor=G.+A.+Higginsauthor=E.+M.+Parker&title=Chronic+treatment+with+the+gamma-secretase+inhibitor+LY-411%2C575+inhibits+beta-amyloid+peptide+production+and+alters+lymphopoiesis+and+intestinal+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BT.%26aulast%3DManfra%26aufirst%3DD.%26aulast%3DPoulet%26aufirst%3DF.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPinzon-Ortiz%26aufirst%3DM.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520gamma-secretase%2520inhibitor%2520LY-411%252C575%2520inhibits%2520beta-amyloid%2520peptide%2520production%2520and%2520alters%2520lymphopoiesis%2520and%2520intestinal%2520cell%2520differentiation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12876%26epage%3D12882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+A.+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+Abeta42+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520Abeta42%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Leuchtenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Selective modulation of Abeta42 production in Alzheimer’s disease: non-steroidal anti-inflammatory drugs (NSAIDs) and beyond</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4337</span><span class="NLM_x">–</span> <span class="NLM_lpage">4355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F138161206778793029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17105431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4337-4355&author=S.+Leuchtenbergerauthor=D.+Beherauthor=S.+Weggen&title=Selective+modulation+of+Abeta42+production+in+Alzheimer%E2%80%99s+disease%3A+non-steroidal+anti-inflammatory+drugs+%28NSAIDs%29+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Selective modulation of Aβ42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond</span></div><div class="casAuthors">Leuchtenberger, Stefanie; Beher, Dirk; Weggen, Sascha</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4337-4355</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) peptides and in particular the longer, highly amyloidogenic isoform Aβ42 are believed by many to be the central disease-causing agents in Alzheimer's disease (AD).  Consequently, academic and pharmaceutical labs. have focused on elucidating the mechanisms of Aβ prodn. and developing strategies to diminish Aβ formation for treatment or prevention of AD.  The most substantial advances have been made with respect to inhibitors of the γ-secretase enzyme, which catalyzes the final step in the generation of Aβ from the amyloid precursor protein (APP).  Highly potent γ-secretase inhibitors which suppress prodn. of all Aβ peptides are available today.  However, due to the promiscuous substrate specificity of γ-secretase and its essential role in the NOTCH signaling pathway overt mechanism-based toxicity has been obsd. in preclin. studies of γ-secretase inhibitors.  For that reason, specific blockage of Aβ42 prodn. might be preferable over non-discriminatory γ-secretase inhibition but small mol. inhibitors of Aβ42 prodn. have remained elusive until recently.  This has changed with the discovery that certain non-steroidal anti-inflammatory drugs (NSAIDs) including ibuprofen possess preferential Aβ42-lowering activity.  These compds. seem to offer a window of modulation where Aβ42 prodn. is potently inhibited whereas processing of the NOTCH receptor and other γ-secretase substrates remains unaffected.  The Aβ42-lowering activity of NSAIDs is not related to inhibition of cyclooxygenases and can be dissocd. from the anti-inflammatory properties of this class of drugs.  Ongoing efforts conc. on uncovering the mechanism of action and improving potency and brain permeability of Aβ42-lowering compds.  Hopes are high that in the near future this will lead to the development of clin. viable compds. which selectively target Aβ42 as a key mol. in the pathogenesis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh7VQGQCnNUrVg90H21EOLACvtfcHk0lhOr_hE3_sbOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbO&md5=30dd82a2b1ed0f1062ab908cc2e7f048</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161206778793029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778793029%26sid%3Dliteratum%253Aachs%26aulast%3DLeuchtenberger%26aufirst%3DS.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DSelective%2520modulation%2520of%2520Abeta42%2520production%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520non-steroidal%2520anti-inflammatory%2520drugs%2520%2528NSAIDs%2529%2520and%2520beyond%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4337%26epage%3D4355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J.</span><span> </span><span class="NLM_article-title">NSAIDs: small molecules for prevention of Alzheimer’s disease or precursors for future drug development?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=536-543&author=S.+Weggenauthor=M.+Rogersauthor=J.+Eriksen&title=NSAIDs%3A+small+molecules+for+prevention+of+Alzheimer%E2%80%99s+disease+or+precursors+for+future+drug+development%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DM.%26aulast%3DEriksen%26aufirst%3DJ.%26atitle%3DNSAIDs%253A%2520small%2520molecules%2520for%2520prevention%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520or%2520precursors%2520for%2520future%2520drug%2520development%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D536%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Green, R. C.; Schneider, L. S.; Hendrix, S. B.; Zavitz, K. H.; Swabb, E.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of Tarenflurbil in Subjects with Mild Alzheimer’s Disease: Results from an 18-Month Multi-Center Phase 3 Trial</span>. Presented at the International Conference on Alzheimer’s Disease, Chicago, IL, July 2008; Alzheimer’s and Dementia; No. O3-04-01, T165.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Green%2C+R.+C.%3B+Schneider%2C+L.+S.%3B+Hendrix%2C+S.+B.%3B+Zavitz%2C+K.+H.%3B+Swabb%2C+E.+Safety+and+Efficacy+of+Tarenflurbil+in+Subjects+with+Mild+Alzheimer%E2%80%99s+Disease%3A+Results+from+an+18-Month+Multi-Center+Phase+3+Trial.+Presented+at+the+International+Conference+on+Alzheimer%E2%80%99s+Disease%2C+Chicago%2C+IL%2C+July+2008%3B+Alzheimer%E2%80%99s+and+Dementia%3B+No.+O3-04-01%2C+T165."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BC.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520Tarenflurbil%2520in%2520Subjects%2520with%2520Mild%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Results%2520from%2520an%252018-Month%2520Multi-Center%2520Phase%25203%2520Trial" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">in 't Veld, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruitenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duijn, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stijnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breteler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, B. H.</span><span> </span><span class="NLM_article-title">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1056%2FNEJMoa010178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=11794217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2001&pages=1515-1521&author=B.+A.+in+%27t+Veldauthor=A.+Ruitenbergauthor=A.+Hofmanauthor=L.+J.+Launerauthor=C.+M.+van+Duijnauthor=T.+Stijnenauthor=M.+M.+Bretelerauthor=B.+H.+Stricker&title=Nonsteroidal+antiinflammatory+drugs+and+the+risk+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease</span></div><div class="casAuthors">In't Veld, Bas A.; Ruitenberg, Annemieke; Hofman, Albert; Launer, Lenore J.; van Duijn, Cornelia M.; Stijnen, Theo; Bretteler, Monique M. B.; Stricker, Bruno H. C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1515-1521</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease.  The results, however, have been inconsistent.  Methods: We studied the assocn. between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 yr of age or older who were free of dementia at base line.  The risk of Alzheimer's disease was estd. in relation to the use of NSAIDs as documented in pharmacy records.  We defined four mutually exclusive categories of use: non-use, short-term use (1 mo or less of cumulative use), intermediate-term use (more than 1 but less than 24 mo of cumulative use), and long-term use (24 mo or more of cumulative use).  Adjustments were made by Cox regression anal. for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H2-receptor antagonists, antihypertensive agents, and hypoglycemic agents.  Results: During an av. follow-up period of 6.8 yr, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia.  The relative risk of Alzheimer's disease was 0.95 (95% confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95% confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95% confidence interval, 0.05 to 0.83) in those with long-term use.  The risk did not vary according to age.  The use of NSAIDs was not assocd. with a redn. in the risk of vascular dementia.  Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Ao_Olp-rxrVg90H21EOLACvtfcHk0lhOr_hE3_sbOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Wjt78%253D&md5=d9c721051ba69eb547622be825531202</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa010178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa010178%26sid%3Dliteratum%253Aachs%26aulast%3Din%2B%2527t%2BVeld%26aufirst%3DB.%2BA.%26aulast%3DRuitenberg%26aufirst%3DA.%26aulast%3DHofman%26aufirst%3DA.%26aulast%3DLauner%26aufirst%3DL.%2BJ.%26aulast%3Dvan%2BDuijn%26aufirst%3DC.%2BM.%26aulast%3DStijnen%26aufirst%3DT.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%26aulast%3DStricker%26aufirst%3DB.%2BH.%26atitle%3DNonsteroidal%2520antiinflammatory%2520drugs%2520and%2520the%2520risk%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D345%26spage%3D1515%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Vlad, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D. T.</span><span> </span><span class="NLM_article-title">Protective effects of NSAIDs on the development of Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1672</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=1672-1677&author=S.+C.+Vladauthor=D.+R.+Millerauthor=N.+W.+Kowallauthor=D.+T.+Felson&title=Protective+effects+of+NSAIDs+on+the+development+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlad%26aufirst%3DS.%2BC.%26aulast%3DMiller%26aufirst%3DD.%2BR.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26atitle%3DProtective%2520effects%2520of%2520NSAIDs%2520on%2520the%2520development%2520of%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2008%26volume%3D70%26spage%3D1672%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Porta, E.</span><span> </span><span class="NLM_article-title">Gamma-secretase modulation and its promise for Alzheimer’s disease: a medicinal chemistry perspective</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F156802608783334097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18220931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=38-46&author=I.+Perettoauthor=E.+La+Porta&title=Gamma-secretase+modulation+and+its+promise+for+Alzheimer%E2%80%99s+disease%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective</span></div><div class="casAuthors">Peretto, Ilaria; La Porta, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase modulation holds the promise for the development of a disease-modifying therapy for Alzheimer's disease (AD).  This novel concept of manipulating the cleavage specificity of the γ-secretase enzyme by pharmacol. means implies that steady state levels of the potentially disease-causing amyloid-β(1-42) peptide can be lowered without the undesired side effects assocd. with full inhibition of this aspartyl-type protease.  Following on from the initial discovery that certain non-steroidal anti-inflammatory drugs (NSAIDs) exhibit properties characteristic of γ-secretase modulators, this class of compds. has been extensively studied and exploited, leading to the discovery of NSAIDs derivs. endowed with improved potency for the redn. of amyloid-β(1-42) peptide prodn.  In addn., a very limited no. of non-NSAID derived γ-secretase modulators has also been recently claimed in the patent literature, suggesting that only a restricted no. of pharmacophores might be involved in the modulation of γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYysZpzm8stLVg90H21EOLACvtfcHk0lhP_nWDEir_2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWnt74%253D&md5=0771c6dc024355e125e2554c446d2423</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F156802608783334097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334097%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DLa%2BPorta%26aufirst%3DE.%26atitle%3DGamma-secretase%2520modulation%2520and%2520its%2520promise%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D38%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Generation of Abeta 38 and Abeta 42 is independently and differentially affected by FAD-associated presenilin 1 mutations and gamma-secretase modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=677-683&author=R.+M.+Pageauthor=K.+Baumannauthor=M.+Tomiokaauthor=B.+I.+Perez-Revueltaauthor=A.+Fukumoriauthor=H.+Jacobsenauthor=A.+Flohrauthor=T.+Luebbersauthor=L.+Ozmenauthor=H.+Steinerauthor=C.+Haass&title=Generation+of+Abeta+38+and+Abeta+42+is+independently+and+differentially+affected+by+FAD-associated+presenilin+1+mutations+and+gamma-secretase+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DTomioka%26aufirst%3DM.%26aulast%3DPerez-Revuelta%26aufirst%3DB.%2BI.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGeneration%2520of%2520Abeta%252038%2520and%2520Abeta%252042%2520is%2520independently%2520and%2520differentially%2520affected%2520by%2520FAD-associated%2520presenilin%25201%2520mutations%2520and%2520gamma-secretase%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D677%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jaradat, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wongsud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phornchirasilp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangwala, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romstedt, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noonan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feller, D. R.</span><span> </span><span class="NLM_article-title">Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1587-1595&author=M.+S.+Jaradatauthor=B.+Wongsudauthor=S.+Phornchirasilpauthor=S.+M.+Rangwalaauthor=G.+Shamsauthor=M.+Suttonauthor=K.+J.+Romstedtauthor=D.+J.+Noonanauthor=D.+R.+Feller&title=Activation+of+peroxisome+proliferator-activated+receptor+isoforms+and+inhibition+of+prostaglandin+H%282%29+synthases+by+ibuprofen%2C+naproxen%2C+and+indomethacin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaradat%26aufirst%3DM.%2BS.%26aulast%3DWongsud%26aufirst%3DB.%26aulast%3DPhornchirasilp%26aufirst%3DS.%26aulast%3DRangwala%26aufirst%3DS.%2BM.%26aulast%3DShams%26aufirst%3DG.%26aulast%3DSutton%26aufirst%3DM.%26aulast%3DRomstedt%26aufirst%3DK.%2BJ.%26aulast%3DNoonan%26aufirst%3DD.%2BJ.%26aulast%3DFeller%26aufirst%3DD.%2BR.%26atitle%3DActivation%2520of%2520peroxisome%2520proliferator-activated%2520receptor%2520isoforms%2520and%2520inhibition%2520of%2520prostaglandin%2520H%25282%2529%2520synthases%2520by%2520ibuprofen%252C%2520naproxen%252C%2520and%2520indomethacin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D62%26spage%3D1587%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lehmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenhard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringold, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">3406</span><span class="NLM_x">–</span> <span class="NLM_lpage">3410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=3406-3410&author=J.+M.+Lehmannauthor=J.+M.+Lenhardauthor=B.+B.+Oliverauthor=G.+M.+Ringoldauthor=S.+A.+Kliewer&title=Peroxisome+proliferator-activated+receptors+alpha+and+gamma+are+activated+by+indomethacin+and+other+non-steroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DLenhard%26aufirst%3DJ.%2BM.%26aulast%3DOliver%26aufirst%3DB.%2BB.%26aulast%3DRingold%26aufirst%3DG.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptors%2520alpha%2520and%2520gamma%2520are%2520activated%2520by%2520indomethacin%2520and%2520other%2520non-steroidal%2520anti-inflammatory%2520drugs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D3406%26epage%3D3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lehrke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span> </span><span class="NLM_article-title">The many faces of PPARgamma</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.cell.2005.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16360030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVOj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2005&pages=993-999&author=M.+Lehrkeauthor=M.+A.+Lazar&title=The+many+faces+of+PPARgamma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of PPARγ</span></div><div class="casAuthors">Lehrke, Michael; Lazar, Mitchell A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  In an era marked by the increasing prevalence of obesity, diabetes, and cardiovascular disease, the nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) has emerged as a transcriptional regulator of metab. whose activity can be modulated by direct binding of small mols.  As the master regulator of fat-cell formation, PPARγ is required for the accumulation of adipose tissue and hence contributes to obesity.  Yet PPARγ ligands are clin. effective antidiabetic drugs, although side effects limit their utility.  Can PPARγ be targeted with greater benefit and with less risk to patients.  The answer depends upon the basic biol. of PPARγ, and the possibility of selectively modulating the activity of this nuclear receptor in a tissue- and target-gene-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ7RQYS8G8SbVg90H21EOLACvtfcHk0lgId4HoNCeVvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVOj&md5=ef6bf675ef97d097e6518d5e5c5241ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DLehrke%26aufirst%3DM.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26atitle%3DThe%2520many%2520faces%2520of%2520PPARgamma%26jtitle%3DCell%26date%3D2005%26volume%3D123%26spage%3D993%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Landreth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandrekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M.</span><span> </span><span class="NLM_article-title">PPARgamma agonists as therapeutics for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=481-489&author=G.+Landrethauthor=Q.+Jiangauthor=S.+Mandrekarauthor=M.+Heneka&title=PPARgamma+agonists+as+therapeutics+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DMandrekar%26aufirst%3DS.%26aulast%3DHeneka%26aufirst%3DM.%26atitle%3DPPARgamma%2520agonists%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2008%26volume%3D5%26spage%3D481%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompl, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambareri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobbs, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=902-904&author=L.+Hoauthor=W.+Qinauthor=P.+N.+Pomplauthor=Z.+Xiangauthor=J.+Wangauthor=Z.+Zhaoauthor=Y.+Pengauthor=G.+Cambareriauthor=A.+Rocherauthor=C.+V.+Mobbsauthor=P.+R.+Hofauthor=G.+M.+Pasinetti&title=Diet-induced+insulin+resistance+promotes+amyloidosis+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DPompl%26aufirst%3DP.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCambareri%26aufirst%3DG.%26aulast%3DRocher%26aufirst%3DA.%26aulast%3DMobbs%26aufirst%3DC.%2BV.%26aulast%3DHof%26aufirst%3DP.%2BR.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DDiet-induced%2520insulin%2520resistance%2520promotes%2520amyloidosis%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D902%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchio-Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunieda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurinami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, R.</span><span> </span><span class="NLM_article-title">Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7036</span><span class="NLM_x">–</span> <span class="NLM_lpage">7041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7036-7041&author=S.+Takedaauthor=N.+Satoauthor=K.+Uchio-Yamadaauthor=K.+Sawadaauthor=T.+Kuniedaauthor=D.+Takeuchiauthor=H.+Kurinamiauthor=M.+Shinoharaauthor=H.+Rakugiauthor=R.+Morishita&title=Diabetes-accelerated+memory+dysfunction+via+cerebrovascular+inflammation+and+Abeta+deposition+in+an+Alzheimer+mouse+model+with+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DUchio-Yamada%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DK.%26aulast%3DKunieda%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DD.%26aulast%3DKurinami%26aufirst%3DH.%26aulast%3DShinohara%26aufirst%3DM.%26aulast%3DRakugi%26aufirst%3DH.%26aulast%3DMorishita%26aufirst%3DR.%26atitle%3DDiabetes-accelerated%2520memory%2520dysfunction%2520via%2520cerebrovascular%2520inflammation%2520and%2520Abeta%2520deposition%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520with%2520diabetes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D7036%26epage%3D7041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Biessels, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staekenborg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span> </span><span class="NLM_article-title">Risk of dementia in diabetes mellitus: a systematic review</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2FS1474-4422%2805%2970284-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16361024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD2MnnsVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=64-74&author=G.+J.+Biesselsauthor=S.+Staekenborgauthor=E.+Brunnerauthor=C.+Brayneauthor=P.+Scheltens&title=Risk+of+dementia+in+diabetes+mellitus%3A+a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of dementia in diabetes mellitus: a systematic review</span></div><div class="casAuthors">Biessels Geert Jan; Staekenborg Salka; Brunner Eric; Brayne Carol; Scheltens Philip</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-74</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">The relation between diabetes and major types of dementia is controversial.  This systematic review examines the incidence of dementia in people with diabetes mellitus.  We identified 14 eligible longitudinal population-based studies of variable methodological quality.  The incidence of "any dementia" was higher in individuals with diabetes than in those without diabetes in seven of ten studies reporting this aggregate outcome.  This high risk included both Alzheimer's disease and vascular dementia (eight of 13 studies and six of nine studies respectively).  Detailed data on modulating and mediating effects of glycaemic control, microvascular complications, and comorbidity (eg, hypertension and stroke) were generally absent.  The findings of mechanistic studies suggest that vascular disease and alterations in glucose, insulin, and amyloid metabolism underlie the pathophysiology, but which of these mechanisms are clinically relevant is unclear.  Further high quality studies need to be initiated, with objective diabetes assessment, together with reliable methods to establish the contribution of vascular disease and other comorbidity to dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRw6_2C-aXsbTslzEEsg76ufW6udTcc2eaFfnqoP28oe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnnsVSrtg%253D%253D&md5=c528e0dfbfc47f7b6138090a53b9e5db</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2805%2970284-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252805%252970284-2%26sid%3Dliteratum%253Aachs%26aulast%3DBiessels%26aufirst%3DG.%2BJ.%26aulast%3DStaekenborg%26aufirst%3DS.%26aulast%3DBrunner%26aufirst%3DE.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DScheltens%26aufirst%3DP.%26atitle%3DRisk%2520of%2520dementia%2520in%2520diabetes%2520mellitus%253A%2520a%2520systematic%2520review%26jtitle%3DLancet%2520Neurol.%26date%3D2006%26volume%3D5%26spage%3D64%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Luchsinger, J. A.</span><span> </span><span class="NLM_article-title">Adiposity, hyperinsulinemia, diabetes and Alzheimer’s disease: an epidemiological perspective</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.ejphar.2008.02.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18384771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2qu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2008&pages=119-129&author=J.+A.+Luchsinger&title=Adiposity%2C+hyperinsulinemia%2C+diabetes+and+Alzheimer%E2%80%99s+disease%3A+an+epidemiological+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease</span></div><div class="casAuthors">Luchsinger, Jose Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-129</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The objective of this manuscript is to provide a comprehensive review of the epidemiol. evidence linking the continuum of adiposity, hyperinsulinemia, and diabetes with Alzheimer's disease.  The mechanisms for these assocns. remain to be elucidated, but may include direct actions from insulin, advanced products of glycosilation, cerebrovascular disease, and products of adipose tissue metab.  Elevated adiposity in middle age is related to a higher risk of Alzheimer's disease.  The evidence relating adiposity in old age to Alzheimer's disease is conflicting.  Several studies have shown that hyperinsulinemia, a consequence of higher adiposity and insulin resistance, is also related to a higher risk of Alzheimer's disease.  Hyperinsulinemia is a risk factor for diabetes, and numerous studies have shown a relation of diabetes with higher Alzheimer's disease risk.  Most studies fail the take into account the continuum linking these risk factors which may result in underestimation of their importance in Alzheimer's disease.  The implication of these assocns. is that a large proportion of the world population may be at increased risk of Alzheimer's disease given the trends for increasing prevalence of overweight, obesity, hyperinsulinemia, and diabetes.  However, if proven causal, these assocns. also present a unique opportunity for prevention and treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoovYRswr76fbVg90H21EOLACvtfcHk0lhA55qzekljQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2qu7Y%253D&md5=0d0edcada5526f76f3c96eb5beb77ba5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.02.048%26sid%3Dliteratum%253Aachs%26aulast%3DLuchsinger%26aufirst%3DJ.%2BA.%26atitle%3DAdiposity%252C%2520hyperinsulinemia%252C%2520diabetes%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520epidemiological%2520perspective%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D585%26spage%3D119%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bernardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minghetti, L.</span><span> </span><span class="NLM_article-title">PPAR-gamma agonists as regulators of microglial activation and brain inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F138161206780574579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=16454728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=93-109&author=A.+Bernardoauthor=L.+Minghetti&title=PPAR-gamma+agonists+as+regulators+of+microglial+activation+and+brain+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">PPAR-γ agonists as regulators of microglial activation and brain inflammation</span></div><div class="casAuthors">Bernardo, Antonietta; Minghetti, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-109</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The peroxisome proliferator-activated receptor-γ (PPAR-γ) belongs to a large group of nuclear receptors controlling reprodn., metab., development and immune response.  Upon activation by specific agonists, these receptors form dimers and translocate to the nucleus, where they act as agonist-dependent transcription factors and regulate gene expression by binding to specific promoter regions of target genes.  The observation that PPAR-γ is involved in the regulation of macrophage differentiation and activation in the peripheral organs has prompted the investigation of the functional role of PPAR-γ in microglial cells, the main macrophage population of the CNS.  The present review summarizes the several lines of evidence supporting that PPAR-γ natural and synthetic agonists may control brain inflammation by inhibiting several functions assocd. to microglial activation, such as the expression of surface antigens and the synthesis of nitric oxide, prostaglandins, inflammatory cytokines and chemokines.  Moreover, one of the major natural PPAR-γ agonist, 15d-prostaglandin J2 may contribute to the safe elimination of activated microglia by inducing apoptosis.  Synthetic PPAR-γ agonists do not entirely reproduce the range of 15d-prostaglandin J2 effects, suggesting that PPAR-γ independent mechanisms are also involved in the action of this prostaglandin.  In addn. to microglia, PPAR-γ agonists affect functions and survival of other neural cells, including astrocytes, oligodendrocytes and neurons.  Although most of the evidence comes from in vitro observations, an increasing no. of studies in animal models further supports the potential therapeutic use of PPAR-γ agonists in human brain diseases including multiple sclerosis, Parkinson's disease and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNX9pN2If_nrVg90H21EOLACvtfcHk0lj3NyXwaf44-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGhsg%253D%253D&md5=cc4a06dcf6cde721af01217c7e151a64</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F138161206780574579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206780574579%26sid%3Dliteratum%253Aachs%26aulast%3DBernardo%26aufirst%3DA.%26aulast%3DMinghetti%26aufirst%3DL.%26atitle%3DPPAR-gamma%2520agonists%2520as%2520regulators%2520of%2520microglial%2520activation%2520and%2520brain%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D93%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Combs, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannady, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Inflammatory mechanisms in Alzheimer’s disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=10632585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtF2hsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=558-567&author=C.+K.+Combsauthor=D.+E.+Johnsonauthor=J.+C.+Karloauthor=S.+B.+Cannadyauthor=G.+E.+Landreth&title=Inflammatory+mechanisms+in+Alzheimer%E2%80%99s+disease%3A+inhibition+of+beta-amyloid-stimulated+proinflammatory+responses+and+neurotoxicity+by+PPARgamma+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists</span></div><div class="casAuthors">Combs, Colin K.; Johnson, Derrick E.; Karlo, J. Colleen; Cannady, Steven B.; Landreth, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">558-567</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by the extracellular deposition of β-amyloid fibrils within the brain and the subsequent assocn. and phenotypic activation of microglial cells assocd. with the amyloid plaque.  The activated microglia mount a complex local proinflammatory response with the secretion of a diverse range of inflammatory products.  Nonsteroidal anti-inflammatory drugs (NSAIDs) are efficacious in reducing the incidence and risk of AD and significantly delaying disease progression.  A recently appreciated target of NSAIDs is the ligand-activated nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ).  PPARγ is a DNA-binding transcription factor whose transcriptional regulatory actions are activated after agonist binding.  We report that NSAIDs, drugs of the thiazolidinedione class, and the natural ligand prostaglandin J2 act as agonists for PPARγ and inhibit the β-amyloid-stimulated secretion of proinflammatory products by microglia and monocytes responsible for neurotoxicity and astrocyte activation.  The activation of PPARγ also arrested the differentiation of monocytes into activated macrophages.  PPARγ agonists were shown to inhibit the β-amyloid-stimulated expression of the cytokine genes interleukin-6 and tumor necrosis factor α.  Furthermore, PPARγ agonists inhibited the expression of cyclooxygenase-2.  These data provide direct evidence that PPARγ plays a crit. role in regulating the inflammatory responses of microglia and monocytes to β-amyloid.  We argue that the efficacy of NSAIDs in the treatment of AD may be a consequence of their actions on PPARγ rather than on their canonical targets the cyclooxygenases.  Importantly, the efficacy of these agents in inhibiting a broad range of inflammatory responses suggests PPARγ agonists may provide a novel therapeutic approach to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOOr_ebQNjI7Vg90H21EOLACvtfcHk0lj3NyXwaf44-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtF2hsLk%253D&md5=29681e57cbb5fa43d62a6ed9526663c4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DC.%2BK.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DKarlo%26aufirst%3DJ.%2BC.%26aulast%3DCannady%26aufirst%3DS.%2BB.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DInflammatory%2520mechanisms%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520inhibition%2520of%2520beta-amyloid-stimulated%2520proinflammatory%2520responses%2520and%2520neurotoxicity%2520by%2520PPARgamma%2520agonists%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D20%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumitrescu-Ozimek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiperi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Banion, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1−42 levels in APPV717I transgenic mice</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1442</span><span class="NLM_x">–</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1442-1453&author=M.+T.+Henekaauthor=M.+Sastreauthor=L.+Dumitrescu-Ozimekauthor=A.+Hankeauthor=I.+Dewachterauthor=C.+Kuiperiauthor=K.+O%E2%80%99Banionauthor=T.+Klockgetherauthor=F.+Van+Leuvenauthor=G.+E.+Landreth&title=Acute+treatment+with+the+PPARgamma+agonist+pioglitazone+and+ibuprofen+reduces+glial+inflammation+and+Abeta1%E2%88%9242+levels+in+APPV717I+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDumitrescu-Ozimek%26aufirst%3DL.%26aulast%3DHanke%26aufirst%3DA.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DKuiperi%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Banion%26aufirst%3DK.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DAcute%2520treatment%2520with%2520the%2520PPARgamma%2520agonist%2520pioglitazone%2520and%2520ibuprofen%2520reduces%2520glial%2520inflammation%2520and%2520Abeta1%25E2%2588%259242%2520levels%2520in%2520APPV717I%2520transgenic%2520mice%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1442%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Camacho, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spittaels, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchiers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">10908</span><span class="NLM_x">–</span> <span class="NLM_lpage">10917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1523%2FJNEUROSCI.3987-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=15574741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFShu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10908-10917&author=I.+E.+Camachoauthor=L.+Serneelsauthor=K.+Spittaelsauthor=P.+Merchiersauthor=D.+Dominguezauthor=B.+De+Strooper&title=Peroxisome+proliferator-activated+receptor+gamma+induces+a+clearance+mechanism+for+the+amyloid-beta+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide</span></div><div class="casAuthors">Camacho, Ira Espuny; Serneels, Lutgarde; Spittaels, Kurt; Merchiers, Pascal; Dominguez, Diana; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">10908-10917</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We investigated whether peroxisome proliferator-activated receptor γ (PPARγ) could be involved in the modulation of the amyloid cascade causing Alzheimer's disease.  Inducing expression or activating PPARγ using synthetic agonists of the thiazolinedione family results in a dramatic decrease in the levels of the amyloid-β (Aβ) peptide in the conditioned medium of neuronal and non-neuronal cells.  PPARγ does not affect expression or activity of any of the secretases involved in the generation of the Aβ peptide but induces a fast, cell-bound clearing mechanism responsible for the removal of the Aβ peptide from the medium.  Although PPARγ expression is generally low in the CNS, induction of PPARγ expression during inflammation could be beneficial for inducing Aβ clearance.  We confirm that the Aβ clearance mechanism can indeed be induced by PPARγ activation in primary murine-mixed glia and cortical neuronal cultures.  Our results suggest that PPARγ-controlled mechanisms should be explored further as potential drug targets for Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsr8SzaoJWLrVg90H21EOLACvtfcHk0lj3b2Q3LkSd6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFShu77N&md5=17620a15996c1cd88506c509c5c787cc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3987-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3987-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DCamacho%26aufirst%3DI.%2BE.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DSpittaels%26aufirst%3DK.%26aulast%3DMerchiers%26aufirst%3DP.%26aulast%3DDominguez%26aufirst%3DD.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma%2520induces%2520a%2520clearance%2520mechanism%2520for%2520the%2520amyloid-beta%2520peptide%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D10908%26epage%3D10917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sastre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghgraef, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evert, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumitrescu-Ozimek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs repress {beta}-secretase gene promoter activity by the activation of PPAR{gamma}</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=443-448&author=M.+Sastreauthor=I.+Dewachterauthor=S.+Rossnerauthor=N.+Bogdanovicauthor=E.+Rosenauthor=P.+Borghgraefauthor=B.+O.+Evertauthor=L.+Dumitrescu-Ozimekauthor=D.+R.+Thalauthor=G.+Landrethauthor=J.+Walterauthor=T.+Klockgetherauthor=F.+van+Leuvenauthor=M.+T.+Heneka&title=Nonsteroidal+anti-inflammatory+drugs+repress+%7Bbeta%7D-secretase+gene+promoter+activity+by+the+activation+of+PPAR%7Bgamma%7D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSastre%26aufirst%3DM.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DE.%26aulast%3DBorghgraef%26aufirst%3DP.%26aulast%3DEvert%26aufirst%3DB.%2BO.%26aulast%3DDumitrescu-Ozimek%26aufirst%3DL.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DLandreth%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3Dvan%2BLeuven%26aufirst%3DF.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520repress%2520%257Bbeta%257D-secretase%2520gene%2520promoter%2520activity%2520by%2520the%2520activation%2520of%2520PPAR%257Bgamma%257D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D443%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Nicolakakis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboulkassim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongali, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecrux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa-Neto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Complete rescue of cerebrovascular function in aged Alzheimer’s disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">9287</span><span class="NLM_x">–</span> <span class="NLM_lpage">9296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1523%2FJNEUROSCI.3348-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18784309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sns7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=9287-9296&author=N.+Nicolakakisauthor=T.+Aboulkassimauthor=B.+Ongaliauthor=C.+Lecruxauthor=P.+Fernandesauthor=P.+Rosa-Netoauthor=X.+K.+Tongauthor=E.+Hamel&title=Complete+rescue+of+cerebrovascular+function+in+aged+Alzheimer%E2%80%99s+disease+transgenic+mice+by+antioxidants+and+pioglitazone%2C+a+peroxisome+proliferator-activated+receptor+gamma+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist</span></div><div class="casAuthors">Nicolakakis, Nektaria; Aboulkassim, Tahar; Ongali, Brice; Lecrux, Clotilde; Fernandes, Priscilla; Rosa-Neto, Pedro; Tong, Xin-Kang; Hamel, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9287-9296</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that cerebrovascular dysfunction is an important factor in the pathogenesis of Alzheimer's disease (AD).  Using aged (∼16 mo) amyloid precursor protein (APP) transgenic mice that exhibit increased prodn. of the amyloid-β (Aβ) peptide and severe cerebrovascular and memory deficits, we examd. the capacity in vivo treatments with the antioxidants N-acetyl-L-cysteine (NAC) and tempol, or the peroxisome proliferator-activated receptor γ agonist pioglitazone to rescue cerebrovascular function and selected markers of AD neuropathol.  Addnl., we tested the ability of pioglitazone to normalize the impaired increases in cerebral blood flow (CBF) and glucose uptake (CGU) induced by whisker stimulation, and to reverse spatial memory deficits in the Morris water maze.  All compds. fully restored cerebrovascular reactivity of isolated cerebral arteries concomitantly with changes in proteins regulating oxidative stress, without reducing brain Aβ levels or Aβ plaque load.  Pioglitazone, but not NAC, significantly attenuated astroglial activation and improved, albeit nonsignificantly, the reduced cortical cholinergic innervation.  Furthermore, pioglitazone completely normalized the CBF and CGU responses to increased neuronal activity, but it failed to improve spatial memory.  Our results are the first to demonstrate that late pharmacol. intervention with pioglitazone not only overcomes cerebrovascular dysfunction and altered neurometabolic coupling in aged APP mice, but also counteracts cerebral oxidative stress, glial activation, and, partly, cholinergic denervation.  Although early or combined therapy may be warranted to improve cognition, these findings unequivocally point to pioglitazone as a most promising strategy for restoring cerebrovascular function and counteracting several AD markers detrimental to neuronal function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojir8viGYQ0LVg90H21EOLACvtfcHk0lj3b2Q3LkSd6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sns7nP&md5=7af2862379b34ecc2e92d4ee59b94e16</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3348-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3348-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DNicolakakis%26aufirst%3DN.%26aulast%3DAboulkassim%26aufirst%3DT.%26aulast%3DOngali%26aufirst%3DB.%26aulast%3DLecrux%26aufirst%3DC.%26aulast%3DFernandes%26aufirst%3DP.%26aulast%3DRosa-Neto%26aufirst%3DP.%26aulast%3DTong%26aufirst%3DX.%2BK.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DComplete%2520rescue%2520of%2520cerebrovascular%2520function%2520in%2520aged%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520mice%2520by%2520antioxidants%2520and%2520pioglitazone%252C%2520a%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%2520agonist%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D9287%26epage%3D9296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzimopoulou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvartau-Hind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthewsw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, P. M.</span><span> </span><span class="NLM_article-title">Effects of 12 months of treatment with the PPARgamma agonist rosiglitazone on brain glucose metabolism in Alzheimer’s disease: a 18F-FDG PET study</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.jalz.2009.04.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19362884" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=207&author=E.+A.+Rabinerauthor=S.+Tzimopoulouauthor=V.+J.+Cunninghamauthor=B.+Jeterauthor=M.+Zvartau-Hindauthor=M.+Castigliaauthor=P.+Mistryauthor=N.+P.+Birdauthor=J.+Matthewswauthor=B.+Whitcherauthor=T.+E.+Nicholsauthor=R.+Laiauthor=N.+Lotayauthor=A.+Saundersauthor=E.+Reimanauthor=K.+Chenauthor=M.+Goldauthor=P.+M.+Matthews&title=Effects+of+12+months+of+treatment+with+the+PPARgamma+agonist+rosiglitazone+on+brain+glucose+metabolism+in+Alzheimer%E2%80%99s+disease%3A+a+18F-FDG+PET+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2009.04.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2009.04.117%26sid%3Dliteratum%253Aachs%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DTzimopoulou%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DV.%2BJ.%26aulast%3DJeter%26aufirst%3DB.%26aulast%3DZvartau-Hind%26aufirst%3DM.%26aulast%3DCastiglia%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DP.%26aulast%3DBird%26aufirst%3DN.%2BP.%26aulast%3DMatthewsw%26aufirst%3DJ.%26aulast%3DWhitcher%26aufirst%3DB.%26aulast%3DNichols%26aufirst%3DT.%2BE.%26aulast%3DLai%26aufirst%3DR.%26aulast%3DLotay%26aufirst%3DN.%26aulast%3DSaunders%26aufirst%3DA.%26aulast%3DReiman%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DMatthews%26aufirst%3DP.%2BM.%26atitle%3DEffects%2520of%252012%2520months%2520of%2520treatment%2520with%2520the%2520PPARgamma%2520agonist%2520rosiglitazone%2520on%2520brain%2520glucose%2520metabolism%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%252018F-FDG%2520PET%2520study%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sato, T.; Hanyu, H.; Hirao, K.; Kanetaka, H.; Sakurai, H.; Iwamoto, T.</span><span> </span><span class="NLM_article-title">Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease</span>.  <span class="citation_source-journal">Neurobiol. Aging</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2009.10.009</span> . Published Online: Nov 17, 2009.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.neurobiolaging.2009.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sato%2C+T.%3B+Hanyu%2C+H.%3B+Hirao%2C+K.%3B+Kanetaka%2C+H.%3B+Sakurai%2C+H.%3B+Iwamoto%2C+T.+Efficacy+of+PPAR-gamma+agonist+pioglitazone+in+mild+Alzheimer+disease.+Neurobiol.+Aging+%5BOnline+early+access%5D.+DOI%3A+10.1016%2Fj.neurobiolaging.2009.10.009.+Published+Online%3A+Nov+17%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26atitle%3DEfficacy%2520of%2520PPAR-gamma%2520agonist%2520pioglitazone%2520in%2520mild%2520Alzheimer%2520disease%26jtitle%3DNeurobiol.%2520Aging%26doi%3D10.1016%2Fj.neurobiolaging.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Maeshiba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motohashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanayama, S.</span><span> </span><span class="NLM_article-title">Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=9037440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADyaK2sXptlCmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1997&pages=29-35&author=Y.+Maeshibaauthor=Y.+Kiyotaauthor=K.+Yamashitaauthor=Y.+Yoshimuraauthor=M.+Motohashiauthor=S.+Tanayama&title=Disposition+of+the+new+antidiabetic+agent+pioglitazone+in+rats%2C+dogs%2C+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys</span></div><div class="casAuthors">Maeshiba, Yoshihiro; Kiyota, Yutaka; Yamashita, Kenji; Yoshimura, Yoshinobu; Motohashi, Michio; Tanayama, Shigeharu</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Cantor</span>)
        </div><div class="casAbstract">The disposition of pioglitazone was studied after oral administration to rats, dogs, and monkeys using 14C-labeled drug.  After oral dosing, pioglitazone was well absorbed from the gastrointestinal tract at an extent of 96, 95, and 90% in rats, dogs, and monkeys, resp.  In rats, the concn. of pioglitazone in plasma reached a peak (Cmax 0.71 μg/mL) at 4 h (tmax) after dosing and declined with a half-life (t1/2) of 2.6 h.  In dogs, tmax, Cmax and t1/2 were 0.5 h, 0.32 μg/mL and 2.1 h, and those for monkeys were 4.3 h, 0.48 μg/mL and 5.3 h, resp.  The drug was metabolized mainly to M-I to M-VI including the pharmacol. active metabolites (M-II, III, and IV).  The pharmacol. active compds. (total of the unchanged compd. and the above three active metabolites) accounted for 87, 71 and 73% of the radioactivity in plasma of rats, dogs, and monkeys, resp.  The radioactivity was widely distributed in tissues after oral administration to rats, and decreased to the very low concn. within 24 to 72 h after dosing.  Radioactivity dose was almost completely excreted in urine and feces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOCPe49ZgLkLVg90H21EOLACvtfcHk0lhphya99IQhCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXptlCmtA%253D%253D&md5=7f144eaf15e2bb1e2507316fb2f3df52</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaeshiba%26aufirst%3DY.%26aulast%3DKiyota%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DY.%26aulast%3DMotohashi%26aufirst%3DM.%26aulast%3DTanayama%26aufirst%3DS.%26atitle%3DDisposition%2520of%2520the%2520new%2520antidiabetic%2520agent%2520pioglitazone%2520in%2520rats%252C%2520dogs%252C%2520and%2520monkeys%26jtitle%3DArzneim.%2520Forsch.%26date%3D1997%26volume%3D47%26spage%3D29%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Koeberle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurglics, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werz, O.</span><span> </span><span class="NLM_article-title">Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8068</span><span class="NLM_x">–</span> <span class="NLM_lpage">8076</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801085s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8068-8076&author=A.+Koeberleauthor=H.+Zettlauthor=C.+Greinerauthor=M.+Wurglicsauthor=M.+Schubert-Zsilaveczauthor=O.+Werz&title=Pirinixic+acid+derivatives+as+novel+dual+inhibitors+of+microsomal+prostaglandin+E2+synthase-1+and+5-lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm801085s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801085s%26sid%3Dliteratum%253Aachs%26aulast%3DKoeberle%26aufirst%3DA.%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DGreiner%26aufirst%3DC.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DWerz%26aufirst%3DO.%26atitle%3DPirinixic%2520acid%2520derivatives%2520as%2520novel%2520dual%2520inhibitors%2520of%2520microsomal%2520prostaglandin%2520E2%2520synthase-1%2520and%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8068%26epage%3D8076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Mitsunobu, O.</span><span> </span><span class="NLM_article-title">The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1055%2Fs-1981-29317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1981&pages=1-28&author=O.+Mitsunobu&title=The+use+of+diethyl+azodicarboxylate+and+triphenylphosphine+in+synthesis+and+transformation+of+natural+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29317%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26atitle%3DThe%2520use%2520of%2520diethyl%2520azodicarboxylate%2520and%2520triphenylphosphine%2520in%2520synthesis%2520and%2520transformation%2520of%2520natural%2520products%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4421</span><span class="NLM_x">–</span> <span class="NLM_lpage">4426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4421-4426&author=H.+Zettlauthor=R.+Steriauthor=M.+Lammerhoferauthor=M.+Schubert-Zsilavecz&title=Discovery+of+a+novel+class+of+2-mercaptohexanoic+acid+derivatives+as+highly+active+PPARalpha+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DSteri%26aufirst%3DR.%26aulast%3DLammerhofer%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%25202-mercaptohexanoic%2520acid%2520derivatives%2520as%2520highly%2520active%2520PPARalpha%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4421%26epage%3D4426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuchtenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorner-Ciossek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">Insensitivity to Abeta 42-lowering non-steroidal anti-inflammatory drugs (NSAIDs) and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">24504</span><span class="NLM_x">–</span> <span class="NLM_lpage">24513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=24504-24513&author=E.+Czirrauthor=S.+Leuchtenbergerauthor=C.+Dorner-Ciossekauthor=A.+Schneiderauthor=M.+Juckerauthor=E.+H.+Kooauthor=C.+U.+Pietrzikauthor=K.+Baumannauthor=S.+Weggen&title=Insensitivity+to+Abeta+42-lowering+non-steroidal+anti-inflammatory+drugs+%28NSAIDs%29+and+gamma-secretase+inhibitors+is+common+among+aggressive+presenilin-1+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DLeuchtenberger%26aufirst%3DS.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3DInsensitivity%2520to%2520Abeta%252042-lowering%2520non-steroidal%2520anti-inflammatory%2520drugs%2520%2528NSAIDs%2529%2520and%2520gamma-secretase%2520inhibitors%2520is%2520common%2520among%2520aggressive%2520presenilin-1%2520mutations%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D24504%26epage%3D24513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Karlstrom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lendahl, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naslund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">A sensitive and quantitative assay for measuring cleavage of presenilin substrates</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">6763</span><span class="NLM_x">–</span> <span class="NLM_lpage">6766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=6763-6766&author=H.+Karlstromauthor=A.+Bergmanauthor=U.+Lendahlauthor=J.+Naslundauthor=J.+Lundkvist&title=A+sensitive+and+quantitative+assay+for+measuring+cleavage+of+presenilin+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlstrom%26aufirst%3DH.%26aulast%3DBergman%26aufirst%3DA.%26aulast%3DLendahl%26aufirst%3DU.%26aulast%3DNaslund%26aufirst%3DJ.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DA%2520sensitive%2520and%2520quantitative%2520assay%2520for%2520measuring%2520cleavage%2520of%2520presenilin%2520substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D6763%26epage%3D6766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavatte, P.</span><span> </span><span class="NLM_article-title">Structural insight into PPARgamma ligands binding</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.2174%2F092986709788186165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19442144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslagtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=1768-1789&author=A.+Farceauthor=N.+Renaultauthor=P.+Chavatte&title=Structural+insight+into+PPARgamma+ligands+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into PPARγ ligands binding</span></div><div class="casAuthors">Farce, A.; Renault, N.; Chavatte, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1768-1789</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxisome Proliferator Activated Receptors (PPARs) are a family of three related nuclear receptors first cloned in 1990.  Their involvement in glucidic and lipidic homeostasis quickly made them an attractive target for the treatment of metabolic syndrome, the most prevalent mortality factor in developed countries.  They therefore attracted much synthetical efforts, more particularly PPARγ.  Supported by a large no. of crystallog. studies, data derived from these compds. lead to a fairly clear view of the agonist binding mode into the Ligand Binding Domain (LBD).  Nearly all the compds. conform to a three-module structure, with a binder group involved in a series of hydrogen bonds in front of the ligand-dependent Activation Function (AF2), a linker mostly arranged around a phenoxyethyl and an effector end occupying the large cavity of the binding site.  Following the marketing of the glitazones and the observation of the hepatotoxicity of troglitazone, variations in the binder led to the glitazars, and then pharmacomodulations have been undertaken on the two other modules, leading to a large family of highly related chem. structures.  Some compds., while still adhering to the three-module structure, diverge from the mainstream, such as the phthalates.  Curiously, these plasticizers were known to elicit biol. effects that led to the discovery of PPARs but were not actively studied as PPARs agonists.  As the biol. effects of PPARs became clearer, new compds. were also found to exert at least a part of their actions by the activation of PPARγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXIzPjMWM9rrVg90H21EOLACvtfcHk0lhUedZP2scYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslagtbY%253D&md5=4a5217779abc9d8d640bf8b9f2600599</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F092986709788186165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788186165%26sid%3Dliteratum%253Aachs%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DRenault%26aufirst%3DN.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DStructural%2520insight%2520into%2520PPARgamma%2520ligands%2520binding%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D1768%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kache, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasiadis, P. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1038%2Fnm1235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=15834426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=545-550&author=T.+Kukarauthor=M.+P.+Murphyauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=S.+Weggenauthor=T.+E.+Smithauthor=T.+Laddauthor=M.+A.+Khanauthor=R.+Kacheauthor=J.+Beardauthor=M.+Dodsonauthor=S.+Meritauthor=V.+V.+Ozolsauthor=P.+Z.+Anastasiadisauthor=P.+Dasauthor=A.+Fauqauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Diverse+compounds+mimic+Alzheimer+disease-causing+mutations+by+augmenting+Abeta42+production"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production</span></div><div class="casAuthors">Kukar, Thomas; Murphy, Michael Paul; Eriksen, Jason L.; Sagi, Sarah A.; Weggen, Sascha; Smith, Tawnya E.; Ladd, Thomas; Khan, Murad A.; Kache, Rajashaker; Beard, Jenny; Dodson, Mark; Merit, Sami; Ozols, Victor V.; Anastasiadis, Panos Z.; Das, Pritam; Fauq, Abdul; Koo, Edward H.; Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-550</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increased Aβ42 prodn. has been linked to the development of Alzheimer disease.  We now identify a no. of compds. that raise Aβ42.  Among the more potent Aβ42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID.  Many COX-2-selective NSAIDs tested raised Aβ42, including multiple COX-2-selective derivs. of two Aβ42-lowering NSAIDs.  Compds. devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Aβ42.  These compds. seem to target the γ-secretase complex, increasing γ-secretase-catalyzed prodn. of Aβ42 in vitro.  Short-term in vivo studies show that two Aβ42-raising compds. increase Aβ42 levels in the brains of mice.  The elevations in Aβ42 by these compds. are comparable to the increases in Aβ42 induced by Alzheimer disease-causing mutations in the genes encoding amyloid β protein precursor and presenilins, raising the possibility that exogenous compds. or naturally occurring isoprenoids might increase Aβ42 prodn. in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtRxKDIW3Gh7Vg90H21EOLACvtfcHk0lhUedZP2scYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D&md5=78e435c12ca6f7c6af227cd38bffe131</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnm1235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1235%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DLadd%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DKache%26aufirst%3DR.%26aulast%3DBeard%26aufirst%3DJ.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DMerit%26aufirst%3DS.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DAnastasiadis%26aufirst%3DP.%2BZ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDiverse%2520compounds%2520mimic%2520Alzheimer%2520disease-causing%2520mutations%2520by%2520augmenting%2520Abeta42%2520production%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Popescu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syha, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1002%2Fardp.200700042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=17610302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosV2gsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2007&pages=367-371&author=L.+Popescuauthor=O.+Rauauthor=J.+Bottcherauthor=Y.+Syhaauthor=M.+Schubert-Zsilavecz&title=Quinoline-based+derivatives+of+pirinixic+acid+as+dual+PPAR+alpha%2Fgamma+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline-based derivatives of pirinixic acid as dual PPAR α/γ agonists</span></div><div class="casAuthors">Popescu, Laura; Rau, Oliver; Boettcher, Jark; Syha, Yvonne; Schubert-Zsilavecz, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">367-371</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Pirinixic acid is known for its peroxisome proliferator-activated receptor (PPAR) agonistic action.  In a recent publication, we have shown that aliph. α-substitution of pirinixic acid enhances both PPARα and PPARγ agonism.  The goal of this study was to evaluate, whether the PPAR agonism of pirinixic acid may be also maintained in quinoline-based derivs.  The present study revealed that the mere substitution of the di-Me aniline moiety of pirinixic acid by quinoline leads to a total loss of PPARα/γ agonism, whereas concomitant α-substitution with Bu or n-hexyl groups restores and even enforces PPAR activation, leading to potent dual PPARα/γ agonists.  In the following we report the synthesis of quinoline-based derivs. of pirinixic acid, which in a Gal4-based luciferase-reporter gene assay proved to be potent dual PPARα/γ agonists.  Mol. docking of compd. 4 (I) with FlexX suggests a binding mode resembling to that of tesaglitazar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreXsClnUkbcLVg90H21EOLACvtfcHk0lhCHOSSG3nDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosV2gsbw%253D&md5=113559980eb2dca3ba5d15030d00fc2e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700042%26sid%3Dliteratum%253Aachs%26aulast%3DPopescu%26aufirst%3DL.%26aulast%3DRau%26aufirst%3DO.%26aulast%3DBottcher%26aufirst%3DJ.%26aulast%3DSyha%26aufirst%3DY.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DQuinoline-based%2520derivatives%2520of%2520pirinixic%2520acid%2520as%2520dual%2520PPAR%2520alpha%252Fgamma%2520agonists%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2007%26volume%3D340%26spage%3D367%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Rau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syha, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1002%2Fardp.200700209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=18275039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVersL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=191-195&author=O.+Rauauthor=Y.+Syhaauthor=H.+Zettlauthor=M.+Kockauthor=A.+Bockauthor=M.+Schubert-Zsilavecz&title=Alpha-alkyl+substituted+pirinixic+acid+derivatives+as+potent+dual+agonists+of+the+peroxisome+proliferator+activated+receptor+alpha+and+gamma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">α-Alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma</span></div><div class="casAuthors">Rau, Oliver; Syha, Yvonne; Zettl, Heiko; Kock, Michael; Bock, Andreas; Schubert-Zsilavecz, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-195</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors, playing a pivotal role in energy homeostasis.  Activators of the PPARα subtype are in widespread use for the treatment of hyperlipidemia, while activators of the PPARγ subtype are in clin. use for the treatment of type-2 diabetes.  Since both of these diseases are frequently assocd., the combined treatment with one drug simultaneously activating PPARα and PPARγ seems worthwhile.  Starting with pirinixic acid, which is a moderately active dual PPARα/γ agonist, we improved potency at the human PPARα and PPARγ by substituting the α-position with an aliph. chain.  The maximal effect was achieved at a chain length of four and six carbons, resp., leading to an activity induction by a factor of 36 for PPARα and 18 for PPARγ, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquwvfYMh_G_7Vg90H21EOLACvtfcHk0lhCHOSSG3nDPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVersL4%253D&md5=5e8202ec55cf61294272c0a73728a29c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700209%26sid%3Dliteratum%253Aachs%26aulast%3DRau%26aufirst%3DO.%26aulast%3DSyha%26aufirst%3DY.%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DKock%26aufirst%3DM.%26aulast%3DBock%26aufirst%3DA.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DAlpha-alkyl%2520substituted%2520pirinixic%2520acid%2520derivatives%2520as%2520potent%2520dual%2520agonists%2520of%2520the%2520peroxisome%2520proliferator%2520activated%2520receptor%2520alpha%2520and%2520gamma%26jtitle%3DArch.%2520Pharm.%26date%3D2008%26volume%3D341%26spage%3D191%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proschak, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span> </span><span class="NLM_article-title">Novel pirinixic acids as PPARalpha preferential dual PPARalpha/gamma agonists</span> <span class="citation_source-journal">QSAR Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=576-586&author=H.+Zettlauthor=M.+Dittrichauthor=R.+Steriauthor=O.+Proschakauthor=O.+Rauauthor=D.+Steinhilberauthor=G.+Schneiderauthor=M.+Lammerhoferauthor=M.+Schubert-Zsilavecz&title=Novel+pirinixic+acids+as+PPARalpha+preferential+dual+PPARalpha%2Fgamma+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DDittrich%26aufirst%3DM.%26aulast%3DSteri%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DO.%26aulast%3DRau%26aufirst%3DO.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DLammerhofer%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DNovel%2520pirinixic%2520acids%2520as%2520PPARalpha%2520preferential%2520dual%2520PPARalpha%252Fgamma%2520agonists%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2009%26volume%3D28%26spage%3D576%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lammerhofer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiesel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, W.</span><span> </span><span class="NLM_article-title">Enantiomer separation and indirect chromatographic absolute configuration prediction of chiral pirinixic acid derivatives: limitations of polysaccharide-type chiral stationary phases in comparison to chiral anion-exchangers</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1217</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1217&publication_year=2010&pages=1033-1040&author=M.+Lammerhoferauthor=R.+Pellauthor=M.+Mahutauthor=M.+Richterauthor=S.+Schieselauthor=H.+Zettlauthor=M.+Dittrichauthor=M.+Schubert-Zsilaveczauthor=W.+Lindner&title=Enantiomer+separation+and+indirect+chromatographic+absolute+configuration+prediction+of+chiral+pirinixic+acid+derivatives%3A+limitations+of+polysaccharide-type+chiral+stationary+phases+in+comparison+to+chiral+anion-exchangers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLammerhofer%26aufirst%3DM.%26aulast%3DPell%26aufirst%3DR.%26aulast%3DMahut%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DSchiesel%26aufirst%3DS.%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DDittrich%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DLindner%26aufirst%3DW.%26atitle%3DEnantiomer%2520separation%2520and%2520indirect%2520chromatographic%2520absolute%2520configuration%2520prediction%2520of%2520chiral%2520pirinixic%2520acid%2520derivatives%253A%2520limitations%2520of%2520polysaccharide-type%2520chiral%2520stationary%2520phases%2520in%2520comparison%2520to%2520chiral%2520anion-exchangers%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2010%26volume%3D1217%26spage%3D1033%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Meinert, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitner, J. C.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease anti-inflammatory prevention trial: design, methods, and baseline results</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1016%2Fj.jalz.2008.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19328435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ktFGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=93-104&author=C.+L.+Meinertauthor=L.+D.+McCaffreyauthor=J.+C.+Breitner&title=Alzheimer%E2%80%99s+disease+anti-inflammatory+prevention+trial%3A+design%2C+methods%2C+and+baseline+results"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results</span></div><div class="casAuthors">Meinert Curtis L; McCaffrey Lee D; Breitner John C S</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-104</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) was designed to address whether non-steroidal anti-inflammatory drugs (NSAIDs) can prevent or delay the onset of Alzheimer's disease (AD).  METHODS:  ADAPT was a randomized, double-placebo-controlled, multicenter chemoprevention trial conducted at six U.S. dementia research clinics.  At entry, participants were required to test "normal" on a battery of cognitive tests and to be age 70+ with a family history of Alzheimer-like dementia.  Persons were randomly assigned to 200 mg b.i.d. celecoxib (Celebrex, Pfizer), 220 mg b.i.d. naproxen sodium (Aleve, Bayer), or placebo.  The primary outcome measure was AD.  Secondary outcome measures were cognitive decline and measures related to safety of the treatments when used long term.  ADAPT was designed to detect a 30% reduction in AD incidence with 80% power.  The estimated sample size requirement was 2,625.  RESULTS:  Enrollment began in March 2001 and ended in December 2004 when treatments were suspended because of concerns regarding cardiovascular safety of the treatments.  Followup ranged from 1 to 46 months.  The achieved enrollment was 2,528.  Recruitment was achieved primarily via mailings to people aged 70+ living in the catchment areas of the six field sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-IJDr0TD4ycjl5L8hwNX0fW6udTcc2ea7hVRnh9nhJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ktFGnug%253D%253D&md5=d4f8ff962d90a2e440a49857378ede46</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2008.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2008.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DMeinert%26aufirst%3DC.%2BL.%26aulast%3DMcCaffrey%26aufirst%3DL.%2BD.%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520anti-inflammatory%2520prevention%2520trial%253A%2520design%252C%2520methods%252C%2520and%2520baseline%2520results%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3D93%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Jager, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuchtenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesselowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldron, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span> </span><span class="NLM_article-title">Alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1111%2Fj.1471-4159.2009.06420.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=19804379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A280%3ADC%252BD1MfjtlWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=1369-1382&author=S.+Jagerauthor=S.+Leuchtenbergerauthor=A.+Martinauthor=E.+Czirrauthor=J.+Wesselowskiauthor=M.+Dieckmannauthor=E.+Waldronauthor=C.+Korthauthor=E.+H.+Kooauthor=M.+Henekaauthor=S.+Weggenauthor=C.+U.+Pietrzik&title=Alpha-secretase+mediated+conversion+of+the+amyloid+precursor+protein+derived+membrane+stub+C99+to+C83+limits+Abeta+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation</span></div><div class="casAuthors">Jager Sebastian; Leuchtenberger Stefanie; Martin Anne; Czirr Eva; Wesselowski Johanna; Dieckmann Marco; Waldron Elaine; Korth Carsten; Koo Edward H; Heneka Michael; Weggen Sascha; Pietrzik Claus U</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1369-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Swedish mutation within the amyloid precursor protein (APP) causes early-onset Alzheimer's disease due to increased cleavage of APP by BACE1.  While beta-secretase shedding of Swedish APP (APPswe) largely results from an activity localized in the late secretory pathway, cleavage of wild-type APP occurs mainly in endocytic compartments.  However, we show that liberation of Abeta from APPswe is still dependent on functional internalization from the cell surface.  Inspite the unchanged overall beta-secretase cleaved soluble APP released from APP(swe) secretion, mutations of the APPswe internalization motif strongly reduced C99 levels and substantially decreased Abeta secretion.  We point out that alpha-secretase activity-mediated conversion of C99 to C83 is the main cause of this Abeta reduction.  Furthermore, we demonstrate that alpha-secretase cleavage of C99 even contributes to the reduction of Abeta secretion of internalization deficient wild-type APP.  Therefore, inhibition of alpha-secretase cleavage increased Abeta secretion through diminished conversion of C99 to C83 in APP695, APP695swe or C99 expressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfAmsBbKr5SHRxY89Cm6SyfW6udTcc2ea7hVRnh9nhJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MfjtlWkug%253D%253D&md5=ee577954f25c0f714cfeb2ccefe9f605</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06420.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06420.x%26sid%3Dliteratum%253Aachs%26aulast%3DJager%26aufirst%3DS.%26aulast%3DLeuchtenberger%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DWesselowski%26aufirst%3DJ.%26aulast%3DDieckmann%26aufirst%3DM.%26aulast%3DWaldron%26aufirst%3DE.%26aulast%3DKorth%26aufirst%3DC.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DHeneka%26aufirst%3DM.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26atitle%3DAlpha-secretase%2520mediated%2520conversion%2520of%2520the%2520amyloid%2520precursor%2520protein%2520derived%2520membrane%2520stub%2520C99%2520to%2520C83%2520limits%2520Abeta%2520generation%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26spage%3D1369%26epage%3D1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitasato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1211%2F0022357011778070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm1003073&amp;key=11804398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm1003073&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1alsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=1679-1685&author=M.+Katoauthor=S.+Nishidaauthor=H.+Kitasatoauthor=N.+Sakataauthor=S.+Kawai&title=Cyclooxygenase-1+and+cyclooxygenase-2+selectivity+of+non-steroidal+anti-inflammatory+drugs%3A+investigation+using+human+peripheral+monocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes</span></div><div class="casAuthors">Kato, Miyako; Nishida, Shinichi; Kitasato, Hidero; Sakata, Natsue; Kawai, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1679-1685</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Since the pharmacol. profiles of various non-steroidal anti-inflammatory drugs (NSAIDs) might depend on their differing selectivity for cyclooxygenase 1 (COX-1) and 2 (COX-2), we developed a new screening method using human peripheral monocytes.  Monocytes from healthy volunteers were sepd., and the cells were incubated with or without lipopolysaccharide (LPS).  Monocytes without LPS stimulation exclusively expressed COX-1 on Western blotting anal., whereas LPS stimulation induced COX-2 expression.  Unstimulated monocytes (COX-1) and LPS-stimulated monocytes (COX-2) were then used to det. the COX selectivity of various NSAIDs.  The resp. mean IC50 values for COX-1 and COX-2 IC50 (μM), and the COX-1/COX-2 ratio of each NSAID were as follows: celecoxib, 82, 6.8, 12; diclofenac, 0.076, 0.026, 2.9; etodolac, > 100, 53, > 1.9; ibuprofen, 12, 80, 0.15; indometacin, 0.0090, 0.31, 0.029; meloxicam, 37, 6.1, 6.1; 6-MNA (the active metabolite of nabumetone), 149, 230, 0.65; NS-398, 125, 5.6, 22; piroxicam, 47, 25, 1.9; rofecoxib, > 100, 25, > 4.0; S-2474, > 100, 8.9, > 11; SC-560, 0.0048, 1.4, 0.0034.  The percentage inhibition of COX-1 activity at the IC50 of COX-2 also showed a wide variation among these NSAIDs.  The bioassay system using human monocytes to assess the inhibitory effects of various NSAIDs on COX-1 and COX-2 may become a clin. useful screening method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRB4Yns9-eB7Vg90H21EOLACvtfcHk0lgyskAgF482gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1alsA%253D%253D&md5=e129115e26cfcea58c3468b8ed5537a4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1211%2F0022357011778070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011778070%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DNishida%26aufirst%3DS.%26aulast%3DKitasato%26aufirst%3DH.%26aulast%3DSakata%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%26atitle%3DCyclooxygenase-1%2520and%2520cyclooxygenase-2%2520selectivity%2520of%2520non-steroidal%2520anti-inflammatory%2520drugs%253A%2520investigation%2520using%2520human%2520peripheral%2520monocytes%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2001%26volume%3D53%26spage%3D1679%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Demello, K. L.; Ricketts, A. P.</span><span> </span><span class="NLM_article-title">Cox-2 Selective Carprofen for Treating Pain and Inflammation in Dogs</span>. US2003212123 (A1),<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=K.+L.+Demello&author=A.+P.+Ricketts&title=Cox-2+Selective+Carprofen+for+Treating+Pain+and+Inflammation+in+Dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDemello%26aufirst%3DK.%2BL.%26atitle%3DCox-2%2520Selective%2520Carprofen%2520for%2520Treating%2520Pain%2520and%2520Inflammation%2520in%2520Dogs%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Pairet, M.; van Ryn, J.</span>, Eds.  <span class="citation_source-book">COX-2 Inhibitors</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Birkhäuser</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm1003073&amp;key=10.1007%2F978-3-0348-7879-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Pairet&author=J.+van+Ryn&title=COX-2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2F978-3-0348-7879-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-0348-7879-1%26sid%3Dliteratum%253Aachs%26aulast%3DPairet%26aufirst%3DM.%26btitle%3DCOX-2%2520Inhibitors%26pub%3DBirkh%25C3%25A4user%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a href="/doi/suppl/10.1021/jm1003073">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23874"></div></div></div></div></div><hr /></hr><p class="last">Chemical synthesis, <sup>1</sup>H and <sup>13</sup>C NMR data of intermediates and final compounds, mass spectrometry, combustion analysis, and cytotoxicity data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1003073/suppl_file/jm1003073_si_001.pdf">jm1003073_si_001.pdf (399.28 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1003073&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm1003073%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-12" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1003073" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679961b21aa23d48","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
